Structural Motifs of Novel Metallothionein Proteins by Sutherland, Duncan E K
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
4-25-2012 12:00 AM 
Structural Motifs of Novel Metallothionein Proteins 
Duncan E K Sutherland 
The University of Western Ontario 
Supervisor 
Dr. Martin J. Stillman 
The University of Western Ontario 
Graduate Program in Chemistry 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Duncan E K Sutherland 2012 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Biochemistry Commons, Inorganic Chemistry Commons, and the Molecular Biology 
Commons 
Recommended Citation 
Sutherland, Duncan E K, "Structural Motifs of Novel Metallothionein Proteins" (2012). Electronic Thesis 
and Dissertation Repository. 489. 
https://ir.lib.uwo.ca/etd/489 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
i 
 
 
Structural Motifs of Novel Metallothionein Proteins 
 
(Spine title: Structural Motifs of Metallothionein) 
(Thesis format: Integrated-Article) 
 
 
By 
 
Duncan Ewan Keith Sutherland 
 
Graduate Program in Chemistry 
 
 
Submitted in partial fulfillment of the requirements for the degree of  
Doctor of Philosophy 
 
School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
April, 2012 
 
 
 
 
© Duncan Ewan Keith Sutherland 2012
ii 
 
School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
 
CERTIFICATE OF EXAMINATION 
 
 
 
 
The thesis by 
Duncan Ewan Keith Sutherland 
entitled: 
Structural Motifs of Novel Metallothionein Proteins 
is accepted in partial fulfillment of the requirements for the degree of  
Doctor of Philosophy 
 
 
Date         
 Chair of the Thesis Examination Board 
Supervisor 
 
 
 
Dr. Martin Stillman 
Examiners 
 
Dr. Yining Huang 
 
Dr. John Honek 
 
Dr. Ken K.-C. Yeung 
 
Dr. Graeme Hunter 
 
 
 
iii 
 
ABSTRACT 
Metallothioneins (MT) are a family of small cysteine rich proteins, which since their 
discovery in 1957, have been implicated in a range of roles including toxic metal 
detoxification, protection against oxidative stress, and as a metallochaperone involved in 
the homeostasis of both essential zinc and copper.  The most well studied member of the 
family is the mammalian MT, which consists of two domains: a β-domain with 9 cysteine 
residues, which sequesters 3 Cd
2+
/Zn
2+
 or 6 Cu
+
 ions, and an α-domain with 11 cysteine 
residues, which sequesters 4 Cd
2+
/Zn
2+
 or 6 Cu
+
 ions.  Despite over half a century of 
research, the exact functions of MT are still unknown but must be related to its metalation 
status.  Several areas that are not well studied, but that could lead to the assignment of 
function include 1) the determination of the exact mechanism of metalation and the  
structural characterization of 2) submetalated and 3) supermetalated forms of MT.  
Together these three areas of study will provide a more comprehensive understanding of 
the potential metalation chemistries of MT in vivo. 
Towards this goal, the following thesis presents electrospray ionization mass 
spectrometric (ESI MS) data showing that the mechanism of metalation of MT is 
noncooperative.  That is metalation events occur independently of each other, allowing 
for partially metalated species to exist in vivo.  Further metalation studies using the 
isolated domains of MT as metal ion competitors against the full MT protein have yielded 
evidence that a new Zn5-MT exists in which both domains ‘coalesce.’  In addition, NMR 
and CD spectroscopy, coupled with ESI mass spectrometric data, have shown the 
existence of a new ‘supermetalated’ Cd8-MT, which also results in a ‘coalescence’ of 
both domains.  Taken together these results indicate that 1) partially metalated forms of 
the protein are in fact stable and 2) the traditional structural view of MT, where both 
domains act in isolation, is in fact the exceptional case and that under conditions of metal 
ion deficiency and excess, both domains interact with each other. 
Keywords:  Metallothionein, cadmium, zinc, mechanism of metalation, competitive 
metalation, metal-induced folding, supermetalated metallothionein, ESI mass 
spectrometry, NMR spectroscopy, CD spectroscopy 
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Chapter 1. Introduction
1
 
1.1 Metallothionein  
Metallothioneins (MTs) are a group of metalloproteins characterized by their small 
size (~6,000 – 7,000 Da), high cysteine content, an absence of disulfide bonds, and a lack 
of aromatic amino acids (1).  Metallothioneins bind strongly to the monovalent Group 11 
and the divalent Group 12, d
10
 metals.  The effect of binding to these soft Group 11 and 
12 metals on the cysteinyl thiols is to reduce the pKa of the cysteines by up 6 orders of 
magnitude.  As a consequence, the cysteine sulphurs bind to the metals as thiolates.  Key 
to the discussion is that the formation of these metal-thiolate (cysteine) bonds dominates 
the secondary structure of the protein, so that we may describe the secondary and tertiary 
structures present in the native metalated protein as arising primarily as a result of metal-
induced folding.   
MT was initially isolated by Margoshes and Vallee in 1957 from samples of horse 
kidney cortex that through progressive purification showed an increase in relative 
cadmium content (2).  The protein was named metallothionein for its unusually high 
metal (metallo) and sulphur (thiol) content (3).  Since its discovery, members of the MT 
family have been isolated from a wide array of sources including all animal phyla, fungi, 
plants, as well as cyanobacteria (4).  Owing to both the high cysteine content of these 
proteins (~30%) and their presence in all organisms, MT is implicated in a number of 
physiological processes.  The most commonly cited processes are metal ion homeostasis, 
toxic metal detoxification, and protection against oxidative stress. 
Mammalian MTs comprises 20 cysteine residues that act to encapsulate two metal-
thiolate cores (β and α) using a combination of bridging and terminal thiolates (where 
terminal defines coordination to only a single metal ion) from the cysteinyl residues 
(Figure 1-1).  The two separate domains form a dumb-bell-like structure in the crystal 
first described from analysis of the X-ray diffraction data from rat liver MT (5). The β-
                                                 
1
 A version of this work has been published: 
Reproduced with permission from D.E.K. Sutherland and M.J. Stillman Metallomics 3 
(2011) 444-463.  Copyright 2011 Royal Society of Chemistry. 
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domain with 9 cysteine residues is capable of binding 3 Cd
2+
 or Zn
2+
, or 6 Cu
+
 and an α-
domain with 11 cysteine residues capable of binding 4 Cd
2+
 or Zn
2+
, or 6 Cu
+
.  Molecular 
modeling and later experimental data from solution studies suggests that the two domains 
are not isolated but rather somewhat coalesced.  MT binds a wide range of metals with 
similar stoichiometries, but we may consider them not to be ‘natural’.  We describe these 
additional binding motifs below.  A common thread in the mammalian MTs is, however, 
the formation of the two metal-thiolate clusters where a mixture of metals can bind in 
each domain and where the metals in either domain can be different.  The question of the 
extent of domain interaction in the function of MTs is a current topic of intense research. 
 
Figure 1-1.  Molecular model structure of Cd7-βα-rhMT.  (A) Space filling 
structure of cadmium metalated recombinant human MT-1a (Cd7-βα-rhMT 1a) calculated 
using molecular modeling.  The N-terminal β domain is located on the left hand side, 
while the C-terminal α domain is located on the right-hand side.  (B) The cadmium-
cysteinyl-thiolate connections, both terminal and bridging, in Cd7-βα-rhMT 1a are 
presented as a ball-and-stick model: β domain (left) and α domain (right).  The α domain 
has one bridging and one terminal thiolate labeled to clearly illustrate the different modes 
of coordination. (C) Connectivity diagram of human metallothionein 1a, which shows 
that each of the seven cadmium atoms is connected to exactly four cysteine amino acids 
in a tetrahedral arrangement.  In the nomenclature used here, the 'recombinant' source is 
noted by a prefix of 'r', and the origin of the sequence is indicated by the second prefix, 
here 'h' for human.  Molecular modeling data from Chan et al. (6).   
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The MT family contains a number of isoforms (and subisoforms) where the 
complement of these is organism dependent.  In particular, mammals contain four MT 
subfamilies that have been proposed to exhibit specific roles (7):  MT-1 and MT-2 in the 
liver and kidneys, which are induced by a number of stimuli including metal ions, 
glucocorticoids, cytokines and oxidative stress (4, 8-9), MT-3, primarily found in the 
central nervous system (10), and MT-4, found in certain stratified squamous epithelial 
tissues (11).  While a number of stimuli can induce expression of both MT-1 and MT-2, 
the expression of MT-3 and MT-4 is more strictly controlled.  Presumably, differences in 
expression are the result of both MT-3 and MT-4 having specific biological functions.  
To support the proposal for specificity of function, disruption of the natural expression of 
MT-3, through ectopic expression in mice, has been shown to cause pancreatic acinar cell 
necrosis and death (12). 
1.2 Function 
1.2.1 Metal ion homeostasis 
Naturally occurring MTs are usually isolated as either Zn-MT, Cu-MT or as the mixed 
metal species Zn,Cu-MT and Zn,Cd-MT.  In the case of mammals, Zn-MT is the 
dominant form (13), however, Cu-MT has been isolated from several sources including 
fetal liver MT (14-15), bovine calf liver MT (16), rat kidney (17), as well as brain 
specific MT-3 (10).  Elevated Cu-MT levels have also been found in patients suffering 
from Wilson’s disease (18).  While in the case of yeast and fungi, Cu-MT is the dominant 
species (19). 
At the cellular level both toxic and nontoxic metals are tightly controlled and estimates 
of free Cu
+
 and Zn
2+
 suggest that neither is available in the cytosol (20-21).  The absence 
of freely available Cu
+
 and Zn
2+
 suggests that an organism is able to exist in this state by 
using metallochaperones to transport these ions in a controlled manner.  MT is considered 
one such metallochaperone, which is capable of transporting essential Zn
2+
 and Cu
+
 to 
apo-enzymes (22-25).  Indeed metal exchange experiments have been conducted in which 
Zn
2+
 from Zn7-βα-MT has been transferred to Zn-dependent enzymes, for example, m-
aconitase (22), carbonic anhydrase (23), and the prototypical transcription factor (24), 
4 
 
 
Gal4.  Removal of Zn
2+
 from the zinc finger-containing transcription factor Sp1 
demonstrates that MT may also act as a Zn
2+
 acceptor (25).  It should be noted that zinc 
fingers are structural motifs that coordinate one or more Zn
2+
 ions to stabilize their 
protein fold.  Thus this natural association of MT with the biologically essential Zn
2+
 and 
Cu
+
 has suggested that one of the functions of MT is the maintenance of metal ion 
homeostasis.  While metal exchange to apo-enzymes requiring these metals has been 
reported, no mechanistic details have emerged yet about how the metal transfer takes 
place. 
Support for the role of MT as a metallochaperone is found in the transcription of DNA 
to RNA, which has been shown to be strongly controlled by exposure to metal ions, for 
example in yeast (26-27), Drosophila (28) and mammals (29-31).  In the case of 
mammals, of the four isoforms (MT-1 to -4) only two (MT-1 and MT-2) are strongly 
upregulated by metal ions.  Induction of inducible MT isoforms requires both the 
interaction of a metal response element (MRE) with a metal response element binding 
transcription factor 1 (MTF-1).  MREs are cis-acting DNA sequences necessary and 
sufficient for metallothionein expression under heavy metal load (29, 32).  MTF-1 is a 
zinc binding protein that contains six Cys2-His2 zinc fingers, the presence of these zinc 
fingers, along with differences in their respective affinity, make MTF-1 exquisitely 
sensitive to changes in the concentration of zinc in a cell (33-34).  Cell free transcription 
experiments have shown a number of stresses, including exposure to Cd
2+
, Cu
+
 and H2O2 
function by displacing naturally bound  Zn
2+
 from MT (35).  These free Zn
2+
 ions bind to 
MTF-1 leading to a translocation of MTF-1 from the cytoplasm to the nucleus where the 
Zn-MTF-1 interacts with MREs leading to upregulation of MT.  In this way, MT is 
capable of countering and deactivating a wide range of insults in order to return an 
organism to homeostatic balance. 
1.2.2 Toxic metal detoxification 
The proposed detoxifying properties of MT were inferred from metal analysis of 
samples isolated from human kidneys (36).  These samples contained significant amounts 
of excess Cd
2+
 and some Hg
2+
, the presence of Hg
2+
 being traced back to the use of 
therapeutic mercurial diuretics.  In addition to Cd
2+
 and Hg
2+
, MT is generally understood 
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to coordinate all the group 11 and 12 metals, and is also capable of binding to other 
metals including: Co
2+
, Pb
2+
, Pt
2+/4+
, Fe
2+
, As
3+
, Bi
3+
 and Tc
5+ 
(37-41).  The binding 
affinities of MT for metal ions follows closely with the association constant of metal ions 
for inorganic thiolate ligands (Hg
2+
 > Cu
+ 
> Cd
2+ 
> Zn
2+
).  Thus MT preferentially 
coordinates many toxic metals and ultimately this coordination leads to the release of 
Zn
2+
, which acts to upregulate the production of MT and returns an organism to 
homeostatic balance. 
The requirement for and the toxicological effects of excess Zn
2+
 have been well 
documented (42).  MT knockout studies have highlighted the importance of this protein 
in the homeostasis of Zn
2+ 
(43).  For example, MT-null mouse pups fed severely deficient 
Zn
2+
 diets, showed delays in kidney development when compared to wild-type controls.  
These pups lacked a hepatic reservoir of zinc critical for proper development.  On the 
other hand, MT-null adult mice challenged with increased Zn
2+
 showed a greater 
incidence of pancreatic acinar cell degeneration.  In this case, MT is able to act as a 
temporary sink to accommodate the influx of Zn
2+
.  These results demonstrate that MT is 
critical in protecting an organism from the extremes of Zn
2+
 exposure, acting as both a 
source and a sink for Zn
2+
 during deficiency and excess, respectively. 
Copper toxicity is also of considerable interest, because unlike zinc, free copper is able 
to catalyze the formation of hydroxyl radicals through Haber-Weiss and Fenton reactions 
(42).  Significant regulation of copper transport in humans relies on two homologous 
copper transport proteins: namely, ATP7A and ATP7B (44).  Mutations to ATP7A result 
in Menkes disease, where copper accumulates in the kidneys and intestinal wall, while 
the brain, serum and liver do not receive adequate amounts (45).  A murine model of 
Menkes disease involving MT-1 and -2 knockout mice demonstrated that in the absence 
of inducible MT, knockout mice were more susceptible to copper toxicity (46).  The 
second disorder, Wilson’s disease, resulting from mutations to ATP7B, is characterized 
by the accumulation of copper in the liver leading to cellular damage and release of free 
copper into the blood serum (44).  Cellular damage is somewhat mitigated by the 
accumulation of copper in the form of Cu-MT (18, 47).  In this manner, MT is able to 
sequester Cu
+
, and with 20 thiol groups can act as a reducing agent to further protect 
against oxidative stress (48-49). 
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Chronic cadmium poisoning significantly affects the kidneys.  Traditionally, the 
nephrotoxicity of Cd
2+
 exposure was thought to be the result of a transfer of Cd-MT from 
the liver to the kidneys with subsequent degradation leading to a high local concentration 
of Cd
2+
.  Indeed liver transplant studies aimed at monitoring Cd-MT levels have shown a 
time dependent decrease in Cd-MT present in the liver with concomitant increase of Cd-
MT present in the kidneys (50).  Further complicating the problem, recent studies have 
demonstrated that MT knockout mice are hypersensitive to Cd
2+
, while only 
accumulating 7% Cd
2+
 compared to their wild-type mice.  However, it is not a paradox 
that MT-knockout mice only accumulate little Cd
2+
, but are sensitive to Cd
2+
.  Little 
accumulation in knockout mice would suggest that free Cd
2+
 is travelling directly to the 
kidneys and subsequently harming the organ.  These results indicated that MT enhances 
the accumulation of Cd
2+
 in the kidneys but that it also significantly reduces the 
associated toxic effects (51).  It should be noted at this point that retention of Cd
2+
 in 
humans is primarily attributed to MT and that the biological half-life of Cd
2+
 in the 
human body is on the order of several decades (52-53). 
MT knockout mice, in which both MT-1 and MT-2 were inactivated, experience 
enhanced hepatic Cd
2+
 poisoning, but under control conditions these MT-null mice were 
viable and reproduced normally (54).  These results suggest that MT acts to buffer the 
toxic effects of Cd
2+
 to an organism by sequestering the Cd
2+
, likely leading to the release 
of Zn
2+
, which would act to upregulate MT.  To further support the buffering role of MT, 
wild-type mice given increasing doses of Cd
2+
 developed a tolerance to Cd
2+
 lethality, as 
evidenced by a 7-fold increase in the LD50 (55).  While under the same conditions, the 
LD50 of MT-null mice was unaffected.  These pretreatment experiments underscore the 
importance of not only MT in toxic metal detoxification, but also the total MT pool in an 
organism. 
The ability of methylmercury (MeHg
+
) to induce neurotoxic effects in a cell is related 
to the amount of MT present, with increasing amounts directly attenuating the associated 
toxic effects.  The astrocyte is thought to play a pivotal role in MeHg
+
 mediated death, 
because it expresses three times as much MT as its associated neurons and could 
potentially function as a buffer to protect these neurons, and consequently the organism, 
from toxic insult (8-9, 56).  Surprisingly MeHg
+
 is not capable of directly inducing MT in 
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spite of its large affinity for thiol groups.  We consider that MT, binding metals in a 
noncooperative fashion, will coordinate MeHg
+
 through the available thiols found in any 
of the partially metalated forms (57-59). 
1.2.3 Protection against oxidative stress 
The high thiol content of MT makes it an ideal molecule to interact with and inhibit 
reactive oxygen species (ROS).  Indeed, animal studies, in which cardiac specific MT is 
overexpressed, have shown that MT functions to protect against oxidative stress, 
specifically in the inhibition of ischemia-reperfusion induced myocardial injury (60-61).  
MT is upregulated by ROS through the antioxidant response element (ARE), a promoter 
region on the MT gene, ARE-binding transcription factors, as well as MTF-1.  Perhaps 
the most well known reactivity of MT is that with air leading to oxidation of the cysteine 
residues and subsequent formation of sulfonic acid and disulfide bonds.  Metal free (apo-) 
MT is particularly susceptible to oxygen, and metalation experiments should be carried 
out under strictly anaerobic conditions.   
Nitric oxide has also been shown to increase the intracellular release of Zn
2+
 through 
the oxidation of Zn-MT in mouse lung fibroblasts (62).  In vitro analysis of the oxidation 
products of the three isoforms (MT -1, -2, and -3), suggests the mechanism of oxidation 
of each is different.  In the case of mouse MT-1, the β-domain metals are exclusively 
released (63), while the products from the oxidation of rabbit MT-2 show a more 
distributed release pattern (64), and finally, for human MT-3 a long lived Cd2-α-domain 
intermediate exists when nitric oxide induces oxidation of the protein (65).  It is probable 
that these differences in metal release are the result of the distinct functions of each 
isoform under nitrosative stress.  Both cell free and cell culture studies of Zn-MT in the 
presence of H2O2 have also shown that MT is capable of acting as an antioxidant leading 
to release of Zn
2+
, which acts to upregulate MT through MTF-1 (35, 66-67).   
Metal ions are a significant source of ROS cellular chemistry with both copper and 
iron capable of producing hydroxyl radicals (68).  Zn-MT is capable of inhibiting the 
production of copper catalyzed hydroxyl radicals in vitro.  With 20 cysteine residues, MT 
is capable of reducing Cu
2+
 to Cu
+
, after which it can be coordinated with high affinity to 
MT. 
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As a reducing agent that readily coordinates Zn
2+
, a proposed function of MT is 
sensing the presence of incoming oxidants.  In this redox cycle, an ROS oxidizes MT 
leading to Zn
2+
 release (49, 69).  This Zn
2+
 is responsible for upregulating Zn-dependent 
proteins through MTF-1.  Either reduction of the previously oxidized MT with 
glutathione, or complete replacement with de novo MT then leads to a reestablishment of 
zinc homeostasis.  In this manner, MT may either directly interact with the ROS, or in 
cases where ROS production is the result of a metal ion that readily coordinates MT, such 
as copper, MT may act to sequester the metal ion and effectively neutralize ROS activity. 
1.3 Structural Characterization 
X-ray diffraction results have been reported from just two crystals, the first successful 
example was for rat Cd5Zn2-MT-2 (5), and the second was for yeast Cu8-MT (70).  It 
should be noted that MT has been described as being notoriously difficult to crystallize, 
and much of our structural knowledge is the result of the many NMR-based studies 
reported.  Structures based on analyses of the NMR data have been reported from several 
mammalian sources (71-74).  These structures provide the absolute connectivities of all 
atoms and their spatial relationship with the metal-thiolate core but not the alignment of 
the linkage between the two domains.  The domain alignments were determined from the 
X-ray diffraction studies for the rat liver Cd5,Zn2-MT (5).  In the case of the X-ray crystal 
structure of rat Cd5Zn2-MT-2 species, all metal centres were tetrahedrally coordinated by 
cysteinyl-thiolates; later, when compared to the NMR structure, both showed identical 
molecular architectures (75).  A comparison of the NMR-based structures of human Cd7- 
and Zn7-MT-2 has shown overall maintenance of cluster geometry and demonstrated that 
MT can accommodate metal ions of varying size (76).  The ability of Cd
2+
 to replace Zn
2+ 
isomorphously is exploited in many experiments due to several advantageous properties 
of the cadmium-thiolate cluster, such as the availability of 
113/111
Cd NMR active isotopes, 
as well as the red shifted ligand-to-metal charge transfer band in the optical spectrum.   
Copper(I) is capable of coordinating with a range of geometries depending on the 
Cu(I) : MT stoichiometric ratio.  Digonal and trigonal geometries were found in the X-
ray diffraction structure of the Cu-MT from yeast (70).  While no mammalian Cu-MT X-
ray diffraction structure exists, spectroscopic data have demonstrated the existence of 
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both a Cu12-MT and a Cu15-MT for the two-domain, rabbit liver MT 2a, the former likely 
being mainly copper coordinated in a trigonal geometry, while the latter is likely a 
mixture of trigonal and digonal geometries (77).  In addition to these fully metalated 
structures, a copper folding intermediate in the β-domain, Cu4-MT, has been isolated for 
both rat liver MT-1 and mouse MT-3 but is of unknown coordination geometry (78).  It is 
probable that this intermediate is related to the mixed metal species, Cu4Zn4-MT-3, 
thought to a critical product in controlling the oxidative damage caused by the Cu
+
/Cu
2+
 
redox cycle in Alzheimer’s disease (79).  Previous NMR metal exchange experiments, in 
which Cd
2+
 was reacted with calf liver Zn4,Cu3-MT-1 and -2 have shown that cadmium 
ions could only displace the zinc ions (16).  Based on the NMR chemical shifts, it was 
concluded that these zinc ions were almost exclusively located in the α-domain, while the 
copper ions were located preferentially in the β-domain.  From these results it has been 
proposed that MT is capable of separating metal types into different domains, essentially 
isolating the chemistry of both essential zinc and copper. 
While NMR spectroscopy and X-ray diffraction studies have yielded the most 
significant information about the structure of MT, other techniques have also greatly 
contributed including CD, emission and Raman spectroscopy.  In the case of CD 
spectroscopy, the ligand-to-metal charge transfer is strongly affected by the chirality of 
the protein and changes to the chirality can affect the signal observed (80-81).  For 
example, due to exciton coupling in mammalian MT, a typical spectrum has the cross-
over of the derivative envelope centered at ~250 nm, however upon supermetalation 
exciton coupling is broken and a CD band maximum at ~250 nm is now observed (82-
83).  In this way, one is able to infer that the metal coordination of both clusters is 
symmetric and that supermetalation results in a loss of this symmetry.  Emission 
spectroscopy is also useful and in the case of copper emission is most intense when 12 
equivalents of Cu
+
 have been added forming Cu12-MT.  Loss of emission intensity past 
12 equivalents of Cu
+
 added to rabbit liver MT demonstrates that the protein is opening 
and assuming a less compact and more porous form (84).  Raman spectroscopy is also 
gaining interest because of its ability to determine the oxidation state of cysteine residues, 
the identity of coordinating ligands and finally identification of cysteine residues that 
could be modified by radical attack (85).  These techniques, while not as structurally 
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specific as NMR spectroscopy, X-ray absorption spectroscopic methods or X-ray 
diffraction studies, provide useful information that help in the determination of the 
dynamic structures of MT and further our understanding of its overall function(s). 
1.4 Zinc and Cadmium binding to MT 
Zinc is critical to the continued health of an organism and is required for the proper 
functioning of a number of enzymes and transcription factors.  With 5-20% of all cellular 
Zn associated with MT, structural motifs of Zn-MT are of critical importance (86).  
Exposure of an organism to cadmium will negatively affect the health of an individual, 
including both liver and kidney damage.  Cadmium is also a known carcinogen, capable 
of both inhibiting several DNA repair systems, as well as indirectly producing ROS to 
further DNA damage (87-88).  Perhaps the most well known disease associated with 
cadmium poisoning is Itai-Itai, made famous by mass cadmium poisoning in Toyama 
Prefecture, Japan, and most strikingly characterized by an increase in bone brittleness 
leading to an increased incidence of fractures (89).  While it may seem initially odd to 
include Zn
2+
, an essential element, with Cd
2+
, a toxic metal, both share similar 
coordination geometries.  This is best demonstrated by NMR spectroscopy that has 
shown an almost identical protein fold when either metal is bound and a significant 
portion of the structural information known is derived from Cd-MT (76). 
For both Zn
2+
 and Cd
2+
, the most well characterized form of MT is mammalian, with 
an N-terminal β-domain containing 9 cysteine residues and a C-terminal α-domain 
containing 11 cysteine residues.  The traditional number of metals bound to the full 
protein are 7 metal ions, 3 in the β-domain (Zn3- or Cd3-β-MT) and 4 in the α-domain 
(Zn4- or Cd4-α-MT).  More recent evidence points towards a new supermetalated form of 
the protein that is discussed in Chapters 5 and 6. 
Several studies have together provided compelling evidence that the two domains of 
mammalian MT are structurally independent.  To illustrate, the 
113
Cd chemical shifts of 
the isolated α-domain are remarkably similar to those of the full protein indicating that 
the complete loss of the β-domain does not affect, to a large extent, the environment of 
the α-domain (90).  While NMR structural studies from several MT sources, including 
mouse (74) and human (72), show a lack of interdomain peaks associated with the 
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nuclear overhauser effect (NOEs), which would strongly suggest that the fully metalated 
domains are independent of each other.  It is possible that the independence of the two 
domains is critical to the function of MT.   
The initial proton NMR studies of MT demonstrated that in the absence of metal 
binding the structure was a random coil (although we note that proposed models of the 
apo-MT support the presence of a motif-like structure), however, upon addition of either 
Cd
2+
 or Zn
2+
 the structure became significantly more rigid (91-93).  Further analysis of 
the chemical shifts of cadmium atoms, as well as the splitting pattern, lead to the 
determination of the stoichiometry of the polynuclear clusters: Cd3S9 and Cd4S11 (90, 94-
97).  Since these initial studies, solution structures have been determined from a number 
of MT sources including mammalian (human, rat, rabbit and mouse) (71-76), plant (98) 
and cyanobacteria (99).  The critical step in the determination of the overall structure of 
mammalian MT was the X-ray crystallographic structure showing an identical molecular 
architecture to the previously determined NMR structure but with the alignment of the 
two domains now defined (5).   
1.5 Copper binding to MT 
Copper is vital for the continued health of all organisms.  Copper induced toxicity is of 
considerable interest and its dyshomeostasis can lead to a number of diseases including 
Wilson’s disease and Menkes disease (44).  Unlike zinc, free copper is redox active and 
able to catalyze the formation of hydroxyl radicals through Haber-Weiss and Fenton 
reactions (42).  A murine model of Menkes disease involving MT-1 and MT-2 null mice 
have shown enhanced sensitivity to copper toxicity (46).  In the case of Wilson’s disease, 
a marked increase in Cu-MT has been demonstrated (18, 47).  These two examples 
emphasize the importance of MT in maintaining health through the control of transient 
fluctuations in Cu
+
 availability (42, 100). 
In the case of copper, it has been reported that there exists a preference for its 
accumulation in the β-domain of mammalian MT before binding under thermodynamic 
control in the α-domain.  In essence, this would allow simultaneous involvement of both 
Zn
2+
 and Cu
+
 in the homeostatic functioning of the organism.  This dual nature of the 
metal-binding properties of MTs could be critical to the brain specific MT-3 and its 
12 
 
 
interactions with the protein Aβ1-40-Cu
2+
, a producer of reactive oxygen critical to 
Alzheimer’s disease (79, 101).  In this fashion Zn7-MT-3 is capable of deactivating Aβ1-
40-Cu
2+ 
by exchanging Cu
2+ 
for Zn
2+
.  Following this exchange Cu
2+
 is reduced and 
sequestered specifically into the β domain of MT-3. 
Emission spectroscopy has been particularly useful in studying Cu
+
 binding to MT.  
The first such study was for the fungus Neurospora crassa (102). Since this initial study, 
both equilibrium and kinetic emission data have been reported for both Cu
+
 and Ag
+
 
binding to different MTs.  In these studies, excitation of Cu
+
 at 300 nm leads to a spin 
forbidden transition of 3d
103d94s1, or alternatively 3d103d94p1, with subsequent 
emission from a long-lived state at a wavelength significantly red shifted from the initial 
excitation band (near 600 nm for Cu
+
 and 570 nm for Ag
+
).  Because the emission 
intensity is dependent on the environment of the metal ion, any changes in this intensity 
as a function of metal stoichiometry is the result of the dynamics of protein folding. 
The spectroscopic data (absorption, CD and emission) indicate that for the two-
domain βα-MT-2a protein that there exist two significant saturation points, the “magic 
numbers” of copper binding, with Cu(I) : MT ratios (i) of 12 and (ii) of 15 (77).  Each 
domain is independently capable of binding 6 Cu
+
 ions leading to the formation of metal 
clusters with the stoichiometry Cu6S9 and Cu6S11 for the β- and α-domains, respectively 
(103-104).  Domain mixing experiments have shown the fluctionality of these clusters as 
Cu
+
 ions located in the α-domain migrate to the β-domain displacing metal ions of 
weaker affinity in the process.  Interestingly, the emission of Cu12-βα-MT formed by the 
stepwise addition of Cu
+
 to a solution of Zn7-βα-MT is very time and temperature 
sensitive (77, 84).  These results demonstrate that the initial Cu
+
 binding is distributive 
without particular preference for either the α- or β-domain, which is the kinetic product of 
metalation.  Given sufficient time and thermal energy, rearrangement of the protein leads 
to preferential accumulation of Cu
+
 in the β-domain. 
An unusual species was identified during titrations of Cd7-MT 2 with Cu
+
.  The 
spectroscopic maxima were found for a mixed metal species with 12 Cu
+
 and four Cd
2+
, 
Cd4Cu12-MT.  It was proposed that the 4 Cd
2+
 were mixed with 6 Cu
+
 in the α domain 
and the remaining 6 Cu
+
 were bound in the β domain (77).  Like Hg18-MT 2 (see below), 
it is possible that this species is in fact a single domain species. 
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To summarize, “the magic numbers” of the metalation of MT with Cu+ are 6 for the 
isolated β- and α-domains and 12 and 15 for the full protein.  When multiple metals are 
present both Cu9Zn2-MT and Cu12Cd4-MT form.  Interestingly, Cu
+
 has a preference of 
the β-domain, which has been used to interpret the location of Cu+ in many of these 
species.  
1.6 Mercury binding to MT 
Mercury has no known physiological role and environmental exposure can come in 
several forms including elemental mercury (Hg
0
), inorganic mercury (Hg
2+
 and Hg2
2+
) 
and organic forms of mercury, such as methylmercury (CH3Hg
+
), and toxicity is greatest 
for the alkylated species.  Mercury has long been associated with MT, with early 
copurification attributed, in part, to the therapeutic use of mercurials (36).  MT-null mice 
have been instrumental in demonstrating the protective role of MT against Hg
 
induced 
toxicity (105-108).  It should be noted that like CH3Hg
+
, Hg
0
 is lipid soluble and can 
cross the blood brain barrier, where it can be oxidized to Hg
2+
 with catalase and H2O2 
(109).  MT has a critically important role in protecting an organism against 
methylmercury poisoning, and pretreatment experiments in which administration of MT 
inducers (Zn
2+
 and Cd
2+
) caused an increase in the tolerance of astrocytes against toxic 
methylmercury insult (56, 110-111).  The above examples highlight the importance of 
MT in the maintenance of neurological health. 
A significant body of work has been produced describing not only the structurally 
significant stoichiometries of Hg-MT, but also the factors that influence their formation, 
such as time, temperature, presence of MT coordinated metals and the identity of the 
counter ions used in Hg
2+
 addition (112-115).  Four saturation points have been 
spectroscopically observed including Hg7-, Hg11-, Hg18-, and Hg20-MT.  The latter, 
having a very weak CD spectrum, is likely the result of a complete unwinding of the 
protein leading to a random coil with Hg
2+
 coordinated in a linear fashion.  The most 
notable technique used in titrations of MT with Hg
2+
 to date is CD spectroscopy.  The 
technique measures the difference between left and right circularly polarized light caused 
by the chirality of the chromophore.  In this case, the chirality of the ligand-to-metal 
charge transfer of each mercury-thiolate cluster is measured.  Because the metals that 
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bind MT form predefined structures that exhibit specific chirality, CD spectroscopy is 
extremely sensitive in monitoring the metalation of MT.  The CD bands specifically 
probes the metal-cysteine binding site structure because the chirality arises from a 
combination of the chiral wrapping of the peptide chain around the binding site and the 
exact energy of the ligand-to-metal charge transfer band (LMCT band).  The energies of 
the LMCT depend on the coordination number of the Hg
2+
 and, therefore, on the structure 
adopted at a each specific Hg(II) : MT stoichiometric ratio.  Changes in the wavelength 
of bands and the band morphologies in the CD spectrum as a function of Hg
2+
 loading 
indicate changes in binding site geometry as a function of the Hg
2+
 stoichiometric ratio. 
While the metalation reactions of MT by Hg
2+ 
have been studied for apo-MT, Zn-MT 
and Cd-MT, the importance of MT in zinc chemistry suggests that the displacement of 
Zn
2+
 by Hg
2+
 in MT is the most biologically relevant.  It should be noted that: 1) 
displacement of Cd
2+
 in Cd-MT is the result of a distributive metalation, in which Hg
2+
 
binds statistically to both the β- and α- domain, and 2) the metalation of apo-MT with 
Hg
2+
 follows a very similar pattern to that measured when Hg
2+
 is added to Zn-MT with 
the singular exception that in the early stages of the reaction no isolated HgSR4 units are 
observed. 
Hg18-βα-MT-2 from rabbit liver has been reported to be a structurally significant 
species, where it was proposed that each Hg
2+
 atom adopts a pseudotetrahedral structure, 
each with two bridging thiolates and outlying chloride anions (113, 115).  The necessity 
for Hg
2+
 to be coordinated to two cysteine residues and chloride ions has been confirmed 
by XAFS measurements (116).  In this way, each Hg
2+
 atom is effectively stacked on the 
others leading to the formation of one large domain instead of two smaller ones.  
Interestingly this species may only be formed from isoform 2, unless isoform 1 is first 
lyophilized and then dissolved in acid.  Formation of Hg18-βα-MT-2 has been attributed 
to residues 38-40, where the unique presence of two consecutive proline residues allows 
the twisting of the protein to accommodate a single domain structure.  In the case of 
lyophilized protein, breaking of the solvent-protein bonds allows an alternate 
conformation to be adopted in acid, which upon addition of Hg
2+
 leads to the formation 
of Hg18-βα-MT-1.  We will return to the formation of a single-domain species in Chapter 
6, but to summarize the “magic numbers” of Hg2+ to MT binding are 7, 11 and 18. 
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1.7 The mechanism of metalation of MT 
In recent years there has been considerable debate regarding the mechanism of 
metalation of MT (57-59, 117-118).  Specifically, do the metals bind in a noncooperative 
manner, that is one at a time, or do they bind in a cooperative manner, that is all-or-
nothing?  Briefly a noncooperative mechanism of metalation implies that the binding of 
one metal ion is independent of the others, and as such, throughout metalation a decrease 
in the association constants is related to a decrease in the number of available sites.  
While a cooperative mechanism of metalation implies that binding of one metal 
facilitates the binding of further metals leading to an increase in the association constants. 
The mechanism of metalation has significant consequences for our understanding of the 
protein and its interactions with the cellular environment.  For example, several MT 
polymorphisms have been linked to the longevity of certain human groups, with both low 
Zn-MT levels and satisfactory Zn
2+
 bioavailability being good markers for human health 
(119-121).  Exposure of this mutant MT to nitric oxide, resulted in less Zn
2+
 release 
compared to the wild-type.  If the Zn
2+
 binds to MT in a cooperative fashion, then one 
can infer that the mutant is inherently less reactive, however if Zn
2+
 binds to MT in a 
noncooperative fashion, then there is potential that a large pool of partially oxidized MT 
exists.  In both cases, the mechanism of metalation, and the potential for partially 
metalated species taking part in cellular chemistry has significant consequences in the 
understanding of the relationship between Zn
2+
 bioavailability, MT and the overall health 
of an individual. 
Early research supported a cooperative mechanism of metalation.  For example, a 
titration of 
113
Cd
2+
 with MT, as monitored by 
113
Cd-NMR, demonstrated the apperance of 
only fully metalated MT and no intermediates (118).  If the metals were to bind 
sequentially, then one would have predicted the appearance and disappearance, as a 
function of the amount of 
113
Cd
2+
 added to solution, of 
113
Cd-NMR signals associated 
with isolated tetrahedral cadmium-thiolates.  The absence of those signals, and the 
presence of only signals associated with fully metalated Cd7-MT, would suggest a 
cooperative mechanism of metalation.  However, this assumes that the isolated 
tetrahedral cadmium-thiolate units are not significantly mobile. 
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A significant problem with studying metalation reactions with metals that are 
biologically relevant to the chemistry of MT, such as Zn
2+
, Cd
2+
 and Cu
+
, is that these are 
d
10
 metals, and consequently are chromophorically silent in many spectroscopies.  In such 
cases, researchers have, until recently, been limited to the ligand-to-metal charge transfer 
bands in the optical spectrum (using absorption, emission, circular dichroism (CD) and 
magnetic circular dichroism (MCD) techniques) making their coordination properties 
difficult to study.  One way to overcome this problem, involves using Co
2+
 as a 
spectroscopic probe for Zn
2+
.  The metalation of apo-MT to form Co7-MT is of interest, 
because the results indicate that for the binding of at least the first three Co
2+
 atoms, the 
spectroscopic signature indicates the presence of isolated Co-tetrathiolate units within the 
MT binding site.  As further Co
2+
 is added, both electronic absorption, EPR and 
1
H NMR 
spectra indicate thiolate bridging occurs as the coordination remains tetrahedral by 
sulphur (122-123).  These results are significant in that if MT were to bind metal ions in a 
cooperative fashion then cluster formation would be immediate upon addition of Co
2+
 
leaving a significant fraction of the protein in the unmetalated apo-MT state.  The 
experimental data indicate that cluster formation requires the addition of several 
equivalents, and consequently binds Co
2+
 in a noncoooperative manner. 
Recently the technique of ESI-mass spectrometry, which detects each unique protein 
species with a different mass-to-charge ratio, has allowed the study of dilute protein 
solutions as a function of metal loading; data that complements the optical spectroscopic 
data.  Using this technique, two papers have provided evidence for the mechanism of 
metalation of MT to occur in a noncooperative fashion.  Specifically, the addition of Cd
2+
 
to MT-3 (59), the brain specific isoform, and the α-domain of MT-1 (58).  This data, 
however, cannot be immediately generalized to all mammalian MTs, because unlike MT-
1, -2 and -4, MT-3 has an additional threonine (Thr5) in a TCPCP motif, and a glutamate-
rich hexapeptide near the C-terminal that have both been shown to be critical to its 
function (124-125).  Consequently, the mechanism of MT-1 or -2 will need to be 
determined. 
17 
 
 
1.8 Scope of the Thesis 
The metalation chemistry of MT has typically focused on its fully metalated states, 
that is Zn7- and Cd7-MT.  Consequently the overall structure of this state is well known, 
but such questions as the mechanism of metalation and the mechanism of metal exchange 
have been largely overlooked.  In addition, the respective structures of these submetalated 
and metal exchange intermediates have not been characterized. 
This thesis is composed of seven Chapters.  The first Chapter gives on overview of 
MT, both its functions and its metalation chemistry, with an emphasis placed on the wide 
array of metals that are capable of binding.  Chapter two gives a complete description of 
the recombinant preparation methods of the MT, both the full protein and its isolated 
domains, as well as a brief description of the instrumental techniques (UV absorption, 
CD and NMR spectroscopy, as well as ESI-mass spectrometry and molecular 
mechanics/dynamics) used to probe the metalation reactions of MT.  The remainder of 
this thesis focuses on determining the mechanism of metalation, as well as the metalated 
structures that may exist in vivo.   
Chapter three describes an equilibrium study in which the cooperative nature of the 
metal binding mechanism is explored by examination of the speciation of both the 
isolated β-domain, as well as the full MT protein, using electrospray ionization mass 
spectrometry.  While Chapter four describes the first ever competition reaction between 
the isolated domains and the full MT protein, as well as provide metalation evidence for a 
new Zn5-MT structure that may be a partially metalated stable intermediate.  The results 
from this study are necessary to allow for a generalization of the noncooperative 
mechanism of metalation to all mammalian MT isoforms. 
Chapter five discusses the structural determination of a new Cd4-β-rhMT-1a structure 
by examination of the domain speciation under metal ion excess.  This novel cluster 
arrangement is characterized by CD and UV absorption spectroscopy, ESI mass 
spectrometry and 
113
Cd NMR spectroscopy.  Chapter six extends these excess metal ion 
studies to the full MT protein, and provides evidence for the existence of a novel Cd8-βα-
rhMT-1a structure, in which both domains act to coordinate the eighth metal ion.   
Finally, Chapter seven draws together the result of these studies, presented in Chapter 
three through six, and discusses them with respect to the known functions of MT. 
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Chapter 2. Methods for Preparation and 
Characterization of Recombinant MT
2
 
2.1 Introduction  
Metallothionein (MT) was first isolated from horse kidney cortex in 1957.  This first 
isolation of MT relied upon retaining the cadmium content present in kidney homogenate 
following a series of purifications.  In fact, early in vitro studies of MT relied upon 
purification from natural sources, the most well studied of which were those from 
mammalian sources including, human, rabbit, and horse.  These purification protocols 
relied upon rigorous and time consuming metal ion injection procedures, where the lab 
animal was euthanized and the organ of interest, usually the liver or the kidney, was 
isolated with subsequent MT extraction.  Studies on human MT were further complicated 
by the necessity to isolate MT from cadavers.  The above described procedure, while 
inefficient, is well suited for studying MT isoforms -1 and -2, because both can be 
induced by a number of stimuli including metal ions, glucocorticoids, cytokines and 
oxidative stress.  However expression of other MT isoforms, MT-3 and MT-4, are more 
strictly controlled.  This restriction is a contributing factor to their relatively late isolation 
and discovery.   
Modern studies rely heavily on recombinant protein expression systems, where the 
MT of interest is grown and isolated from a non natural source, for example human MT 
grown and purified from Escherichia coli (E. coli).  In these systems, the MT gene has 
been inserted into a host organism, which will produce significant quantities of the 
protein.  There are several advantages when compared to isolation from natural sources, 
including enhanced purity and efficiency.  MT from natural sources is composed of a 
mixture of isoform that must be separated using lengthy chromatographic methods.  
Since only a single isoform is inserted into the host system, these purification steps are 
avoided.  By using recombinant protein expression systems, unusual MT proteins have 
                                                 
2
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Diseases and Metalloproteins (Brown, D., Davies, P. Eds.) Pan Stanford Publishing, 
Chicago. [ISBN: 9789814316019].  Copyright 2011 Pan Stanford Publishing. 
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been designed, including single domain studies (β or α-rhMT) and different domain 
combinations (αβ-, ββ-, βββ-, αα- and ααα- rhMT).  There are, however, several 
disadvantages to these systems including necessary alterations of the MT-protein 
sequence to enhance expression and addition of peptide sequences, for example S-tag 
purification system, to the protein in order to allow for efficient purification from the cell 
lysate.  Finally, there is also the potential for post-translational modifications that may 
significantly alter the chemical properties of the protein. 
In this Chapter, the recombinant protein preparation is described for the production of 
the isolated β- and α-domains, and full MT protein of isoform 1a referred to as β-rhMT, 
α-rhMT and βα-rhMT, respectively.  A brief description of the instrumental techniques 
used to characterize MT and its domains are also provided. 
2.2 Recombinant Expression and Purification of MT 1a  
2.2.1 Materials and solution preparation 
Materials 
Table 2-1 provides a list of the chemicals and biological agents used in the preparation 
of MT and its isolated domains.  All experiments described throughout this thesis used 
these compounds. 
Solutions preparation 
All solutions were prepared with deionized water (di-H2O) with a resistivity greater 
than 14 MΩ•cm (Barnstead, Dubuque, IL, USA).  The kanamycin antibiotic solution was 
prepared by adding di-H2O to 0.5 g of solid kanamycin to a final volume of 10 mL (50 
mg/mL final conc.).    Large particulate was then removed by filtering the kanamycin 
solution through 0.2 μm syringe filters.  The filtrate was separated into 1 mL aliquots in 
sterile Eppendorf tubes and stored in a freezer at -20 ⁰C.  The isopropyl-β-D-
thiogalactoside (IPTG) was prepared by adding di-H2O to 2.38 g of solid IPTG to a final 
volume of 10 mL (1 M final conc.).  This solution was then separated into 0.7 mL 
aliquots in sterile Eppendorf tubes and stored in a freezer at -20 ⁰C.  The LB Miller Broth 
was prepared by adding 25 g to each of the 4-Fernbach flasks containing 1 L of di-H2O 
and lightly sealed with aluminum foil.  The LB Agar gel was prepared by adding di-H2O 
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to 4 g of agar to a final volume of 100 mL.  This solution was lightly sealed with 
aluminum foil.  In order to sterilize the solutions, both the LB Miller Broth and Agar 
were autoclaved for 20 min at 121 ⁰C.  When the LB Agar was warm to the touch, 
kanamycin antiboitc solution was added (final conc. 50 μg/mL).  The LB Agar was 
poured into disposable sterile Petri dishes and the gel was allowed to solidify to room 
temperature.  These dishes were parafilmed and stored in a fridge at 4 ⁰C. 
Table 2-1. Chemical and biological reagents used. 
CHEMICAL F. W. 
(g/mol) 
GRADE SUPPLIER 
Ammonium Formate, NH4COOH 63.06 Reagent J. T. Baker 
Ammonium Hydroxide, NH4OH 
 
35.05 Reagent Caledon 
BL21(DE3) Strain of E. coli  Biotech  
Cadmium sulfate, 3CdSO4•8H2O 769.56 ACS Fisher 
Cadmium(113)chloride, 
113
CdCl2 183.9 >96% Trace Sciences 
International 
Formic Acid (88%), HCOOH 46.03 Reagent Caledon 
Hydrochloric Acid, HCl 36.46 Reagent Caledon 
Isopropyl-β-D-thiogalactoside 238.31 Biotech Fisher 
Kanamycine, monosulfate, 
C18H36N4O11•H2SO4 
582.58 Biotech EMD 
LB Agar, Miller  Biotech Difco Laboratories 
LB Broth, Miller  Biotech Fluka Analytical 
Sephadex G-25 Fine  Biotech Amersham 
Biosciences 
Thrombin CleanCleave™ Kit  Biotech Sigma-Aldrich 
Tris(2-carboxyethyl)phosphine (TCEP), 
C9H15O6P 
286.65 Reagent Sigma-Aldrich 
Tris(hydroxymethyl)aminomethane (Tris), 
(CH2OH)3CNH2 
121.14 Reagent EMD 
Zinc sulfate, 3ZnSO4•7H2O 287.56 ACS Caledon 
 
MT was purified from the cell homogenate by using an SP ion exchange column and 
required four solutions:  10 mM Tris-HCl, pH 7.4 (Solution A), 10 mM Tris-HCl + 1 M 
NaCl, pH 7.4 (Solution B), 350 mM ammonium formate (Solution C), and di-H2O 
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(Solution D).  All four buffers were prepared by dissolving the appropriate amount of 
chemical into di-H2O and the pH was adjusted using either concentrated hydrochloric, 
formic acid, or ammonium hydroxide.  The pH of the solutions was monitored using a pH 
meter (Accumet Basic AB15, Fisher Scientific, Ottawa, ON, Canada) with an Accumet 
Semimicro pH electrode.  MT can readily oxidize upon exposure to oxygen.  To impede 
oxidation of the cysteine residues to disulfide bonds by oxygen, all solutions were 
rigorously evacuated and argon saturated. 
Metallothionein Transformed Bacterial Cells 
The MT DNA was provided by Peter Kille (Cardiff, Wales) and transformed by Jayna 
Chan, Christie Vermieren and Thanh Ngu (U.W.O).  The following sections briefly 
discuss the MT construct and describe in detail, the growth, isolation and purification of 
MT from bacterial cells.  
The DNA constructs of the isolated β- and α-domains and the full MT protein 
engineered from human MT 1a (Table 2-2).  The pET-29a plasmids (Novagen/EMD 
Biosciences, San Diego, CA, USA), which the MT protein and its isolated domains were 
transformed into, contained a kanamycin-resistance gene allowing selective growth of 
bacteria that have taken up the plasmid.  This plasmid contains an S-tag™ 
(Novagen/EMD Biosciences) upstream of the MT DNA sequence.  Consequently, all 
expressed protein will be S-tag fusion proteins with the tag attached to the N-terminus.  
Plasmids were transformed into competent E. coli BL21(DE3) cells (Novagen/EMD 
Biosciences).  All transformed cell lines were grown to an optical density of 0.6 and 
stored in a 50% (v/v) solution of glycerol at -80 ⁰C. 
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Table 2-2. Amino acid sequences used in study.  Amino acid sequence of human 
MT 1a (hMT-1a), recombinant human MT 1a (rhMT-1a), the isolated β-domain of 
human MT 1a (β-rhMT-1a), the isolated α-domain of human MT 1a (α-rhMT-1a) and 
finally the S-tag used to stabilize the expression of the MT protein.  The N-terminus is 
located on the left hand side, while the C-terminus is located on the right.  Colour legend: 
Red – cysteine residues, Green – inserts to align sequences of different lengths, blue – 
modified amino acids found in constructs.  
 
 
2.2.2 Overexpression of Recombinant Cd-Metallothionein 
The protocol for MT, and its isolated domains, preparation is presented in Figure 2-1.  
It should be noted that this protocol allows for the production of metalated Cd-MT, 
specifically Cd7-βα-rhMT, Cd3-β-rhMT and Cd4-α-rhMT.  From the glycerol stocks, a 
small portion of frozen cells were plated onto room temperature agar plates containing 50 
μg/mL (final conc.) kanamycin sulfate. The presence of the antibiotic ensures that only 
cells that have been transformed with the MT plasmid will grow.  These plates were kept 
overnight at 37 ⁰C.  To four 2 L Fernbach flasks, 1 L of sterilized LB liquid media was 
added, as well as kanamycin and CdSO4 to a final concentration of 50 μg/mL and 50 μM, 
respectively.  The CdSO4 was added to ensure that any MT grown prior to induction 
would be stabilized and it also provided a secondary selective pressure for bacteria that 
express MT.  The cells were transferred into the LB liquid media and placed in an 
incubator-shaker at 37 ⁰C and 150 rpm to facilitate aeration of the cells.  Protein 
expression was induced at an optical density of 0.5-0.6 at 600 nm, which corresponds to 
the mid-log phase of the bacterial growth cycle.  At this point, IPTG was added to a final 
concentration 0.7 mM to induce MT expression.  The cells were allowed to express MT 
for 30 min, at which point additional CdSO4 was added to solution to a final total CdSO4 
concentration of 200 μM. 
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2.2.3 Isolation and purification of recombinant Cd-metallothionein 
Following growth, the cells were isolated by centrifugation at 8,983 g for 15 min using 
an Avanti J-series centrifuge (Beckman-Coulter, Mississauga, ON, Canada) with a JLA-
9.1000 rotor. At this point the LB broth supernatant was discarded and the cell pellet was 
resuspended in a deoxygenated 10 mM Tris-HCl solution, pH 7.4.  The cells were lysed 
using a French press and were centrifuged at 20,442 g for 1 hr using a JLA-25.50 rotor to 
remove the cellular debris.  Typical yields were 10 mg of protein per 1 L of LB broth.   
The supernatant was loaded onto a Hi Trap™ SP Sepharose™ HP cation exchange 
chromatographic cartridge.  The elution was monitored using the ligand-to-metal charge 
transfer (LMCT) transition of SCd of MT by UV absorption spectroscopy.  The 
cartridges were washed with solution A that had been argon saturated to remove the 
cellular components that were weakly associated to the column.  Following this wash, a 
stepwise increase in the amount of solution B from 0% to 5% in 1% increments removed 
more tightly bound complexes.  Cd-MT elutes at 5% (50 mM) NaCl.  At this point, the 
salt concentration is increased to 30% in order to remove the protein in as small a volume 
as possible.  A small aliquot of the protein was desalted into 5 mM ammonium formate in 
order to determine the purity by electrospray ionization mass spectrometry.  The protein 
was subsequently concentrated to an 8 mL fraction using the stirred ultrafiltration cell 
(Amicon Bioseparations/Millipore, Bedford, MA, USA) with a YM-3 cellulose 
membrane (3,000 MWCO) under pressure by an inert gas (in this case nitrogen) to avoid 
oxidation of the protein through oxygen exposure.   
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Figure 2-1. Protein preparation protocol for all metallothioneins used. 
2.2.4 Cleavage of the S-tag from recombinant Cd-metallothionein 
Both the isolated domains, and the full MT protein, were expressed with a 27 amino 
acid S-tag (Table 2-2 Figure 2-2) attached to the N-terminus of the recombinant protein.  
This tag has been observed to aid in the stability of the MT protein during expression 
(personal communication with Professor Peter Kille).  For all subsequent experiments, 
the S-tag is cleaved using a Thrombin CleanCleave™ Kit.  This kit contains bovine 
34 
 
 
Thrombin immobilized onto agarose beads.  There are two optimal cleavage sites for the 
thrombin enzyme: The first is P4-P3-Pro-Arg/Lys•P1’-P2’, where P4 and P3 are 
hydrophobic residues and both P1’ and P2’ are non-acidic residues.  The scissile bond is 
the Arg/Lys•P1’.  The second is P2-Arg/Lys•P1’, where P2 or P1’ is a glycine residue 
and Arg/Lys•P1’is the scissile bond.  Figure 2-2 shows that the Thrombin enzyme 
cleaves M7-βα-rhMT 1a at an Arg-Gly bond.  One consequence of this cleavage site is 
that there remain 2 amino acids, glycine and serine, from the S-tag. 
The thrombin suspension was purchased as immobilized agarose beads (Thrombin 
CleanCleave™, Sigma) to facilitate separation from the recombinant protein without the 
need for chromatographic steps.  The thrombin-agarose slurry was stored at -20 ⁰C in a 
50 % (v/v) solution of glycerol and 20 mM Tris-HCl, pH 8.0.  Use of the thrombin-
agarose beads requires two cleavage buffers, 500 mM Tris-HCl, pH 8.0, 100 mM CaCl2 
(10X cleavage buffer) and a 50 mM Tris-HCl, pH 8.0, 10 mM CaCl2 (1X cleavage 
buffer), both of which were rigorously bubbled with argon and evacuated immediately 
prior to use.  The resin was washed by pelleting the beads by centrifugation at 500 g for 5 
min using an Eppendorf centrifuge 5418 (Eppendorf North America, Inc., Westbury, 
NY).  The supernatant was removed and the beads were resuspended in an equal volume 
of 1X cleavage buffer.  The cells were again pelleted and resuspended in 1X cleavage 
buffer to insure complete removal of glycerol. 
To the resuspended beads, 10% (v/v) of 10X deoxygenated cleavage buffer was added 
directly to the Thrombin slurry.  The protein and a magnetic stir bar were added to the 
Thrombin solution, evacuated and sealed under Argon.  The mixture was stirred at 4 ⁰C 
overnight.  The beads were removed by centrifugation at 500 g for 5 min and were 
washed with deoxygenated 1X cleavage to ensure complete removal of the beads.  The 
supernatant from both the initial cleavage and the wash, which contained the protein and 
the S-tag, were pooled. 
A fine G-25 Sephadex size-exclusion column was equilibrated with deoxygenated 10 
mM Tris-HCl, pH 7.4.  The protein solution was loaded onto this column and desalted.  
The protein/S-tag mixture was subsequently loaded onto the SP ion exchange column at a 
rate of 3 mL/min.  All solutions used for the SP ion exchange column are identical to 
those used to purify the recombinant MT from the cell homogenate.  The column was 
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washed with solution A and monitored using UV absorption spectroscopy.  While MT 
requires a solution of 10 mM Tris, pH 7.4 and 50 mM NaCl to elute from the column, the 
S-tag does not adhere strongly and can be eluted by simply washing the column with 
solution A.  Once the UV absorption profile showed that no peptide was being eluted, the 
composition of solution B in the eluent was increased from 0% to 5%, with a concomitant 
decrease in the composition of solution A from 100% to 95%.  This increase facilitates 
the removal of any remaining S-tag, as well as other proteins that may bind weakly to the 
column.  At 5% solution B both the full MT protein, or the isolated fragments, begin to 
elute from the column.  This is observed by an increase in the absorption at 250 nm 
corresponding to the LMCT of the S  Cd bonds in the metal-thiolate clusters.  The 
composition of solution B in the eluent is immediately increased to 30%.  This allows 
complete removal of either MT or its isolated clusters in a minimum volume.  The 
cleaved protein collected from the SP column was concentrated using stirred 
ultrafiltration cell model 8200 (Amicon Bioseparations/Millipore) with the YM-3 
membrane (3,000 MWCO) to 8 mL.   
All cleaved protein was subjected to both mass spectrometric and UV absorption 
spectroscopic analysis.  In the former, electrospray ionization mass spectrometry 
provided the mass of the protein plus any bound Cd
2+
 ions.  The observed mass always 
corresponded well with the theoretical mass.  There were several instances in which a 
loss of amino acids was observed.  In these cases, ESI-mass spectrometric analysis 
revealed the identity of the missing amino acids.  UV absorption spectroscopy provided 
an estimate of the concentration of either of the isolated domains, or the full MT protein.  
2.2.5 Preparation of  metal-free recombinant metallothionein 
A sample of thrombin cleaved metal-free (apo-) MT was prepared by decreasing the 
pH of metalated Cd3-β-, Cd4-α- and Cd7-βα-rhMT to 2 through the stepwise addition of 
concentrated HCl.  The pH was monitored using pHydrion® pH paper (Micro Essential 
Laboratory, Inc.).  A deoxygenated fine G-25 Sephadex size-exclusion column was used 
to remove the previously bound Cd
2+
 ions.  The eluent buffer was chosen to suit the final 
experiment.  For example, apo-MT prepared for electrospray mass spectrometry, was 
exchanged into di-H2O pH adjusted to 2.7 with concentrated formic acid.  Unlike Cd-
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bound MT, apo-MT has no LMCT and metal free fractions were monitored by UV 
absorption at 220 nm.  A small aliquot of buffer exchanged MT was remetalated using 
CdSO4 and the LMCT was monitored in order to determine the apo-protein 
concentration.  The demetalated MT was subsequently evacuated, capped and backfilled 
with argon in order to remove the bulk of oxygen in the sample.  Exposure to oxygen 
oxidizes MT and samples prepared in this manner may last for up to several weeks. 
 
 
Figure 2-2 A connectivity diagram of MT 1a.  This shows that each of the seven 
cadmium atoms is connected to exactly four cysteine amino acids.  The connectivity 
diagram has been renumbered to accommodate the amino acids glycine and serine, both 
of which are a product of S-tag cleavage with Thrombin, located on the N-terminal of the 
β-domain. 
2.2.6 Preparation of  113Cd-recombinant metallothionein 
To a sample of deoxygenated metal-free (apo-) MT 1a, solid 
113
CdCl2 was added 
directly to the solution at a ratio that would lead to complete metalation for either of the 
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isolated domains (3 or 4 Cd
2+
 per β or α-rhMT, respectively), or the full MT protein (7 
Cd
2+
 per βα-rhMT 1a).  The solution was neutralized by the stepwise addition of 
deoxygenated concentrated ammonium hydroxide.  MT spontaneously remetalates when 
neutralized.  The solution is then rigorously evacuated to remove any oxygen that may 
have entered the solution.  A fine G-25 Sephadex size-exclusion column was buffer 
equilibrated with 5 mM ammonium formate that had been pH adjusted to 7.4 with 
deoxygenated concentrated ammonium hydroxide.  The isotopically enriched MT sample 
was then desalted into the 5 mM ammonium formate solution, pH 7.4 in order to remove 
any excess salt of 
113
Cd
2+
 ions that may be present.  The solution was then concentrated 
to 8 mL using an Amicon stirred ultrafiltration cell model 8200.  The MT solution was 
further concentrated to 1-2 mL using an Amicon stirred ultrafiltration cell model 8010.  
The final concentration was determined by UV absorption spectroscopy through a 
thousand fold dilution of an aliquot of the isotopically enriched MT sample.   
2.3 Instrumental Techniques 
Metallothionein binds a wide array of metals, ranging from physiologically crucial 
metals, such as Zn
2+
 and Cu
+
, to the toxic metals, such as Cd
2+
 and Hg
2+
.  We outline 
several techniques, which have been critical to the understanding of metal binding.  
Critical to this thesis include UV absorption, circular dichroism and nuclear magnetic 
resonance spectroscopy, as well as electrospray ionization mass spectrometry.  A brief 
overview of these techniques and the information that can be extracted from them is 
discussed.  A section describing the computational modeling that was used to calculate 
the qualitative models of supermetalated MT is also presented. 
2.3.1 UV absorption spectroscopy 
Metallothionein exhibits a number of characteristic spectroscopic signatures that 
depend on the type of metal bound.  Because of the lack of either aromatic amino acids or 
a defined secondary structure, such a β sheet or an α helix, in the apo-form (1-2) it is far 
easier to measure spectroscopic properties that are entirely dependent on both the type 
and number of metals bound, than is the case with many metalloproteins (3-5).  UV-
visible absorption and circular dichroism spectroscopies have been the key techniques in 
38 
 
 
the determination of the relative affinities of metallothioneins for metal ions, the mode of 
metal coordination and possible stoichiometries of these metals.  In particular, the lack of 
aromatic amino acid residues allows UV absorption spectroscopy to monitor the ligand-
to-metal charge transfer bands above 220 nm without interference.  These techniques are 
widely used to monitor metalation reactions of d
10
 metals, such as Zn
2+
, Cd
2+
, Hg
2+
, Cu
+
 
and Ag
+ 
(6-11).  Typically, a titration with a metal ion leads to a change in the UV 
absorption spectrum of the solution demonstrating either binding of the metal to the metal 
free protein, or, alternatively displacement of an already present metal. The former is 
used to determine binding stoichiometries for high affinity metals, while the latter can be 
used to determine binding affinity and possible mixed metal species.  If, however, the 
incoming metal ion has a low binding affinity, then caution should be taken in directly 
correlating a spectroscopically-determined maximum with a particular metal binding 
stoichiometry. 
 
 
Figure 2-3. UV absorption spectroscopy of rabbit liver metallothionein 2 (βα-
rlMT-2) as a function of increasing additions of aliquots of Cd
2+
.  The concentration 
of protein was 10 μM, while spectra were recorded at pH 7.  There are 11 lines: line 1, 
apo-βα-rlMT-2 at pH 2; line 2, apo-βα-rlMT-2 at pH 7; lines 3-11 for apo-βα-rlMT-2 
with different concentrations of Cd
2+ 
(1.06, 2.14, 3.5, 5.0, 5.95, 6.05, 6.92, 7.61, and 8.82 
molar equivalent).  It should be noted that as the amount of Cd
2+
 added to the solution 
increases, the absorbance at 250 nm increases as well.  The inset represents changes in 
the intensity as monitored by the ligand-to-metal charge transfer band of cadmium 
thiolate at 250 nm, as a function of molar equivalents of Cd
2+
 added.  Adapted from (12) 
with permission from ASBMB Copyright 1987. 
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Figure 2-3 shows a classical titration of rabbit liver apoMT-2 with Cd
2+
 monitored by 
UV-absorption spectroscopy between 210 and 290 nm (12).  Initially, the absorbance is 
associated with the protein backbone, the metal-free apo-MT.  However, upon addition of 
Cd
2+
 a shoulder forms at 250 nm, which corresponds to the ligand-to-metal charge 
transfer of cadmium-thiolate bonds.  The UV absorbance at 250 nm is at a maximum at 7 
Cd
2+
 atoms, corresponding to fully metalated Cd7-βα-MT-2.  Complete binding of the 
Cd
2+
 ions is the result of the high affinity of cysteinyl sulfurs for Cd
2+
, 6.0x10
21
 – 1025.6 
M
-1 
(13-14).  While the stoichiometry of metal binding may be extracted from UV 
absorption spectra, it is the CD spectra that clearly show changes in the metal-binding 
sites indicative of a transition from individual CdS4 sites to the formation of the 
polynuclear clusters (15).  The maximum of seven Cd
2+
 per βα-MT has been confirmed 
by ESI-MS measurements for MTs from many different mammalian sources, for 
example, human MT (16-17).  In the case shown in Figure 2-3, we see a slight reduction 
in absorbance at 250 nm, which has been interpreted as due to non-specific Cd
2+
 
associating with the protein.  That these ions do not change the CD band envelope 
morphology is strong evidence that the Cd7S20 domain structure is not directly affected. 
While metallothionein is key in the cellular homeostasis of both Zn
2+
 and Cu
+
, as d
10
 
metals, their spectroscopic signatures are essentially limited to the ligand-to-metal charge 
transfer bands (thiolate to Zn
2+
 and thiolate to Cu
+
).  On the other hand, metalation of 
metallothionein using metal ions with an incomplete d shell allows dd transitions to be 
monitored.  These transitions are sensitive to the coordination geometry of the metal 
atom, and coupled with information provided by the ligand-to-metal charge transfer 
bands, can allow assignment of both the coordinating ligands and the metal binding 
geometry.  In the following three examples of Co
2+
, Ni
2+
 and Fe
2+
, a maximum metal 
binding stoichiometry of 7 metal atoms has been determined spectroscopically.  The 
spectral data for the binding of Co
2+
 to metallothionein demonstrates that the protein 
enforces a distorted tetrahedral arrangement in which the α-domain has more tetrahedral 
character than the β-domain (18-21).  The spectroscopic data for Ni2+ binding to 
metallothionein does not have distinct dd transitions, however, the spectrum was 
similar to Ni
2+
 bound to azurin, and this suggests a tetrahedral coordination.  Fe
2+
 has also 
been shown to bind in a tetrahedral manner, with a dd transition in the near infrared 
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region (22).  While these metals may not be naturally associated with the protein, their 
spectroscopic characteristics are useful in determining the flexibility of the protein in 
accommodating different metals. 
2.3.2 Circular Dichroism (CD) spectroscopy 
CD spectroscopy is an extremely valuable method used to measure the difference in 
absorption between left- and right-circularly polarized light caused by chirality in the 
chromophore as a function of the wavelength of light used.  This method is highly 
sensitive to conformations of optically active chiral molecules.  Traditionally in 
biochemistry, the CD technique has been used to determine the extent of secondary 
structure of a protein, such as α-helices, β-sheets and turns in the protein, or the status of 
complexation based on the relative differential absorbance of the amino acids in the 
peptide chain.  In this manner the effects of denaturing agents, temperature, potential 
ligands and mutations can be readily and reliably monitored. 
In MT much greater structural sensitivity is found in the CD spectrum, because the 
metals that bind form structurally significant binding sites that exhibit specific chirality 
and cause the protein to fold into a predefined structure (Figure 2-2).  These chiral 
structures are composed of the metal ion and the thiolate donor atoms of the cysteine 
residues.  The ligand to metal charge transfer transitions in MTs are easy to measure 
above 230 nm because they occur in the region of the electronic spectrum devoid of the 
usual transitions associated with aromatic amino acids.  This window region has allowed 
detailed spectroscopic analyses of the metalation reactions of MT to be carried out for the 
d
10
 metals that are otherwise chromophorically-silent.  The CD spectrum of MT to the red 
of 220 nm is completely dependent on the binding of metal ions. 
Possibly the first CD spectrum of MT was published for Zn,Cd-βα-MT (23).  In 
subsequent studies of the rabbit liver Cd7-βα-MT-2a, it was reported that the morphology 
of the CD spectrum resembled a derivative shape with the cross-over point aligned with 
the 250 nm band of the SCd2+ ligand-to-metal charge transfer (12, 24-25).  The origin 
of this morphology was explained by Stillman et al. as resulting from exciton coupling 
between pairs of Cd
2+
 ions in the α-domain through the interpretation of CD spectral 
changes that took place following the titration of Cd
2+
 into rabbit liver Zn7-βα-MT-2a 
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(12).  That this CD band envelope represented a specific metalated structure was again 
demonstrated when the supermetalated Cd5-α-hMT-1a was formed (26).  Figure 2-4 
shows the titration of human Cd3-β-MT-1a with excess Cd
2+
 to form the Cd4-β-MT-1a 
species, also the associated ESI-MS and 
113
Cd NMR support the formation of a new 
species.  It is in this way that CD data may act as a fingerprint for the determination of 
specific metalated species in MT. 
Because of the utility of the CD technique, CD spectroscopic studies have been 
reported for a wide variety of metals (11), including Ag-MT (27-28), Cu-MT (6, 24, 29-
31), Zn-MT (6, 12, 25, 31-32), Cd-MT (6, 12, 24-25, 29), and Hg-MT (8, 33-34).  In this 
thesis, CD spectroscopy is used to investigate changes in the chirality of both the isolated 
β-domain and full MT protein upon binding of an additional Cd2+ ion to form Cd4-β-
rhMT (Chapter 5) and Cd8-βα-rhMT (Chapter 6), respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-4 Circular dichroism spectral changes observed upon titrating human 
Cd3-β-rhMT with an additional 4.4 molar equivalents of Cd
2+
 to form Cd4-β-rhMT.  
Adapted from Sutherland et al.(35).  
 
2.3.3 Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR spectroscopy is one of the most powerful techniques used to analyze the 
structure and dynamics of metalloproteins.  It should be noted that MT has been 
described as being notoriously difficult to crystallize, and much of our structural 
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knowledge is the result of many NMR-based studies.  Structures based on analyses of the 
NMR data have been reported from several mammalian sources.  These structures 
provide the absolute connectivities of all atoms and their spatial relationship within the 
metal-thiolate core. Specifically, structural studies of metallothionein have focused 
largely on 
111/113
Cd binding.  There are several advantages to using Cd
2+
 to study the 
metalation of metallothionein including the natural presence of Cd
2+
 in metallothionein 
(36), Cd
2+
 having a similar coordination geometry to Zn
2+
, and enhanced resistance to 
oxidation due to Cd
2+
 having a high affinity for thiolates. 
Both isotopes (
111/113
Cd) have a spin of ½: 
111
Cd has a natural abundance of 12.75% 
but a relative sensitivity to 
1
H (
1
H = 1) of only 9.54×10
-3
, while 
113
Cd has a natural 
abundance of 12.26% and a relative sensitivity of 1.09×10
-2
.  The increased relative 
sensitivity of 
113
Cd compared with 
111
Cd makes the former isotope more widely used.  
The chemical shift range of 
113
Cd has been recorded for a number of structurally 
characterized 
113
Cd-substituted metalloproteins (37).  With a chemical shift range of 
roughly 900 ppm (relative to 0.1 M Cd(ClO4)2), each 
113
Cd is extremely sensitive to the 
coordinating ligands: heptacoordinate oxygen ligands are the most shielded, while 
tetrathiolate ligands are the most deshielding. 
Enrichment with 
113
Cd leads to an eight-fold enhancement of sample sensitivity over 
those measurements based upon natural abundance 
113
Cd.  This enhancement allows for 
data acquisition on low concentration (mM) samples in a reasonable amount of time.  
Samples can be prepared by demetalation at low pH, followed by removal of metal ions 
using gel filtration, and finally, remetalation using isotopically enriched 
113
CdCl2.  It 
should be stressed at this point that the high concentrations of a typical NMR sample 
have been reported to cause dimerization.  Further complicating this issue are reports 
suggesting that demetalation through the use of strong acid leads to structural changes in 
metallothionein itself.  As such, NMR spectral data should be correlated with other 
spectroscopic techniques (above), as well as spectrometric techniques, such as ESI-MS 
(below), which do not necessarily rely on either acid-induced demetalation or the large 
concentrations necessary for this technique (38-40). 
Through an analysis of both the 1-D 
113
Cd-NMR chemical shifts and splitting patterns, 
the structures of the polynuclear clusters within MT were determined. These experiments 
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identified the coordinating ligands as cysteinyl-thiolates and formulated the polynuclear 
centers as Cd3S9 and Cd4S11, corresponding to the β-domain and α-domain, respectively 
(41-44).  While 1-D 
113
Cd-NMR spectroscopy provides key information regarding the 
number of Cd
2+
 ions bound and their respective coordinating ligands, these experiments 
are resource intensive, requiring several days of acquisition.   
A newer NMR method that is being used extensively in MT studies is Heteronuclear 
Single Quantum Coherence (HSQC), which provides increased sensitivity by using easily 
observed nuclei, such as 
1
H, to obtain NMR information on insensitive nuclei, such as 
113
Cd.  A 
1
H{
113
Cd} HSQC experiments polarizes a 
1
H nuclei and transfers that 
polarization to 
113
Cd J-coupled  nuclei.  The signal is then allowed to evolve, and the 
polarization is transferred back to the 
1
H nuclei, where acquisition occurs.  A sensitivity 
increase of γ1H/γ113Cd, where γ is the magnetogyric ratio of the nuclei in question, is 
theoretically possible.  
1H nuclei have a magnetogyric ratio, γ1H, of 267 radians/Tesla and 
113Cd nuclei have a magnetogyric ratio, γ113Cd, of 59.6 radians/Tesla.  From this 
combination of nuclei one can theoretically expect an additional 4.5-fold increase in 
sensitivity.  Additionally, it may be possible to determine some of the terminal and 
bridging cysteine residues, where terminal coordination defines a cysteine residue bound 
to a single Cd
2+
 ion.  The experiment may also provide some discriminatory evidence 
towards either a one- or two-domain model.  Perhaps most importantly, good quality 
spectra are possible within a 12 hr period, as opposed to the much longer timescales of 
the 
113
Cd 1-D NMR. 
In this thesis, both 1-D and 2-D NMR spectroscopies are used to investigate Cd3- and 
Cd4-β-rhMT 1a (Chapter 5) and Cd7- and Cd8-βα-rhMT 1a (Chapter 6).  Specifically, 1-D 
NMR spectroscopy provides the number of unique Cd
2+
 ions, while 2-D NMR 
spectroscopy is used to determine the identity of different Cd
2+
 ion.  In both cases, the 
chemical shift provides information about the identity of the coordinating ligands. 
2.3.4 Electrospray Ionization Mass Spectrometry (ESI-MS) 
Electrospray ionization mass spectrometry (ESI-MS) measures the mass-to-charge 
ratio (m/z) of analytes, and because the ionization method allows the infusion of the 
analyte directly from solution, this method has become critical to many metallothionein 
44 
 
 
binding experiments.  Unique to this technique is its ability to determine not only the 
number of metals bound but also the types of metals bound, which allows for a direct 
correlation between the spectroscopy and speciation of a sample.  A brief description of 
the technique, followed by how data is interpreted, will allow for a better understanding 
of its usefulness in studying the complex metal binding properties of metallothioneins. 
In the ESI-MS experiment, a sample in solution is introduced, under atmospheric 
pressure, into the tip of the electrospray capillary (Figure 2-5).  This tip is electrically 
charged to several thousand volts and causes the solution to accumulate positive charge.  
Enrichment of the tip with positive ions leads to the formation of a Taylor cone, which 
ejects small positively charged droplets.  Solvent evaporation decreases the radius of the 
droplet, while the charge remains constant.  When Coulombic forces, due to the nearness 
of positively charges ions, overcome the surface tension, fission of the droplet occurs.  
Evaporation-fission events repeat until very small charged droplets are produced.  
Eventual formation of the multiply charged protein is thought to occur via the charged 
residue model (CRM) (45-46).  The CRM mechanism of gas phase ion formation states 
that the small highly charged droplet will evaporate to dryness leaving any unpaired ions 
as adducts to the protein.  Since each droplet will have varying numbers of charges, a 
distribution of mass-to-charge ratios will be observed.  The charge state distribution is 
directly related to both the number of basic sites on the protein, as well as the size of the 
protein, as such any alterations to this size, or site exposure, through folding or through 
denaturation, will lead to changes in the charge state distribution. 
Charged proteins are separated by differences in the m/z ratio; common analyzers 
include the quadrupole and time-of-flight mass analyzers, allowing detection of species 
even with very similar m/z values.  The ESI-MS technique allows for the introduction of 
samples in aqueous solution and at physiological pH.  Folding experiments can be 
conducted, in which the charge state distribution can be directly related to changes in 
sample conditions, such as pH or metal added, and changes in metalation status can be 
monitored by mass changes.  By knowing the concentration of protein, from 
spectroscopic techniques, accurate quantification is possible through a comparison of the 
deconvoluted peaks.  This, however, assumes that all species in solution ionize at the 
same rate, and may not always be true. 
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In the case of MT, metal induced folding experiments may be performed by the 
addition of small aliquots of metal ions to apo-MT (17, 47).  In this way both the number 
of metals bound and changes in the folding of the protein may be observed.  For example, 
Figure 2-6 compares the ESI-mass spectral data for metal-free (apo-) MT 1a recorded 
when 0 and 7.3 eq. Cd
2+
 have been added to solution.  It is immediately obvious that apo-
MT possesses a greater number of charge states (+8 to +5) than Cd7-MT (+6 and +5) and 
indicates that a folding event has occurred.  The speciation of MT in solution may also be 
observed from the deconvoluted spectra, Figure 2-6 (right).  These spectra are the result 
of the analysis of the m/z data, and allow slight shifts in the charge state of the protein to 
be interpreted as the relative populations of differently metalated species.  Consequently, 
the folding of the protein is the result of metalation and has decreased the overall volume 
of space occupied by MT and/or the solvent exposed residues.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-5. Electrospray ionization mass spectrometer.  (A) Instrumental 
configuration of the electrospray ionization mass spectrometer.  Depicted is the ‘Z-spray’ 
configuration of Waters Micromass ESI-MS operating in positive ion mode.  (B) The 
charged residue model for analyte desolvation, where evaporation leads to the deposition 
of unpaired protons on the surface of the protein. 
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Figure 2-6. ESI mass spectra recorded during the titration of MT with Cd
2+
.  (A) 
metal-free (apo)-MT 1a at 0 eq. Cd
2+
 added to solution and (B) Cd6/7/8-MT 1a at 7.3 eq. 
Cd
2+
 added to solution.  Charge states +5’ to +8’ correspond to a less prevalent truncated 
species.   
 
In this thesis, mass spectrometric analysis of MT and its isolated domains is present in 
all Chapters.  Specifically in the Chapters 3 and 4, metal binding reactions of MT 1a 
under equilibrium conditions is used to determine both the mechanism of metal binding 
and the relative affinity of the isolated domains.  A great strength of this technique is in 
allowing the correlation of spectroscopic data with speciation in solution.  In Chapters 5 
and 6, ESI-MS is used to rationalize distinct changes in the spectroscopy of β-rhMT 1a 
and βα-rhMT 1a. 
2.3.5 Computational modeling 
MT is notoriously difficult to crystallize and while structural information has been 
made available in the form of NMR data, these studies require a complete backbone 
assignment of the protein.  The particular isoform studied in this thesis, isoform 1a, has 
not had a complete backbone assignment performed.  Consequently, a complete structure 
for either Cd4-β- (Chapter 5) or Cd8-βα-rhMT 1a (Chapter 6) is not possible at this time.  
In order to circumvent this problem, the work included in this thesis has produced 
tentative models based upon the modified crystal structure of MT isoform 2 reported by 
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Chan et al. (16).  This thesis has used both molecular mechanics and molecular dynamics 
to produce the qualitative structures of supermetalated MT and below is a brief 
description of the computational techniques used. 
 Molecular mechanics (MM) uses Newtonian physics to model molecular system.  All 
atoms in the system are treated as hard spheres with a defined radius and the bonds 
between these atoms are treated as a series of springs with associated lengths and force 
constants.  As an empirical technique, MM relies upon experimental data to construct the 
force field necessary to calculate the structure of the molecule.  The CACHE system used 
for all calculations is based upon parameters published by Allinger for the MM force 
field directly for all elements, except metals (48).  The total energy of the system is given 
by the following equation: 
Etotal = Ebonding + Etheta + Ephi + Eimprop + Eelec + Evdw + EH-bond 
The above terms describe the energies involved in the bond, angles, dihedral angles, 
improper torsions, electrostatic potential, van der Waals interactions, and hydrogen 
bonding, respectively. Common force fields used for biological molecules are Allinger’s 
MM2/3/4 (48-52), CHARMM (53) and AMBER (54-55).   However in bioinorganic 
chemistry, the presence of metal ions necessitates modification of the above force fields 
to account for their presence.  Thus the difficulty lies in obtaining an accurate force field 
for the metal ion, specifically the metal-thiolate bonds found in metallothionein.  The 
force field used in this study was specifically tailored by Chan et al. to take into account 
the cadmium-thiolate bonds present in MT (16, 56). 
Molecular dynamics (MD) uses a classical mechanics approach to simulate the motion 
of the atoms as a function of time according to the temperature and the calculated forces 
exerted on the atoms.  This method allows the user to search for energy minima by 
injecting energy directly into the bonds, causing motion.  At every time-step of the 
dynamic simulation, the potential energy is calculated using molecular mechanics 
(MM/MD).  Conformational slices can be extracted and structurally relaxed by MM.  The 
lowest energy conformer of the supermetalated Cd4-β- and Cd8-βα-rhMT is presented in 
both Chapter 5 and 6. 
48 
 
 
2.4 References 
1. Rigby-Duncan, K. E., and Stillman, M. J. (2006) Metal-dependent protein 
folding: Metalation of metallothionein, J. Inorg. Biochem. 100, 2101-2107. 
2. Rigby, K. E., Chan, J., Mackie, J., and Stillman, M. J. (2006) Molecular dynamics 
study on the folding and metalation of the individual domains of metallothionein, 
Proteins: Struct. Funct. Bioinf. 62, 159-172. 
3. Kagi, J. H. R. (1993) Evolution, structure and chemical activity of class I 
metallothioneins: An overview, Birkhauser-Verlag, Berlin. 
4. Kojima, Y. (1991) Introduction [2] Definitions and nomenclature of 
metallothioneins, Vol. 205, Academic Press, Inc., San Diego. 
5. Kagi, J. H. R., Vasak, M., Lerch, K., Gilg, D. E. O., Hunziker, P., Bernhard, W. 
R., and Good, M. (1984) Structure of mammalian metallothionein, Environ. 
Health Perspect. 54, 93-103. 
6. Presta, A., Green, A. R., Zelazowski, A., and Stillman, M. J. (1995) Copper 
binding to rabbit liver metallothionein: Formation of a continuum of copper(I)-
thiolate stoichiometric species, Eur. J. Biochem. 227, 226-240. 
7. Zelazowski, A. J., Szymanska, J. A., Law, A. Y. C., and Stillman, M. J. (1984) 
Spectroscopic properties of the α fragment of metallothionein, J. Biol. Chem. 259, 
12960-12963. 
8. Leiva-Presa, A., Capdevila, M., and Gonzalez-Duarte, P. (2004) Mercury(II) 
binding to metallothioneins: Variables governing the formation and structural 
features of the mammalian Hg-MT species, Eur. J. Biochem. 271, 4872-4880. 
9. Bofill, R., Palacios, O., Capdevila, M., Cols, N., Gonzalez-Duarte, R., Atrian, S., 
and Gonzalez-Duarte, P. (1999) A new insight into the Ag
+
 and Cu
+
 binding sites 
in the metallothionein β domain, J. Inorg. Biochem. 73, 57-64. 
10. Vasak, M., Kagi, J. H. R., and Hill, H. A. O. (1981) Zinc(II), cadmium(II), and 
mercury(II) thiolate transitions in metallothionein, Biochemistry 20, 2852-2856. 
11. Stillman, M. J. (1995) Metallothioneins, Coord. Chem. Rev. 144, 461-511. 
12. Stillman, M. J., Cai, W., and Zelazowski, A. J. (1987) Cadmium binding to 
metallothioneins:  Domain specificity in reactions of α and β fragments, 
apometallothionein, and zinc metallothionein with Cd
2+
, J. Biol. Chem. 262, 
4538-4548. 
13. Kagi, J. H. R., and Vallee, B. L. (1961) Metallothionein: A cadmium and zinc-
containing protein from equine renal cortex, J. Biol. Chem. 236, 2435-2442. 
14. Zhang, B. L., Sun, W. Y., and Tang, W. X. (1997) Determination of the 
association constant of platinum(II) to metallothionein, J. Inorg. Biochem. 65, 
295-298. 
15. Willner, H., Vasak, M., and Kagi, J. H. R. (1987) Cadmium-thiolate clusters in 
metallothionein:  Spectrophotometric and spectropolarimetric features, 
Biochemistry 26, 6287-6292. 
16. Chan, J., Huang, Z., Watt, I., Kille, P., and Stillman, M. J. (2007) Characterization 
of the conformational changes in recombinant human metallothioneins using ESI-
MS and molecular modeling, Can. J. Chem. 85, 898-912. 
49 
 
 
17. Sutherland, D. E. K., and Stillman, M. J. (2008) Noncooperative cadmium(II) 
binding to human metallothionein 1a, Biochem. Biophys. Res. Commun. 372, 840-
844. 
18. Vasak, M., Kagi, J. H. R., Holmquist, B., and Vallee, B. L. (1981) Spectral 
studies of cobalt(II)- and nickel(II)-metallothionein, Biochemistry 20, 6659-6664. 
19. Vasak, M. (1980) Spectroscopic studies on cobalt(II) metallothionein:  Evidence 
for pseudotetrahedral metal coordination, J. Am. Chem. Soc. 102, 3953-3955. 
20. Good, M., Hollenstein, R., and Vasak, M. (1991) Metal selectivity of clusters in 
rabbit liver metallothionein, Eur. J. Biochem. 197, 655-659. 
21. Vasak, M., and Kagi, J. H. R. (1981) Metal thiolate clusters in cobalt(II)-
metallothionein, Proc. Natl. Acad. Sci. USA 78, 6709-6713. 
22. Good, M., and Vasak, M. (1986) Iron(II)-substituted metallothionein:  Evidence 
for the existence of iron-thiolate clusters, Biochemistry 25, 8353-8356. 
23. Weser, U., Rupp, H., Donay, F., Linnemann, F., Voelter, W., Voetsch, W., and 
Jung, G. (1973) Characterisation of Cd, Zn-thionein (metallothionein) isolated 
from rat and chicken liver, Eur. J. Biochem. 39, 127-140. 
24. Stillman, M. J., and Szymanska, J. A. (1984) Absorption, circular dichroism, 
magnetic circular dichroism and emission study of rat kidney Cd,Cu-
metallothionein, Biophys. Chem. 19, 163-169. 
25. Stillman, M. J., and Zelazowski, A. J. (1988) Domain specificity in metal binding 
to metallothionein.  A circular dichroism and magnetic circular dichroism study of 
cadmium and zinc binding at temperature extremes, J. Biol. Chem. 263, 6128-
6133. 
26. Rigby-Duncan, K. E., Kirby, C. W., and Stillman, M. J. (2008) Metal exchange in 
metallothioneins a novel structurally significant Cd5 species in the alpha domain 
of human metallothionein 1a, FEBS J. 275, 2227-2239. 
27. Zelazowski, A. J., Gasyna, Z., and Stillman, M. J. (1989) Silver binding to rabbit 
liver metallothionein.  Circular dichroism and emission study of silver-thiolate 
cluster formation with apometallothionein and the α and β fragments, J. Biol. 
Chem. 264, 17091-17099. 
28. Zelazowski, A. J., and Stillman, M. J. (1992) Silver binding to rabbit liver zinc 
metallothionein and zinc α and β fragments.  Formation of silver metallothionein 
with Ag(I):protein ratios of 6,12 and 18 observed using circular dichroism 
spectroscopy, Inorg. Chem. 31, 3363-3370. 
29. Vaher, M., Romero-Isart, N., Vasak, M., and Palumaa, P. (2001) Reactivity of 
Cd7-metallothionein with Cu(II) ions: Evidence for a cooperative formation of 
Cd3,Cu(I)5-metallothionein, J. Inorg. Biochem. 83, 1-6. 
30. Roschitzki, B., and Vasak, M. (2002) A distinct Cu4-thiolate cluster of human 
metallothionein-3 is located in the N-terminal domain, J. Biol. Inorg. Chem. 7, 
611-616. 
31. Meloni, G., Sonois, V., Delaine, T., Guilloreau, L., Gillet, A., Teissie, J., Faller, 
P., and Vasak, M. (2008) Metal swap between Zn7-metallothionein-3 and 
amyloid-β-Cu protects against amyloid-β toxicity, Nat. Chem. Biol. 4, 366-372. 
32. Meloni, G., Polanski, T., Braun, O., and Vasak, M. (2009) Effects of Zn
2+
, Ca
2+
, 
and Mg
2+
 on the structure of Zn7metallothionein-3: Evidence for an additional 
zinc binding site, Biochemistry 48, 5700-5707. 
50 
 
 
33. Lu, W., Zelazowski, A. J., and Stillman, M. J. (1993) Mercury binding to 
metallothioneins:  Formation of the Hg18-MT species, Inorg. Chem. 32, 919-926. 
34. Lu, W., and Stillman, M. J. (1993) Mercury-thiolate clusters in metallothionein.  
Analysis of circular dichroism spectra of complexes formed between α-
metallothionein, apometallothionein, zinc metallothionein, and cadmium 
metallothionein and Hg
2+
, J. Am. Chem. Soc. 115, 3291-3299. 
35. Sutherland, D. E. K., Willans, M. J., and Stillman, M. J. (2010) Supermetalation 
of the  domain of human metallothionein 1a, Biochemistry 49, 3593-3601. 
36. Margoshes, M., and Vallee, B. L. (1957) A cadmium protein from equine kidney 
cortex, J. Am. Chem. Soc. 79, 4813-4814. 
37. Oz, G., Pountney, D. L., and Armitage, I. M. (1998) NMR spectroscopic studies 
of I = 1/2 metal ions in biological systems, Biochem. Cell Biol. 76, 223-234. 
38. Ejnik, J. W., Munoz, A., DeRose, E., Shaw-III, C. F., and Petering, D. H. (2003) 
Structural consequences of metallothionein dimerization: solution structure of the 
isolated Cd4-α-domain and comparison with the holoprotein dimer, Biochemistry 
42, 8403-8410. 
39. Gan, T., Munoz, A., Shaw-III, C. F., and Petering, D. H. (1995) Reaction of 
111
Cd7-metallothionein with EDTA.  A reappraisal., J. Biol. Chem. 270, 5339-
5345. 
40. Namdarghanbari, M. A., Meeusen, J., Bachowski, G., Giebel, N., Johnson, J., and 
Petering, D. H. (2010) Reaction of the zinc sensor FluoZin-3 with Zn7-
metallothionein: Inquiry into the existence of a proposed weak binding site, J. 
Inorg. Biochem. 104, 224-231. 
41. Sadler, P. J., Bakka, A., and Beynon, P. J. (1978) 
113
Cd nuclear magnetic 
resonance of metallothionien: Non-equivalent CdS4 sites, FEBS Lett. 94, 315-318. 
42. Otvos, J. D., and Armitage, I. M. (1979) 
113
Cd NMR of metallothionein: direct 
evidence for the existence of polynuclear metal binding sites, J. Am. Chem. Soc. 
101, 7734-7736. 
43. Otvos, J. D., and Armitage, I. M. (1980) Structure of the metal clusters in rabbit 
liver metallothionein, Proc. Natl. Acad. Sci. USA 77, 7094-7098. 
44. Boulanger, Y., and Armitage, I. M. (1982) 
113
Cd nmr study of the metal cluster 
structure of human liver metallothionein, J. Inorg. Biochem. 17, 147-153. 
45. Felitsyn, N., Peschke, M., and Kebarle, P. (2002) Origin and number of charges 
observed on multiply-protonated native proteins produced by ESI, Int. J. Mass 
Spectrom. 219, 39-62. 
46. Kebarle, P., and Verkerk, U. H. (2009) Electrospray: From ions in solution to ions 
in the gas phase, what we know now, Mass Spectrom. Rev. 28, 898-917. 
47. Rigby-Duncan, K. E., and Stillman, M. J. (2007) Evidence for noncooperative 
metal binding to the α domain of human metallothionein, FEBS J. 274, 2253-
2261. 
48. Allinger, N. L. (1977) Conformational analysis. 130. MM2. A hydrocarbon force 
field utilizing V1 and V2 torsional terms, J. Am. Chem. Soc. 99, 8127-8134. 
49. Lii, J.-H., and Allinger, N. L. (1989) Molecular mechanics.  The MM3 force field 
for hydrocarbons.  2.  Vibrational frequencies and thermodynamics, J. Am. Chem. 
Soc. 111, 8566-8575. 
51 
 
 
50. Lii, J.-H., and Allinger, N. L. (1989) Molecular mechanics.  The MM3 force field 
for hydrocarbons.  3.  The van der Waals' potentials and crystal data for aliphatic 
and aromatic hydrocarbons, J. Am. Chem. Soc. 111, 8576-8582. 
51. Allinger, N. L., Yuh, Y. H., and Lii, J.-H. (1989) Molecular mechanics.  The 
MM3 force field for hydrocarbons. 1, J. Am. Chem. Soc. 23, 8551-8566. 
52. Allinger, N. L., Chen, K., and Lii, J.-H. (1996) An improved force field (MM4) 
for saturated hydrocarbons, J. Comput. Chem. 17, 642-668. 
53. Brooks, B. R., Brooks-III, C. L., Mackerell-Jr., A. D., Nilsson, L., Petrella, R. J., 
Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, 
L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., 
Kuczera, K., Lazaridis, T., Ma, J., Ovchinnikov, V., Paci, E., Pastor, R. W., Post, 
C. B., Pu, J. Z., Schaefer, M., Tidor, B., Venable, R. M., Woodcock, H. L., Wu, 
X., Yang, W., York, D. M., and Karplus, M. (2009) CHARMM: The 
biomolecular simulation program, J. Comput. Chem. 30, 1545-1614. 
54. Ponder, J. W., and Case, D. A. (2003) Force fields for protein simulations, Adv. 
Protein Chem. 66, 27-85. 
55. Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., 
Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005) The amber 
biomolecular simulation programs, J. Comput. Chem. 26, 1668-1688. 
56. Chan, J., Merrifield, M. E., Soldatov, A. V., and Stillman, M. J. (2005) XAFS 
spectral analysis of the cadmium coordination geometry in cadmium thiolate 
clusters in metallothionein, Inorg. Chem. 44, 4923-4933. 
 
 
 
 
 
 
 
 
 
 
52 
 
 
Chapter 3. Noncooperative Cadmium binding to 
human MT 1a
3
 
3.1 Introduction  
Metallothionein (MT) is a ubiquitous metalloprotein found in bacteria, mammals and 
invertebrates (1-3).  Characteristic features of MT include its small size, high cysteine 
content, and lack of aromatic amino acids.  Although the exact in vivo function of MT is 
unknown, it has been implicated as a metallochaperone involved in essential zinc and 
copper homeostasis, as a detoxifying agent of toxic metals, and as a protective agent 
against oxidative stress (4-7).  The most well characterized member of the MT family is 
mammalian MT and structural analysis of its fully metalated form by NMR and X-ray 
crystallography have shown it to contain two separate metal binding domains: the N-
terminal β-domain with 9 cysteine residues capable of binding three Cd2+/Zn2+, or 6 Cu+ 
and the C-terminal α-domain with 11 cysteine residues capable of binding four Cd2+/Zn2+ 
or 6 Cu
+ 
(8-11).  Both the isolated β- and α-domain encapsulate a metal thiolate core as 
shown in Figure 3-1, and the metalation chemistry of each is thought to be independent.  
Specifically, the β-domain of MT has been shown to have a preference for Cu+ 
coordination, while the α-domain has been shown to have a preference for Zn2+/Cd2+ 
coordination.  In this manner, MT is thought to be able to separate the redox active Cu
+
 
chemistry from the redox inactive Zn
2+
 chemistry. 
While Cu-MT has been isolated from a number of sources including, fetal liver (12-
13), bovine calf liver (14), rat kidney (15), brain specific MT-3 (16), as well as patients 
suffering from Wilson’s disease (17), it is the zinc form that is most commonly found in 
healthy adult mammals.  These observations have led to a long association of MT with 
zinc homeostasis.  Specifically, MT is thought to act as a robust metallochaperone, 
capable of donating Zn
2+
 ions to apo-enzymes and accepting Zn
2+
 in cases of excess.  
Indeed metal exchange experiments have been conducted in which Zn
2+
 from Zn7-βα-MT 
                                                 
3
A version of this work has been published: 
Reproduced with permission from D.E.K. Sutherland and M.J. Stillman Biochem. 
Biophys. Res. Commun 372 (2008) 840-844.  Copyright 2008 Elsevier. 
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has been transferred to Zn-dependent enzymes, for example, m-aconitase (18), carbonic 
anhydrase (19), and the prototypical transcription factor, Gal4 (20).  Removal of Zn
2+
 
from the zinc finger-containing transcription factor Sp1 demonstrates that MT may also 
act as a Zn
2+
 acceptor (21).  Thus this natural association of MT with the biologically 
essential Zn
2+
 and Cu
+
 has suggested that one of the functions of MT is the maintenance 
of metal ion homeostasis.  To support this view a recent report by Krezel & Maret 
demonstrated the presence of three sets of binding affinities (22):  four Zn
2+
 ions that 
bind strongly (logK = 11.8), 2 with intermediate affinity (logK~10) and finally a single 
weakly bound Zn
2+ 
(logK = 7.7).  Thus MT is able to act as a dynamic metallochaperone 
capable of binding and donating Zn
2+
 ions over a range of concentrations.   
 Several MT polymorphisms have been linked to the longevity of certain human 
groups, with both low Zn-MT levels and satisfactory Zn
2+
 bioavailability being good 
markers for human health (23).  Mutations of MT-1a (Asn27Thr) have also been 
associated with diabetes type 2 and cardiovascular complications (24-25), where nitric 
oxide, an oxidizing agent, was used to determine the availability of Zn
2+
 from Zn-MT.  
Exposure of the mutant MT to nitric oxide, resulted in less Zn
2+
 release compared to the 
wild-type, suggesting that either the mutant is inherently less reactive, or that a large pool 
of partially oxidized MT exists.  In both cases, the mechanism of metalation, and the 
potential for partially metalated species taking part in cellular chemistry has significant 
consequences in the understanding of the relationship between Zn
2+
 bioavailability, MT 
and the overall health of an individual.   
 Specifically, if the mutant is inherently less reactive to NO, then one would 
predict the mutation has affected the most weakly bound Zn
2+
 ion.  However, this 
mutation may have also affected the stability of the protein leading to the accumulation of 
partially oxidized MT, where loss of Zn
2+
 ions from weakly bound sites has led to an 
accumulation of stronger binding sites.  These strong binding sites would decrease 
cellular availability of Zn
2+
 and impede the health of the individual.  It should be made 
clear that while this was an in vivo study and no information about the metal loading of 
the mutant MT is available, the final result of the individual is the same:  only tightly 
bound Zn
2+
 exists and cannot be released easily either because of an increase in the 
stability of a weaker binding site, or partial oxidation and subsequent loss of a weaker 
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binding site.  In either case, MT impacts pathogenesis through both Zn buffering and 
antioxidant dysfunction, which in turn rely on the metalation status in vivo.  It is clear that 
knowledge of the mechanism of metalation is needed to establish the metal status in vivo, 
which will aid in determining the exact involvement of MT in these disorders. 
 
 
Figure 3-1. Molecular model structure of Cd7-βα-rhMT.  A) space filling; B) Ball-
and-stick with the domains in space filling form; C) Ball and stick models of Cd3-β- (left) 
and Cd4-α- (right) rhMT cadmium-cysteinyl-thiolate clusters.  Cysteinyl sulphurs are 
coloured yellow, while cadmium atoms are coloured green.  Data of Chan et al. (26). 
 
Surprisingly, while the stoichiometric ratios of 3 (β) and 4 (α) for Zn2+/Cd2+ ions are 
well known, there has been considerable debate regarding the mechanism of MT 
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metalation. It has been frequently proposed that the mechanism occurs in a cooperative 
fashion, that is, the binding of one metal facilitates the binding of the next metal (27-28).  
In this mechanism, one would expect only the metal free (apo-MT) and fully metalated 
(holo-MT) forms to be relevant.  Several experiments support this viewpoint.  Most 
notably in an NMR titration of apo-MT with 
113
Cd
2+
, the appearance of four 
113
Cd-NMR 
peaks associated with the α-domain could be clearly observed at 2.8 equivalents of 
113
Cd
2+
 per MT molecule, and the remaining 3 peaks, associated with the β-domain, 
appeared at 5.3 equivalents of 
113
Cd
2+
 per MT molecule (28).  It should be noted that at 
2.8 equivalents of Cd
2+
 per MT molecule, a broad peak is observed at 685 ppm and could 
be the result of chemical exchange or overlap of peaks in the sample. 
Contrary to a cooperative mechanism of metalation, a noncooperative mechanism is 
also possible in which metalation events occur independently of each other (29-31).  In 
this alternate hypothesis, it would be expected that apo-MT, partially metalated MT and 
completely metalated MT would coexist.  In this situation, the mechanism of MT 
metalation determines the number of possible physiologically relevant structures that can 
be present in the cell.  Several studies support this alternative mechanism of metalation 
including Zn7-MT titration, where chelator agents were used to determine the presence of 
three distinct binding sites with log(K) affinities of 11.8, ~10 and 7.7 (22).  In addition, 
S-nitrosylation studies of brain-specific MT-3, as monitored by NMR spectroscopy, 
demonstrated the persistence of two α-domain-Cd2+ atoms, even in the presence of excess 
nitric oxide (32).  If the mechanism of metalation were cooperative then in the first case, 
one would predict increasing log(K) affinities as metalation progressed, and in the latter 
case oxidation would lead to a destabilization of partially metalated β- and α- clusters.  In 
addition, enhanced resistance to S-nitrosylation has been reported in MT-1a mutants 
(Asn27Thr) (24-25). These results may be reasonably interpreted if a noncooperative 
mechanism is in effect; however this has not been proven experimentally to date.   
A recent report has provided convincing evidence for noncooperative binding of 
cadmium to the isolated α-domain of human MT-1a (33) but not the complete protein or 
the isolated β-domain.  Determination of the mechanism of the β-domain and the 
complete protein is important, because in a recent paper by Palumaa et al. (34) the 
authors comment that while the brain-specific MT-3 exhibits noncooperative binding, β–
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MT domains from other species bind cooperatively.  For this reason, we have studied the 
step-wise metalation of the isolated β-domain and the two-domain βα human protein so 
that the metalation properties of this human protein can be firmly established. 
This chapter provides the necessary data establishing unambiguously the 
noncooperative nature of cadmium binding to both the isolated domains and the 
combined βα-MT protein (βα-rhMT) of human MT-1a.  Section 3.2 describes the 
experimental details used to study the mechanism of metalation.  Mass spectrometric 
results are presented in section 3.3 and, finally section 3.4 discusses these results in the 
context of current research and its implications.  Briefly, the dominant metalation state 
(1-3 for β- and 1-7 for β-) was directly dependent on the stoichiometric ratio of Cd2+ 
added, and interestingly, titration of apo-MT (β or βα) with excess CdSO4 yielded 
supermetalated (metalation in excess of the normal maximum levels) species for the β- 
and full-MT protein not previously reported. 
3.2 Experimental Methods 
In this section, the details of the protein preparation protocol for the metal-binding 
studies (Section 3.2.1) and the instrumental parameters (Section 3.2.2) will be described, 
as well as a detailed account of the experimental design for the metalation of apo-β- and 
apo-βα-rhMT 1a with Cd2+ at pH 9.4 and 8.4, respectively (Section 3.2.3). 
3.2.1 Protein preparation for metal binding studies  
Chemicals 
CdSO4 (J.T. Baker Chemical Company).  All chemicals used in this study were of the 
highest-grade purity from commercial sources.  All solutions were made with  
>14MΩcm-1 deionized water (Barnstead Nanopure Infinity).  Protein purification steps 
were performed on Hi Trap SP ion exchange columns, fine G-25 Sephadex (Amersham 
Biosciences) and a stirred ultrafiltration cell (Amicon Bioseparations/Millipore) with a 
YM-3 membrane (3000 MWCO). 
Protein preparation 
The expression and purification methods have been previously described in detail in 
chapter 2.  The β-rhMT and βα-rhMT proteins used in this study were based on the 38-
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residue and 72-residue sequences, respectively: β-rhMT MGKAAAACSC 
ATGGSCTCTG SCKCKECKCN SCKKAAAA, βα-rhMT MGKAAAACSC 
ATGGSCTCTG SCKCKECKCN SCKKAAAACC SCCPMSCAKC AQGCVCKGAS 
EKCSCCKKAA AA.  There are 9 and 20 cysteine residues present in β-rhMT and βα-
rhMT, respectively, and no disulfide bonds.  The expression system included, for stability 
purposes, an N-terminal S-tag (MKETAAAKFE RQHMDSPDLG TLVPRGS).  
Recombinant β-rhMT was expressed in BL21(DE3) Escherichia coli (E. coli.), while βα-
rhMT was expressed in ER2566 E. coli..  Both cell lines were transformed using the 
pET29a plasmid.  Removal of S-tag was performed using a Thrombin CleanCleave
TM
 Kit 
(Sigma).  To impede oxidation of the cysteine residues to disulfide bonds, all protein 
samples were argon saturated and rigorously evacuated.   
A general description of the demetalation procedure can be found in chapter 2 (Section 
2.2.6).  In this experiment, concentrated formic acid was used to lower the pH of the MT 
sample to 2 with concomitant demetalation.   Previously bound Cd
2+
 ions were removed 
by buffer exchange using a G-25 (Sephadex) column into deoxygenated di-H2O pH 
adjusted to 2.7.  The solution was evacuated, septum capped and backfilled with argon. 
Small aliquots of both the apo-β- and apo-βα-rhMT 1a were remetalated using Cd2+ 
and their concentrations were determined to be 18.0 and 18.4 μM from the ligand-to-
metal charge transfer band (LMCT band) centered at 250 nm (ε250β = 36,000 and ε250βα = 
89,000 M
-1
cm
-1
).  Cadmium solutions were prepared as the sulfate salt in di-H2O to a 
final concentration of 7.1 mM as determined by atomic absorption spectroscopy (AAS).   
3.2.2 Mass spectrometric measurements  
ESI-MS procedures.   
All data were collected on an electrospray ionization time-of-flight (ESI-TOF) mass 
spectrometer (Waters Micromass Inc.) in the positive ion mode.  NaI was used as the 
calibrant, because of its ability to form salt clusters that cover the m/z range of the 
protein.  The scan conditions for the spectrometer were: capillary, +3000.0 V; sample 
cone, 15 V; extraction cone, 10 V; RF lens, 450 V; desolvation temperature, 20.0 
°
C; 
source temperature, 80.0 
°
C; cone gas flow, 52 Lhr
-1
; and desolvation gas flow, 514 Lhr
-1
.  
The m/z range was 500.0-2000.0; the scan mode was continuum, with a scan time of 2.4 s 
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and an interscan delay of 0.10 s.  Spectra were constructed and deconvoluted using the 
MASSLYNX v.4.0 software package.   
3.2.3 Metalation of apo-β- and apo-βα-rhMT 1a with Cd2+  
 The pH of the apo-β- and apo-βα-rhMT 1a solutions were raised to 9.4 and 8.4, 
respectively, through the stepwise addition of concentrated NH4OH.  This stepwise 
addition was initially monitored through the use of pHydrion® pH paper (Micro Essential 
Laboratory, Inc.) and immediately following the titration, the pH was determined using a 
pH meter (Accumet Basic AB15, Fisher Scientific, Ottawa, ON, Canada) with an 
Accumet Semimicro pH electrode.   
After the addition of each aliquot of Cd
2+
, the solution was thoroughly mixed and 
allowed to equilibrate for 5 min.  Mass spectra were then acquired of the MT solution.  
Following the ESI-MS titration, AAS was used to calibrate the exact equivalents added to 
solution at each step of the titration.   
3.3 Results 
In this section, the ESI mass spectral results for the titration of the isolated apo-β-
domain and full MT 1a protein with Cd
2+
 are outlined.  Specifically, the effects of 
metalation on the isolated β-domain (Section 3.3.1), the full MT protein (Section 3.3.2) 
and an analysis of the deconvoluted mass spectral data as a function of Cd
2+
 added to 
solution (Section 3.3.3). 
3.3.1 Metalation of apo-β-rhMT 1a with Cd2+ at pH 9.4  
The mass spectra recorded during the titration of apo-β-rhMT are shown in Figure 3-2.  
The data clearly show that stepwise addition of Cd
2+
 to the initially metal-free protein 
results in the formation of partially-metalated (β<3 Cd2+) species until saturation occurs 
with the fully metalated species at 2.8 equivalents Cd
2+
 added to solution.  It should be 
noted that there is some error in the measurement of Cd
2+
 added to solution and that 2.8 
equivalents represents complete metalation, either because of an overestimation of the 
protein content or an underestimation of the Cd
2+
 added to solution.  In Figure 3-2, the 
observed charge states (A-E) and their corresponding deconvoluted spectra are shown as 
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a function of increasing concentration of Cd
2+
.  Cleavage of the S-tag leaves the residues 
GS attached to the N-terminal of the protein.  Theoretical mass values for β-rhMT are as 
follows: apo-β-rhMT 3753.46 Da, Cd1 3863.85 Da, Cd2 3974.24 Da, Cd3 4084.63 Da and 
Cd4 4195.02 Da.    
In more detail, Figure 3-2 shows the bound-metal speciation for β-rhMT as a function 
of the number of Cd ions added at pH 9.4.  One Zn
2+
 is bound to about 25% of the total 
protein.  The binding persists until the Zn
2+
 is displaced at the Cd3 point, (D).  
Surprisingly, addition of five molar excess led to the quantitative formation of a new 
species Cd4-β-rhMT forms (E).  Metal free apo-β-rhMT exhibits significant intensity in 
charge states corresponding to +5, +4, and +3 at the 0 Cd
2+
 added point (A1).  The +5 
charge state intensity is no longer apparent when Cd1-β-rhMT forms.  The loss of the +5 
charge state clearly indicates some degree of folding has occurred as a result of the 
conformational changes required following binding of just the first Cd
2+
 or the Zn
2+
 to the 
apo-β-rhMT to form Cd1-β-rhMT or Zn1-β-rhMT (B1).  After the disappearance of the +5 
charge state, there is very little change in the charge state distribution with further 
additions of Cd
2+
, indicating that the most significant folding occurs upon binding of the 
first metal ion.   
3.3.2 Metalation of apo-βα-rhMT 1a with Cd2+ at pH 9.4  
The mass spectra recorded during the titration of apo-βα-rhMT Cd2+ are shown in 
Figure 3-3.  As in the case of apo-β-rhMT 1a, the data show that stepwise addition of 
Cd
2+
 to the initially metal-free protein species results in the formation of partially-
saturated (β- <7 Cd2+) metalated species until saturation occurs with the fully metalated 
species, which forms when stoichiometric amounts of Cd
2+
 are added.  In Figure 3-3, the 
observed charge states (A-E) and the corresponding deconvoluted spectra are shown as a 
function of increasing concentration of Cd
2+
.  Cleavage of the S-tag leaves the residues 
GS attached to the N-terminal of the protein.  However, the mass spectra show that 
several amino acids of βα-rhMT were truncated either during the cleavage, or in the mass 
spectrometer itself producing two different species: one in which the N-terminal G 
residue and C-terminal AA residues were truncated, and a second in which the N-
terminal GSMGK as well as A from either the N-terminal or C-terminal were truncated.  
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None of the highly conserved cysteine residues were truncated.  By assuming both 
species of βα-rhMT are equivalently ionized, the first species is more prevalent.  
Theoretical mass values for the predominant βα-rhMT species are as follows: apo-βα-
rhMT 6874.37 Da, Cd1 6984.76 Da, Cd2 7095.15 Da, Cd3 7205.54 Da, Cd4 7315.93 Da, 
Cd5 7426.32 Da, Cd6 7536.71 Da, Cd7 7647.10 Da and Cd8 7757.49 Da.   
 
Figure 3-2.  ESI mass spectral titration of apo-β-rhMT with CdSO4. The protein 
concentration was 18.0 μM and a pH of 9.4. Mass spectral data (Left) and the 
corresponding deconvolutions (Right) were recorded as aliquots of Cd
2+
 (7.1 mM) were 
titrated into the solution at 22 °C.  The * refers to a +5 m/z minority species 
corresponding to slight dimer formation of β-rhMT.  
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Figure 3-3. ESI mass spectral titration of apo-βα-rhMT with CdSO4. The protein 
concentration was 18.4 μM and a pH of 8.4. Mass spectral data (Left) and the 
corresponding deconvolutions (Right) were recorded as aliquots of Cd
2+
 (7.1 mM) were 
titrated into the solution at 22 °C.  Two sets of m/z refer to the presence of two βα-rhMT 
species, see text. 
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Cd-loading of the two-domain protein is shown in Figure 3-3 with the metal-
speciation in βα-rhMT measured as a function of added Cd2+.  Cd-species from 1 to 8 at 
pH 8.4 are observed with stoichiometric addition of Cd
2+
.  A single Zn
2+
 persists in 25% 
of the protein as the Zn1-βα-rhMT species in (A).  The Zn
2+
 is only displaced when Cd7- 
species forms.  The important feature in Figure 3-3 is the step-wise increases in Cd
2+
-
loading as a function of added Cd
2+
 and the appearance of Cd8-βα-rhMT with excess 
added Cd
2+
.  Apo-βα-rhMT (A) exhibits charge states corresponding to +8, +7, +6, and 
+5 (+5’ to +8’ correspond to the less prevalent truncated βα-rhMT species).  Addition of 
1 Cd
2+
, data in (B), causes a significant reduction in the intensity of the +8 and +7 charge 
states, again, indicating that a conformational change takes place reducing the exposed 
basic amino acids.  Complete loss of the +8 charge state occurs with formation of Cd2-
βα-rhMT, which corresponds to the complete loss of apo-βα-rhMT species.  As the 
titration proceeds, up to 7 equivalents of Cd
2+
 are added, the intensity of +6 relative to +5 
increases.  This reversal in trend in the charge state intensity indicates an increase in 
volume of the structure.  The deconvoluted spectra in (E) show that this corresponds to 
the emergence of Cd8-βα-rhMT.  The appearance of the lower mass signals at the end of 
the titration, Cd3/Cd4/Cd5-βα-rhMT, are due to the presence of metalated, truncated βα-
rhMT.  
3.3.3 Relative abundance of apo-β- and apo-βα-rhMT 1a with Cd2+  
Assembled in Figure 3-4 are the relative abundances of each metalated protein species 
shown in Figure 3-2 and 3-3.  Because there is a small fraction of Zn
2+
 bound, it has 
shown that Zn
2+
 and Cd
2+
 bind isomorphously, all Zn
2+
 species are counted as if Cd
2+
 
were bound (35).  Of course, Cd
2+
 binds with a greater KF and so displaces the Zn
2+
 when 
no other binding sites are available in the noncooperative model, as observed here.  The 
value of Figure 3-4 is that it clearly demonstrates that partial metalation occurs; hence the 
extent of metalation is directly dependent on the amount of metal in solution.  At low 
equivalents of metal only partially metalated species are observed and addition of excess 
Cd
2+
 to β-rhMT and βα-rhMT lead to the formation of Cd4-β-rhMT and Cd8-βα-rhMT, 
respectively.   
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Figure 3-4.  The metalation state as a function of Cd
2+
 added.  This plot assumes 
that the binding of zinc and cadmium are equivalent and treats them interchangeably.  (A) 
refers to the metalation of β-rhMT, whereas (B) refers to the metalation of βα-rhMT.  The 
second βα-rhMT truncation, accounts for 13% of total signal, which must be spread over 
several species, no adjustment was made to metal speciation. 
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3.4 Discussion 
3.4.1 Cooperative versus noncooperative metalation of 
metallothionein  
Mammalian metallothioneins bind metals in metal-cysteinyl-thiolate clusters with 
stoichiometries dependent on the associated metal: Cd7-MT, Zn7-MT, Ag12-MT, Cu12-
MT, Hg18-MT, and As6-MT (9, 11, 36-38).  The details of the metal binding mechanisms 
are important because of implications in the possible metalation status of the protein in 
vivo, especially, whether partially metalated species exist under normal conditions.  There 
are two overall mechanisms (i) a cooperative mechanism in which only the metal-free 
(apo-MT) and the metal-saturated (holo-MT) are significantly populated and a 
noncooperative mechanism, which would allow for the presence of partially metalated 
species that could potentially serve a biological function, such as controlling the 
bioavailability of zinc (4, 22).  Previous attempts to determine the mechanism of 
metalation have relied on techniques that do not produce direct evidence for the 
absence/presence of intermediate species (28-31) or may be more sensitive to specific 
species, for example, the CD spectrum of Cd4--domain dominates the spectrum 
compared with the partially metalated Cd1-3 (33).  ESI-MS data reported over several 
years, and the specific recent results for the metalation of the α-domain of rhMT 1a (33, 
39) show that ESI-MS data exhibit the discriminating power required to detect and 
quantify the presence of partially metalated metallothioneins. 
Cooperative metalation 
A cooperative mechanism of metalation implies that the binding of one metal ion, for 
example Cd
2+
, affects the binding of subsequent metal ions.  There are two cases of 
cooperative metalation: positive cooperativity, where the binding of one ligand facilitates 
the binding of subsequent ligands (Kn+1> Kn, where n is the number of ligands bound), 
and negative cooperativity, where the binding of one ligand hinders the binding of 
subsequent ligands (Kn> Kn+1, where n is the number of ligands bound).  The traditional 
view of MT is that metalation occurs in a positive cooperative fashion with only the fully 
metalated (holo-) and metal free (apo-) MT taking part in cellular chemistry.  As such, 
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research of the metalation properties of MT have focused primarily on the metal free, and 
fully metalated forms.      
Noncooperative metalation 
A noncooperative mechanism of metalation implies that the each binding event is 
independent of the others.  In this model, one would expect the binding affinity to 
decrease as a function of metals bound, because as each metalation site becomes 
occupied the number of available sites decreases.  Kinetic experiments involving As
3+
 
binding to MT have supported the noncooperative mechanism of metalation.  
Specifically, by studying the ESI-mass spectral metalation of the triple MT mutants (βββ- 
and ααα-rhMT) and comparing it to the isolated β- and α-domains, as well as the full MT 
1a protein, it was shown that the rate of metalation is directly dependent upon the number 
of available sites.  This experiment was possible, because metalation of MT with As
3+
 
occurs on the order of minutes to hours.  Unlike As
3+
, Cd
2+
 metalation is complete in the 
4 ms of the dead time of a stopped-flow machine, and ESI-mass spectral data on the 
metalation of MT with Cd
2+
 is not currently available.  Recent ESI-mass spectral studies 
of the isolated α-domain of MT-1 by Rigby and Stillman, and full MT-3 protein by 
Palumaa et al. have shown that partially metalated Cd-MT species are in fact stable and 
that the dominant metalation state is directly dependent on the equivalents of Cd
2+
 added 
to solution.  These results support a noncooperative mechanism of metalation.  However, 
in the former case no metalation data are available without the metalation properties of 
the isolated β-domain and the full MT protein no mechanism can be conclusively 
supported. 
3.4.2 Noncooperative metalation: ESI-mass spectral evidence  
Many of the previous MT metalation experiments were based on optical techniques 
and included CD, EPR, and UV spectroscopy.  These techniques, while sensitive to the 
metal-thiolate bond, provide an average of the metalation state of MT, and consequently 
do not have the discriminating power necessary to determine the mechanism of 
metalation.  ESI-mass spectrometry, a unique technique in that it is able to 
simultaneously determine the number and type of metals bound to the protein.  In 
addition, by monitoring changes to the charge state profile, protein folding information 
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may also be extracted.  Recently, ESI-MS has been extensively used to analyze the 
metalation of MT through both the kinetics of metal binding and the discovery of a new 
low affinity binding site.  Specifically, the metalation of the isolated α-domain of human 
MT-1a and the full MT-3 both support a noncooperative mechanism of metalation. 
The present study demonstrates that the partially metalated species of the isolated β-
domain and the two-domain protein of MT 1a are stable.  Following the step-wise 
addition of 1 to 4 (β) or 1 to 7 (βα) equivalents of Cd2+, all metalated species are observed 
ranging from apo-MT to holo-MT depending on the amount of Cd
2+
 added, Figure 3-2 
and 3-3.  When combined with the kinetics of As
3+
 metalation and the stability of the 
partially metalated species in the α-domain of MT 1a, we can now conclusively say that 
both the isolated domains and full protein of metallothionein isoform 1a bind metals in a 
noncooperative manner.  It is very likely that noncooperative metalation applies to all 
metals capable of binding metallothionein although this has yet to be proven.  
Significantly, a noncooperative mechanism allows for partially metalated and metal 
exchange intermediates to be stable and, therefore, to be able to take part in cellular 
chemistry. 
In addition to the metalation status, information from the charge state populations, 
specifically changes in these populations, provides conformational information about the 
protein.  These charge state distributions are directly dependent on both the number of 
basic sites and size of the protein.  As such, any alterations to this size, or site exposure, 
through folding or through denaturation, will lead to changes in the charge state 
distribution.  Higher charge states correspond to a more open, solvent exposed, 
conformation, while lower charge states correspond to more closed, solvent unexposed, 
conformation. 
The ESI-mass spectral data presented in Figures 3-2 and 3-3 show that the addition of 
the first metal ion to both β-rhMT and βα-rhMT result in loss of intensity in the highest 
charge states, +5 for the β-domain and +8 for the full protein, which indicates that 
binding of this first metal leads to significant folding of the protein.  The lack of change 
in the distribution of the intensity in the charge states with further Cd
2+
 addition up to 3 
(β) or 7 (β) indicates the first metal locks the structure in place and that, unexpectedly, 
further metalation does not require significant rearrangement of the polypeptide backbone 
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to occur.  This compares well the α-domain of MT 1a, which upon binding the first Cd2+ 
ion losses the +7 and +6 charge states after which there is very little change to the charge 
state spectra.   
The dominant charge state of both fully metalated Cd3-β-rhMT and Cd4-α-rhMT is +4, 
while the dominant charge state of the full MT protein is +6.  One would predict that the 
dominant charge state of the full MT protein would be the sum of the isolated domains.  
This prediction is based upon the traditional view of the individual domains acting in 
isolation of each other and is supported by a number of NMR studies, most convincingly 
the almost identical location of the 
113
Cd-NMR peaks associated with the isolated α-
domain when compared to the full MT protein (10).  However, contrary to this traditional 
view, the dominant charge state of the fully folded MT protein is in fact +6 and is 
significantly lower than the expected charge state of +8.  This finding would suggest that 
there is, in fact, some domain-domain interactions, which act to attenuate to total charge 
that the protein is capable of holding.  These domain-domain interactions, while not well 
characterized may be critical in the equilibration of metal ions within each domain and 
may help to explain the metal-ion preference of each domain (Zn
2+
 and Cd
2+
 in the α-
domain and Cu
+
 in the β-domain) (40-41). 
3.4.3 Implications of a noncooperative mechanism of metalation  
The most significant consequence of a noncooperative mechanism of metalation is the 
prospect of the existence of stable partially metalated MT species.  For example, a recent 
isolation of partially oxidized cardiac-specific MT from overexpressing transgenic mice 
was somewhat surprising because in a cooperative mechanism partial oxidation of the 
MT protein would act to labilize the remaining metal ions and facilitate complete 
oxidation (42).  Prior to this study, isolation of partially metalated MT could be 
interpreted as an artifact of purification and of no biological relevance.  However, this 
data establishes a noncooperative mechanism of metalation, which allows for the stability 
of partially metalated intermediates.  Under this mechanism, partially metalated MT is 
likely to have several free thiol groups that can oxidize without interfering with the 
remaining thiol-bound metal ions.   
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The traditional functions of MT include the protective roles as a buffering agent 
against both toxic metal exposure and oxidative stress.  In both cases, interaction of MT 
with the insult leads to a release of naturally bound Zn
2+
, which coordinates to metal-
regulatory transcription factor 1 (MTF-1).  Zn-MTF-1 translocates to the nucleus and 
upregulates MT, allowing the cell to deal with the insult.  In the former case, MT has 
been shown to protect an organism against a wide range of metals including Cd
2+
, Hg
2+
 
and As
3+ 
(43-44).  In the latter case, exposure of MT to oxidizing agents, such as H2O2, 
facilitates the oxidation of cysteine thiols to disulfide bonds (45). 
A significant exception to this pattern of protection is methylmercury (MeHg
+
) (46).  
The neurotoxicity of MeHg
+
 is well known and the expression of MT has been shown to 
protect an organism against it.  However induction of MT in vivo and in vitro with 
MeHg
+
 using both astrocytes and neurons has not been possible (43-44).  An analysis of 
the binding affinities suggests that MeHg
+
, binding thiols with an association constant 
ranging from 10
15
 to 10
23
 (46), would be able to effectively outcompete zinc, which has 
an association constant ranging from 10
7
 to 10
12
 (22).  Taken together, these results 
suggest that while at equilibrium MeHg
+
 should be able to displace Zn
2+
 from Zn-MT, in 
a cellular environment it is not able to effectively compete.  It has, however, been shown 
that a pretreatment of the cell with either zinc or cadmium, both known to induce MT-1 
and -2, is capable of aiding in metal-induced resistance to neurotoxicity (47-48).  A 
noncooperative mechanism is critical since it affords stability to partially metalated 
species in the cellular environment.  These partially metalated species, having several 
non-coordinating thiols, would likely be more susceptible to MeHg
+
 binding.  Without 
the necessity for Zn
2+
 to dissociate from MT, MeHg
+
 coordination acts to sequester the 
toxic metal insult and is likely the cause of the observed resistance.   
3.4.4 Supermetalation: Cd4-β-rhMT 1a and Cd8-βα-rhMT 1a  
Supermetalated forms of metallothionein were also observed for both the β- and the 
β-proteins studied, where we define supermetalation as metalation in excess of 
traditionally measured values.  In the case of Cd3-β-rhMT and Cd7-βα-rhMT, addition of 
excess Cd
2+
 led to the formation of Cd4-β-rhMT and Cd8-βα-rhMT, respectively.   These 
results complement well with the previously discovered supermetalated Cd5-α-rhMT, 
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which was postulated to be a metal-exchange intermediate essential for MT’s ability to 
maintain metal ion homeostasis (39).   
Supermetalation of the β-domain has been previously postulated following analysis of 
CD and UV-visible absorption spectral data (49).  Capdevila et al. have postulated from 
their spectral data, with excess Cd
2+
, that Cd4-β-rhMT subsequently unwound to form 
Cd9-β-rhMT in a cooperative manner.  It was proposed the unwinding required addition 
of 9 excess equivalents of Cd
2+
.  The ESI-MS data described here demonstrates that the 
mechanism is noncooperative for metalation of apo-β-rhMT to Cd3-β-rhMT, Figure 3-2, 
and subsequently excess Cd
2+
 forms only Cd4-β-rhMT. 
Interestingly, based on the supermetalated data of the isolated domains we would 
predict that supermetalation of the full MT protein would lead to the formation of Cd9-
βα-rhMT and not Cd8-βα-rhMT.  Based solely on the ESI-mass spectral evidence two 
possibilities exist: 1) supermetalation of one of the two domains inhibits supermetalation 
of the other, or 2) coordination of the additional Cd
2+
 metal ion requires cysteine residues 
from both domains.  Meloni and Vasak recently determined that there exists an eighth 
metal ion binding site in MT-3 (50).  In the case of MT-3, the formation of 
supermetalated Cd8-βα-hMT-3 results in a decrease in the Stoke’s radius of the protein, 
which suggests the mutual approach of the two domains.  Based on both this data, and the 
existence of Cd8-βα-rhMT and not Cd9-βα-rhMT in our ESI-mass spectra titration, we 
predict that supermetalation involves both domains.   
3.5 Conclusion 
In summary, addition of Cd
2+
 to β-rhMT and βα-rhMT results in noncooperative 
binding of to both.  It can now be conclusively stated that the metalation of MT 1a with 
Cd
2+
 occurs in a noncooperative manner for both the isolated domains and the full MT 
protein.  It was also shown that addition of excess Cd
2+
 to Cd3-β-rhMT and Cd7-βα-rhMT 
leads to the formation of Cd4-β-rhMT and Cd8-βα-rhMT, respectively.  This result was 
surprising, since previous supermetalation studies of the isolated α-domain have also 
shown an additional Cd
2+
 ion is capable of binding to form Cd5-α-rhMT and one would 
predict that supermetalation of the full MT protein would be merely the sum of the 
supermetalated isolated domains (Cd9-βα-rhMT).  Based on ESI-mass spectral evidence, 
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it is unclear if the additional Cd
2+
 ion coordinates to a single domain in Cd7-βα-rhMT or 
involves both domains.  The model of metal binding in metallothionein is now clearly 
more complex than previously thought, with the existence of partially- as well as super-
metalated species.  With the elucidation of noncooperative metalation of mammalian 
metallothionein, determination of both the presence and function of intermediate species 
are now possible. 
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Chapter 4. Single domain MT: Evidence for the onset 
of clustered metal binding domains
4
 
4.1 Introduction  
Metallothionein (MT) is a small cysteine rich protein found in all organisms.  MT 
coordinates a variety of metals including the biologically essential Zn
2+
 and Cu
+
, as well 
as toxic Cd
2+
, Hg
2+
 and As
3+ 
(1-2).  These metal ions are capable of coordinating in a 
number of geometries, including digonal, trigonal, and tetrahedral (3).  For Zn
2+
 and Cd
2+
 
tetrahedral coordination by a mixture of terminal (binding to only a single metal-ion) and 
bridging cysteine residues (Cys) is critical to the metal binding site structure.  As a 
consequence, we find ‘magic numbers’ for metal binding, formally defined as the 
stoichiometric ratios that appear to represent stable saturated clusters, that range from 7 to 
18 metal ions per MT protein (4).  While the exact in vivo functions of MT are unknown, 
MT has been implicated in toxic metal detoxification, metal ion homeostasis and as a 
protective agent against oxidative stress.  All of these processes rely on MT’s dynamic 
ability to bind and release metal ions within the cellular environment.  The key to 
understanding the different roles of MTs is in a precise description of the metalation 
reactions – this allows a definitive description of the allowed metalation states possible 
for MTs and therefore an assessment of the functional metalation states.  In previous 
studies, 7 Zn
2+
 is known as the ‘fully metalated’ state, while loss of 1 or 2 Zn2+ ions 
meant the protein had available binding sites and the cysteine residues not bound to Zn
2+
 
would be exposed to oxidation.  The result presented here show that the 5 Zn
2+
 metalation 
state is the protective level leaving no accessible cysteine residues. 
The most well characterized members of the MT family are the mammalian MTs 
(Figure 4-1), for which X-ray diffraction and NMR studies of the fully metalated protein 
show that metal ions form two essentially isolated and distinct metal-thiolate clustered 
binding domains using the 20 cysteine residues of the protein.  The N-terminal β-domain 
is capable of binding 3 Zn
2+
 , 3 Cd
2+
 or 6 Cu
+
 metal ions using 9 cysteine residues, while 
                                                 
4
 A version of this work is in preparation 
D.E.K. Sutherland, K.L. Summers and M.J. Stillman (2012). 
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the C-terminal α-domain is capable of binding 4 Zn2+ , 4 Cd2+ or 6 Cu+ metal ions using 
11 cysteine residues (5-7).  The current view of these domains is that each acts as an 
effectively isolated metal-thiolate cluster.  This view has been supported by a number of 
NMR studies of mammalian MT, where no inter-domain peaks associated with the 
nuclear overhauser effect (NOEs) were found (7-8).  Since NOEs are a through space 
phenomenon it has been inferred that the two domains are not physically near one 
another.  The sole exception to this observation is supermetalation of MT, where addition 
of excess Cd
2+
 results in formation of a single Cd8Cys20 ‘super-domain’ (9-10).  Based on 
a combination of electrospray ionization mass spectrometry (ESI-MS) and absorption, 
circular dichroism and NMR spectroscopy it was determined that the addition of the 8
th
 
Cd
2+
 ion resulted in rearrangement of all 8 Cd
2+
 ions to form a single clustered Cd8-S20-
βα-rhMT domain. 
One important feature in many of the MT's studied is the existence of multiple, often 
2, isolated domains that are reported to coordinate both different numbers and different 
types of metal ions.  It has been suggested that the existence of the two domain structure 
present in many MTs allows the protein to function simultaneously in both Zn
2+
 and Cu
+
 
chemistries (11-12).  The potential for MT to be able to spatially separate metal ion 
chemistry into different domains has significant consequences for our understanding of 
the role of MT in metal ion homeostasis and as a protective agent against oxidative stress.  
For instance, MT-3 has been proposed to play an important role in maintaining the 
balance of metals in the brain (13) and it has been reported to be downregulated in 
patients with Alzheimer’s disease.  A recent paper has shown that Zn7-βα-MT 3 is 
capable of metal exchange with the copper bound amyloid-β-peptide (Aβ1-40-Cu
2+
) (14).  
The exchange reaction and subsequent reduction to Cu
+
 leads to the formation of Cu4Zn4-
βα-MT 3.  This process eliminates the production of reactive oxygen species and related 
toxic effects, and it is thought to somewhat protect the individual from Alzheimer’s 
disease.  While the exact structure of this Cu4-motif is not known, it has been reported as 
a stable folding intermediate leading towards the complete metalation of MT (Cu12-βα-
MT) (15). 
Currently, little is known about the exact mechanism of the metalation of MT.  
However, it has been demonstrated through ESI-MS that MT binds Cd
2+
 and As
3+
 in a 
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noncooperative manner, meaning that in addition to apo- and holo-MT, partially 
metalated species may also exist in vivo (2, 16-18).  Furthermore these partially metalated 
species may be critical in the metal-exchange reactions necessary for maintenance of 
metal-ion homeostasis. 
While the fully metalated proteins have been studied in detail by numerous methods, 
there are few studies that specifically focus on the metal binding reaction to the apo-
metal-free protein other than the recent As
3+
 kinetic data (2, 18).  A key feature of the 
conclusions from those As
3+
 data was that each As
3+
 ion was bound to exactly 3 cysteinyl 
thiolates, meaning that no clustering took place.   
With the noncooperative mechanism of metalation recently established, it is now 
crucial to determine the structural features of MT in the early stages of metalation (before 
the protein is saturated) with Zn
2+
, the key biologically significant metal.  The importance 
of determining the 'holding point' for MT, that is the minimum 'safe' metalation point 
against oxidative stress, is to answer the question of what is the naturally-metalated state 
and the effects expected from demetalation when MT is part of a redox cycle. 
In this chapter, we report on a series of Zn
2+
 competition experiments performed using 
the metal-free isolated fragments apo-β- and apo-α- and the metal-free full protein apo-
βα-rhMT 1a.  Individual titrations of both the isolated domains and the full MT protein 
demonstrated that Zn
2+
 metalation occurs in a noncooperative manner.  Competition 
experiments using the very slight differences in the formation constants (KF) introduced 
by co-metallating the isolated fragments containing the individual β- and α-domains, and 
the isolated domains and the full MT protein probe the metalation reaction in detail not 
previously reported.  The data show that KF is sensitive to the metalation status and 
particularly to the onset of clustering.  We interpret the ESI-MS results to indicate that 
initial metalation of MT does not occur in a domain specific manner, rather the 
availability of up to 20 cysteines means that Zn
2+
 up to and including 5 bind tetrahedrally 
to four terminal cysteinyl thiolates (each cysteine residue coordinates only a single metal 
ion) that do not bridge in a ‘beaded necklace’-like fashion.  Only then does clustering 
take place via bridging interactions and a concomitant reduction in KF for those sites.  
The subsequent metalation of the full protein to Zn6- and Zn7-βα-rhMT 1a requires a 
complete structural rearrangement, loss of the single domain structure, together with 
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development of the clusters associated with the formation of the more traditional Zn3- 
and Zn4-domains.  
 
 
 
Figure 4-1. Structure of MT 1a. (A) A space filling structure of Cd7-βα-rhMT 1a.  
The N-terminal β-domain is located on the left hand side, while the C-terminal α-domain 
is located on the right hand side.  (B) Cadmium-cysteinyl-thiolate clusters of Cd7-βα-
rhMT 1a presented as a ball and stick model:  β-domain (left) and α-domain (right).  (C) 
A connectivity diagram of MT 1a, which shows each of the seven cadmium atoms 
connected to exactly four cysteine amino acids.  The connectivity diagram has been 
renumbered from the original to accommodate the amino acids glycine and serine, both 
of which are a product of S-tag cleavage with thrombin, located on the N-terminal of the 
β-domain.  Numbering of the Cd-thiolate centers is based on the NMR assignment by 
Messerle et al. (7).  Data from Chan et al. were used to produce the molecular models 
seen in (A) and (B) (19). 
4.2 Experimental Methods 
Chemicals: cadmium sulfate (Fisher Scientific); zinc sulfate (Caledon Laboratory 
Chemicals); ThrombinCleanCleave
TM
 Kit (Sigma); Tris, 
tris(hydroxymethyl)aminomethane (EMD Chemicals/VWR); ammonium hydroxide 
(Caledon Laboratory Chemicals); formic acid (Caledon Laboratory Chemicals); and 
hydrochloric acid (Caledon Laboratory Chemicals). All solutions were made with >16 
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MΩ·cm deionized water (Barnstead Nanopure Infinity). HiTrapTM SP HP ion exchange 
columns (Amersham Biosciences/ GE Healthcare), superfine G-25 Sephadex (Amersham 
Biosciences/ GE Healthcare), stirred ultrafiltration cell Model 8200 (Amicon 
Bioseparations/Millipore) with a YM-3 membrane (3000 MWCO) were used in protein 
preparation steps. 
Protein preparation: The expression and purification methods have been previously 
reported (19). β-rhMT, α-rhMT and βα-rhMT 1a proteins used in this study were based 
on the 38-residue, 41-residue, and 72-residue sequences, respectively: β-rhMT 
MGKAAAACSC ATGGSCTCTG SCKCKECKCN SCKKAAAA, α-rhMT 
MGKAAAAC CSCCPMSCAK CAQGCVCKGA SEKCSCCKKA AAA, βα-rhMT 
MGKAAAACSC ATGGSCTCTG SCKCKECKCN SCKKAAAACC SCCPMSCAKC 
AQGCVCKGAS EKCSCCKKAA AA. There are 9, 11, and 20 cysteine residues present 
in β-rhMT, α-rhMT and βα-rhMT, respectively, and no disulfide bonds. The expression 
system included, for stability purposes, an N-terminal S-tag (MKETAAAKFE 
RQHMDSPDLG TLVPRGS). Recombinant proteins were expressed in BL21(DE3) 
Escherichia coli.  All cell lines were transformed using the pET29a plasmid. Removal of 
S-tag was performed using a Thrombin CleanCleave
TM
 Kit (Sigma). To impede oxidation 
of the cysteine residues to disulfide bonds, all protein samples were argon saturated and 
rigorously evacuated to remove any residual oxygen that may be present in the solution. 
Concentrated hydrochloric acid was used to demetalate protein samples, followed by 
desalting on a G-25 (Sephadex) column. 
ESI MS procedures: Protein solutions were prepared in dilute formic acid in deionized 
water (pH 2.7).  Final ESI MS solutions were pH adjusted using concentrated ammonium 
hydroxide.  A small aliquot of protein was remetalated with cadmium to determined the 
protein concentration by UV absorption spectroscopy using the absorbance at 250 nm, 
which corresponds to the ligand-to-metal charge transfer transition generated by the 
metal-thiolate bond (Ɛβ250= 36,000 M
-1
cm
-1
;
 Ɛα250= 45,000 M
-1
cm
-1; Ɛβα250= 89,000 M
-
1
cm
-1
).  Zinc sulfate was prepared in deionized water.  The concentration of zinc sulfate 
and all molar equivalents added to MT solutions were measured through calibration of 
the Zn
2+
 content using atomic absorption spectrometry (AAS). 
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All data were collected on an electrospray-ionization time-of-flight (ESI-TOF) mass 
spectrometer (Bruker Daltonics) in the positive ion mode.  NaI was used as the calibrant.  
The scan conditions for the spectrometer were: end plate offset, -500V; capillary, +4200 
V; nebulizer, 2.0 bar; dry gas flow, 8.0 L/min; dry temperature, 80ᵒC; capillary exit, 180 
V; skimmer 1, 22.0 V; hexapole 1, 22.5 V; hexapole RF, 600 Vpp; skimmer 2, 22 V; lens 
1 transfer, 88 µs; lens 1 pre pulse storage 23 µs. The range was 500.0–3000.0 m/z, 
averaging 2 × 0.5 Hz.  Spectra were deconvoluted using the Bruker Compass 
DataAnalysis software package. 
Molecular Model: MM3 and MD calculations parameterized using the modified force 
field described by Chan et al. and the dielectric constant for water (78.4) were carried out 
to obtain the minimum-energy structure for apo-βα-rhMT 1a to Zn7-βα-rhMT 1a (20).  
All MM3 and MD calculations and model-structure rendering were carried out using 
CAChe WorkSystem Pro 6.1.1 software (Fujitsu America).  The original Cd7-βα-rhMT 
1a was modified to produce molecular models for Zn5-βα-rhMT 1a (19).  The structure 
was energy minimized using the MM3 calculation followed by the MD simulation at 300 
K for 5000 ps. 
4.3 Results 
4.3.1 Noncooperative metalation of isolated apo-β and apo-α- and 
apo-βα-rhMT 1a by Zn2+   
The mass spectral data recorded during the titration apo-β-rhMT 1a, apo-α-rhMT 1a, 
and apo-βα-rhMT 1a with Zn2+ are shown in Figure 4-2 with their corresponding 
deconvoluted spectra (right hand columns).  Stepwise metalation of apo-β-rhMT (A-E) 
leads to the formation of partially metalated species (Zn1-, Zn2-β-rhMT 1a) at 
substoichiometric equivalents (β < 3 Zn2+).  Complete metalation occurs when 3.5 
equivalents of Zn
2+/β-rhMT 1a are added to solution.  From the data it can be clearly seen 
that the dominant metalation state is a direct result of the number of equivalents of Zn
2+
 
added to solution: at 1.7 eq. Zn
2+
 the dominant species is Zn1-β-rhMT 1a, while at 2.6 eq. 
Zn
2+
 the two most abundant species are fully metalated Zn3-β-rhMT 1a and partially 
metalated Zn2-β-rhMT 1a.  Metal free apo-β-rhMT 1a exhibits charge states 
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corresponding to 4+, 3+ and 2+ at 0.1 eq. Zn
2+
.  The most significant change in the 
charge state profile is the decrease in intensity of the 2+ charge state at 1.7 equivalents of 
Zn
2+
 added to solution.  There is also a 20% decrease in the intensity of the 3+ relative to 
the 4+ charge state when comparing apo-β-rhMT 1a to Zn3-β-rhMT 1a.  Taken together, 
these results suggest that the addition of the first two metal ions stabilize a slightly more 
open conformation of apo-β-rhMT 1a.   
Stepwise metalation of apo-α-rhMT (F-J) leads to the formation of partially metalated 
species (Zn1-, Zn2-, Zn3-α-rhMT 1a) at substoichiometric equivalents (α < 4 Zn
2+
).  The 
dominant metalation state is a direct result of the number of equivalents of Zn
2+
 added to 
solution:  at 2.2 eq. Zn
2+
 the dominant species is Zn1-α-rhMT 1a, while at 3.7 and 3.9 eq. 
Zn
2+
 the dominant species are Zn2- and Zn3-α-rhMT 1a, respectively.  Complete 
metalation is observed at 4.1 eq. Zn
2+
 added to solution, however, there still exists a 
relatively small (~15% of total species present) population of Zn3-α-rhMT 1a, which we 
attributes to slight errors in the calculation of the equivalents of Zn
2+
 added.  Much like 
the β-domain, apo-α-rhMT 1a exhibits significant changes in the  4+, 3+ and 2+ charge 
state distribution when even a low stoichiometric ratio of Zn
2+
 has been added (e.g. 0.4).  
Also like apo-β-rhMT 1a, the 2+ and 3+ charge state decrease in intensity upon addition 
of one equivalent or more Zn
2+
, relative to the 4+ charge state (compare the ESI-mass 
spectral data of apo-α-rhMT to Zn4-α-rhMT).  These changes in the overall charge state 
profile demonstrate that the metalated forms of both β- and α-rhMT, while similar to that 
of the apo-forms of the protein, occupy a somewhat larger volume.   
The mass spectral data recorded during the titration of apo-βα-rhMT 1a with Zn2+ and 
the corresponding deconvoluted spectra are shown in Figure 4-2 (K-O).  As is the case 
for both the β- and α-domain, stepwise metalation of apo-βα-rhMT leads to the formation 
of partially metalated species (from Zn1 to Zn6) at substoichiometric equivalents (βα < 7 
Zn
2+
) confirming the noncooperative nature of the metalation reaction.  The endpoint of 
the titration occurs after 7 equivalents of Zn
2+
 have been added to the solution.  In each 
step of the titration, the dominant metalation state is a direct result of the number of 
equivalents of Zn
2+
 added to solution.  Apo-βα-rhMT 1a exhibits a charge state profile 
that ranges from +8 to +3.  The increase in the total number of charge states, as compared 
to the isolated domains, is because the full protein occupies a larger volume than either of 
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the two isolated domains.  At 2.7 equivalents of Zn
2+
, the dominant metalation states are 
Zn2- and Zn3-βα-rhMT 1a.  A significant reduction in the intensity of the +7 charge state, 
as well as the disappearance of the +8 charge state is also observed at this point.  These 
changes to the charge state envelope suggest that the first metal ion must significantly 
restrict the motion of the protein reducing its volume.  Beyond 2.7 eq. Zn
2+
, there is very 
little change in the +6, +5, +4 and +3 charge state distribution indicating that further 
metalation does not substantially alter the folding of the protein. 
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Figure 4-2. ESI mass spectra recorded during the titration of apo-β-rhMT, apo-α-
rhMT and apo-βα-rhMT, with ZnSO4.  In each column the ESI mass spectral data 
(left) and their deconvolted counterparts (right) were recorded as Zn(II) was added to the 
solution.  Dotted lines follow metal binding.  (A-E) The titration of apo-β-rhMT, 29.2 
µM at pH 9.2, with ZnSO4.  (F-J)  The titration of apo-α-rhMT, 34.1 µM at pH 9.5, with 
ZnSO4.  (K-O) The titration of βα-rhMT, 29.2 μM at pH 9.1, with ZnSO4.   
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4.3.2 Competitive metalation with Zn2+ of the isolated fragments 
containing the β- and α-domains of MT 1a 
The metal binding specificity of each of the two metal binding domains of MT has 
been the subject of many studies.  Yet, no step-wise metalation data have been published 
showing the development of the fully metalated protein from the metal-free apo-protein 
that identifies clearly any specific domain specificity for a metal.  This was determined 
by competitively metalating both the isolated domains with Zn
2+
.  This competitive 
metalation experiment of the isolated β- and α-domains using Zn2+ was monitored with 
ESI-MS.  The value of this technique over those previously used in competition 
experiments is that the exact metalation status of each domain can be monitored for all 
equivalents added during a single titration.  This experimental setup also allows the 
interpretation of results in the context of a noncooperative mechanism of metalation, 
which allows for partial metalation and a continuum of metalated states to exist.  In this 
way one can determine the average metalation of MT and also the exact distribution at 
each step of the titration.  Other competition experiments, such as copper luminescent 
experiments (12), provide only an averaged measure of metalation and not the exact 
speciation over all sites in each domain.  Consequently, it is possible to determine the 
relative affinity of each site in each domain for Zn
2+
 binding from the metalation status. 
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Figure 4-3. ESI mass spectra recorded during the competitive titration of apo-β- 
and apo-α-rhMT with ZnSO4.  Both species were at a concentration of 29.2 µM and at 
a pH of 9.2.  ESI mass spectral data (left) and their deconvoluted counterparts (right) 
were recorded at Zn(II) molar equivalents of 0.4, 2.1, 3.5, 5.4, 7.6, and 8.0.  Dotted lines 
follow metal binding in both β- and α-rhMT.  The most intense species for both the β- 
and α-domain have been normalized to 100% relative abundance.  
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Figure 4-3 (A-F) shows the ESI-MS monitored competition experiment for Zn
2+
 
between the isolated β- and α-domains of MT.  Both domains are present in equal 
concentrations and their metalation status is a function of Zn
2+
 added to solution.  It 
should be noted that there exists a slight Zn
2+
 contaminant, ~0.3 equivalents of total 
protein.  The charge state data (left) have been deconvoluted to obtain the neutral parent 
species (right).  Because two domains are present and each exhibits several metalation 
states, the charge state data are complicated and the deconvolution data fall into two sets 
reflecting the different chain lengths of the β and α fragments.  To our knowledge this is 
the first report of a competition experiment in which metalation data from both domains 
can be monitored at the same time.  Figures 4-4 and 4-5 extract and condense these data 
to show the information contained as function of number of Zn
2+
 equivalents added.  The 
equivalents of Zn
2+
 added to the solution are relative to the total protein concentration of 
a given domain (β-domain plus α-domain).  In this way, one would expect 7 molar 
equivalents to be necessary to fully metalate both domains.  At 0.4 equivalents of Zn
2+
 
added to the solution, it can be seen that metal free (apo-) β-rhMT dominates, but there 
also exists significant Zn1-β-rhMT (relative abundance compared to the most abundant 
metalated species (RA): 70%) and Zn2-β-rhMT (RA: 20%) present in solution.  In the 
case of the α-domain, apo-α-rhMT dominates, but unlike the β-domain, there is very little 
Zn1-α-rhMT (20%).  This strongly suggests that initially metalation of the β-domain is, in 
fact, favored over that of the α-domain when the fragments are studied.  At the 3.5 Zn2+ 
point, (Figure 4-3C) the dominant metalated species are Zn2-β-rhMT and Zn1-α-rhMT, 
respectively.  The metalated profiles observed at 5.4 Zn
2+
 added (Figure 4-3D) are similar 
for both domains.  Prior to this point in the titration, the β-domain consistently binds 
more Zn
2+
 than the α-domain, so this equalizing of the metalated species would suggests 
that the KF for the third binding site for the β-domain, that is the conversion of the Zn2-β-
rhMT with its terminal-Cys-bonded Zn
2+
 (no bridging interactions) to the clustered Zn3-
β-rhMT, is substantially weaker than the previous two. 
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Figure 4-4. The normalized metalation properties of the β- and α-domains.  (A) 
The % metalation of the individual isolated domains (B) The % metalation of the isolated 
domains present in direct competition with each other for metal ions.  The associated 
metalation data for the β-domain is labelled with a solid line ( ), while the α-
domain is labelled with a dashed lined ( ). 
 
This interpretation is based on the uniquely rich nature of these data in which almost 
identical cysteine binding sites compete for the same metal.  In addition, the distribution 
of the Zn
2+ 
(1-bound, 2-bound, etc.) provides a much greater resolution of the binding 
pathway than a simple average and leads to the step-wise data shown below.  The change 
in metalation status of the β-domain can be interpreted as resulting from the necessity for 
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the onset of cluster formation that involves three bridging cysteine residues (Fig 1B) 
when its 9 cysteine residues accommodate all three Zn
2+
 ions.  In sharp contrast, the α-
domain, with 11 cysteine residues, requires only a single shared cysteine residue to bind 
three Zn
2+
 ions.  Complete metalation of the β-domain occurs at 7.6 Zn2+ added (Figure 
4-3E), at which point the α-domain still exists as a mixture of Zn2-, Zn3- and Zn4-α-
rhMT.  Complete metalation of the α-domain is observed at 8.0 eq Zn2+ added (Figure 4-
3F) at which point 5 cysteines are bridging (Figure 4-1).   
Figure 4-4 shows the normalized metalation of the fragments with the isolated 
domains as a function of added Zn
2+
.  In these plots, the fully metalated protein status is 
100% (that is, 3 Zn
2+
 for β and 4 Zn2+ for α).  Figure 4-4A depicts the relative metalation 
of the isolated domains with Zn
2+
 in the absence of any competitor - that is simply the 
metalation of the domains themselves.  Clearly, both domains have similar metalation 
properties, although the β-domain has an advantage over the α-domain.  The 60% mark 
for the β-domain represents the binding of 2 Zn2+ and the change in slope may be 
interpreted as the effect of the extensive bridging required to add the 3
rd
 Zn
2+.  The α 
domain can add 3 Zn
2+
 (75% mark) before significant bridging is required.   
Figure 4-4B shows the normalized metalation of the two domains when in direct 
competition for the added Zn
2+
.  This Figure 4-4 demonstrates that the β-domain 
dominates the titration, completely metalating before the α-domain.  The pause in 
metalation for the α domain at about the 80% mark represents the change from 3 Zn2+ to 
4 Zn
2+
 bound.  These plots highlight the importance of the competition reaction in 
determining the relative metalation of the two domains.  The data suggest that when 
sufficient Zn
2+
 is added, the β domain simply competes directly with the α domain and 
continues to complete metalation.   
4.3.3 Speciation of the β and α fragments with isolated domains-
effect of domain competition 
Figure 4-5 shows the relative abundances of each individual Zn-species formed during 
the metalation of the two isolated fragments and during the competitive metalation 
reaction extracted from the experimental data shown in Figures 4-2 and 4-3 above.  The 
top row of plots (A, C, E) represent the individual Zn-loading as a function of Zn
2+
 added 
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for the β domain and the results of modeling the KF's for each of the three steps.  The 
bottom row of plots (B, D, F) represent the individual Zn-containing species as a function 
of Zn
2+
 added for the α domain and the results of modeling the KF's for each of the four 
steps.  For the isolated fragments (A, B), that is for metalation with no competitor (see 
Figure 4-2 A-E and F-J) we see that the increasingly metalated species coexist throughout 
the metalation reaction until metalation is complete at 100%.  For the β domain, Zn2- 
overlaps Zn1-, followed by almost 100% formation of Zn3-.  On the other hand, the α 
domain metalates stepwise with even the Zn4- species forming while a mixture of Zn2- 
and Zn3- have appreciable content.   
The effect of competition for the Zn
2+
 by the two domains (C, D) is of critical 
importance because the two peptides offer slightly different KF`s for the specific Zn
2+
 
binding so these data allow resolution of each individual step in the metalation pathway.  
Clearly, the data in Figure 4-5 C and D show that the metalation steps are spread out 
compared with A and B - this means that there is direct competition for the Zn
2+
 as the KF 
decreasing as the number of Zn
2+
 ions bound increases.  For example, at the Zn
2+
 added 
point of 4 in (C) there is a mixture of Zn2 (50%), Zn1(25%), Zn3 (25%) - compare this 
mixture with the Zn
2+
 added point of 2 (as the molar ratios of the Zn
2+
 added are scaled 
for the presence of both fragments, 4 approximately scales to 2) for the isolated domain 
in (A): here Zn1 is 60%, Zn2 is 10% and apo is still 20%.  Similar data are observed for 
the α domain (D).    
A model was produced in which the competing sites, each with their own KF values, 
were metalated (Figure 4-5).  The dependence of the individual metalated species on the 
amount of Zn
2+
 ions added to solution are shown for the β-domain, as (E), and the α-
domain, as (F).  The appearance and disappearance of the individual Zn-species was 
modeled by a series of declining KF's for the 7 Zn
2+
-binding steps (E,F), based upon the 
KF values reported by Krezel and Maret (21).  The model emphasizes a steeper decline in 
KF when terminal Cys have been exhausted (at 2 Zn
2+
 bound for the  domain and 3 Zn2+ 
bound for the α domain) arguing that terminal coordination (a cysteine residue that does 
not bridge) is thermodynamically preferred as is expected and now confirmed 
experimentally. 
91 
 
 
 
Figure 4-5. ESI-MS relative abundances for the metalation chemistry of the two 
isolated domains.  Metalation of apo-β-rhMT (A), apo-α-rhMT (B), as well as their 
respective metalation under competitive conditions (C) and (D), respectively, using Zn
2+
 
to form Znn, where n corresponds to the number of metals bound. Simulation of the 
metalation of both the β- and α-rhMT domains were also performed, in which the 
log10(KF) association constants for the α-domain were 10.4, 9.8, 9.3 and 8.6, while the β-
domain was 10.4, 9.9 and 9.2.  Each line corresponds to a different metalation state: Zn0(
), Zn1( ), Zn2 ( ), Zn3( ), and Zn4( ). 
4.3.4 Competitive metalation of the isolated β- and α-domains and full 
protein of MT 1a using Zn2+ 
Figure 4-6 shows the experimental ESI mass spectral data when the metal-free β and α 
fragments are mixed with the full βα-protein and Zn2+ is added incrementally.  This 
experimental arrangement allows comparison of the relative binding constants of the 14 
individual Zn
2+
 binding sites spread over the two fragments and the full protein.  The 
mass spectral data in Figure 4-6 (A-G) are complicated as there is a superposition of the 
charge states for each of the two fragments and the full protein for each metalated state.  
The deconvolution data (on the right hand side) provides greater clarity, and we have 
added guideline for each of the three protein species showing the metalation state.  From 
these data further data sets can be extracted (i) the 'life' of each metalated species up to 
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full saturation, Figure 4-7, and (ii) the average saturation for each species as a function of 
added Zn
2+
 during competition, Figure 4-8.  Those fractional loadings were modeled 
quite accurately based on the 14 KF values, Figure 4-9. 
The transient life of each metalated species in the three-protein competition 
experiment is shown in Figure 4-7.  The data in (A), (B) and (C) are the species 
dependence for the isolated β-fragment, the α-fragment and the full βα-protein in the 
absence of competitors, as described earlier from Figure 4-5 and included here to allow 
direct comparison of the effect of competitive binding.  Figures 4-7 (D, E, F) show that 
the individually metalated species exist for a wider range of added Zn
2+
.  Interestingly, 
Zn1- and Zn2- for both β- and α- form synchronously.  Zn3-β-MT is formed completely 
before Zn3-α-MT and therefore, before Zn4-α-MT.  Panel (F) shows the sequential 
metalation of the βα-apo-MT.  A number of important points can be made.  First, Zn1-, 
Zn2-, and Zn3-βα-rhMT all form when just the Zn1- of the isolated domains forms.  This 
is predicted by the As-analysis of Ngu, et al. because there are simply more available 
sites in the βα-MT than in the isolated domains so the KF's of these first 3 sites of the full 
protein dominate.  Zn4- in (F) exists over a wide range of added Zn
2+
 (2, 18, 22).  Zn5-6-7 
form over a relatively narrow range of added Zn
2+
 once the two domains are completely 
metalated.   
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Figure 4-6. ESI mass spectra recorded during the competitive titration of a 
solution containing equimolar concentrations of apo-β-, apo-α-, and apo-βα-rhMT 
with ZnSO4 at pH 7.8.  ESI mass spectral data (left) and the deconvoluted counterparts 
(right) were recorded as aliquots of Zn(II) were added to the protein at molar equivalents 
of 1.8, 4.6, 6.4, 9.3, 10.3 and 12.5.  Dotted lines follow metal binding in both β-, α- and 
βα-rhMT.  The most intense species for both the β- and α-domain have been normalized 
to 100% relative abundance. 
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The model was applied to the 3-protein metalation (Figure 4-6) to produce Figure 4-7 
as (G), (H), and (I).  The traces shown are the predictions for the simultaneous formation 
of the metalated species based on 14 coupled KF values.  The model requires the KF 
values to decline as a function of metalated number as expected for non-cooperative 
binding.  The very close alignment of the simulation with the very complicated 
experimental data strongly supports the model: that there are declining KF values and 
especially, a sharper reduction when the terminal Cys (cysteine residues bound to one 
metal ion) are exhausted for each protein and cluster formation begins using bridged Cys. 
 
Figure 4-7. ESI MS relative abundance for the metalation chemistry of the two 
isolated domains and full MT protein.  Metalation of apo-β-rhMT (A), apo-α-rhMT 
(B), apo-βα-rhMT (C), as well as their respective metalation under competitive 
conditions (D) and (E), and (F), respectively, using Zn
2+
 to form Znn, where n 
corresponds to the number of metals bound.  A simulation of the metalation of both 
domains and the full MT protein was also performed, in which the log10(KF) of the 
association constants for the α-domain were 10.4, 9.8, 9.3 and 8.6, while for the β-domain 
were 10.4, 9.9 and 9.2, and finally for the full MT protein were 11.8, 11.2, 10.6, 10.0, 9.4, 
8.8 and 8.2.  Each line corresponds to a different metalation state: Zn0( ),   Zn1(
), Zn2( ), Zn3( ), Zn4( ), Zn5( ), Zn6( ) and Zn7( ). 
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Figure 4-8.  Average metalation properties of the isolated β- and α-domains and 
the full MT protein as a function of added Zn
2+
.  (A) The average number of metals 
bound to all three species: β-domain ( ), the α-domain ( ) and, finally, 
the full MT protein ( ) in separate solutions (based on data in Figure 4-2).  (B) 
The average number of metals bound in the competition reaction between the isolated 
fragment domains and full MT protein (based on data in Figure 4-6).  (C) Comparison 
between the sum of the average Zn
2+
 metalated states of the two isolated domains as a 
function of added Zn
2+
when competing with the full protein ( ) and the average 
Zn
2+
 metalated state of the full MT protein ( ).  The lines show that the full 
MT protein is able to outcompete the sum of the isolated domains up until it has bound 4 
Zn
2+
 ions.  After that point, the two isolated domains outcompete the full MT protein.   
 
Figure 4-8 provides the average metalation data for two experiments: first metalation 
of the two isolated fragments and the full protein, and second the single competition 
experiment in which the full MT protein and the isolated fragments compete for the same 
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Zn
2+
 as described above.  Figure 4-8A demonstrates that for metalation in the absence of 
a competitor, metalation of both the isolated domains and full MT protein proceeds in a 
similar manner initially.  In isolation, the only observable change in the slope of 
metalation occurs at approximately the 2 molar equivalents of Zn
2+
 added to solution for 
the β domain, 3 for the α domain, and 5 for the full βα-protein.  These changes can be 
interpreted as arising from the onset of cluster formation - that is the points at which 
cysteine residue bridging must occur for metalation to continue.  However, when a 
competitor is present (Figure 4-8B), significant differences in the affinity of each 
component of the solution become apparent because now, first the β- clearly outperforms 
the α- domain but also, they both metalate at a lower fraction than the full protein.  Figure 
4-8B shows that at each molar equivalent of Zn
2+
 added to the solution up to 4, the full 
MT protein has bound more metal ions than the sum of the two isolated domains. 
Significantly, when the metalation status of the isolated domains is summed (Figure 4-
8C) so that the total of Zn
2+
 bound in sites on the isolated fragment domains can be 
compared directly with the Zn
2+
 bound in the full protein, we see that, in fact, the full 
protein dominates at added Zn
2+
 molar equivalents <8; after this point the sum of the 
isolated domains dominates.   
This result is surprising, since it has been a traditional view of metallothionein 
chemistry that the two domains of mammalian MT act in isolation, and consequently that 
the metalation of the isolated domains should be equal to that of the full MT protein - that 
is the two domains in the full protein are expected to perform like the two domains in 
isolation.  Our interpretation of this result is that the 5-Zn-species using all 20 Cys with 
no bridging interactions must now rearrange significantly to allow the 6
th
 Zn
2+
 to be 
bound.  In effect this is the point at which the domain structure of the metallothionein 
first develops.  We interpret these results to mean that at the 8 molar equivalents of Zn
2+
 
added point the full MT protein must have a significant drop in the value of KF for further 
metalation (the 6
th
 and 7
th
 Zn
2+
) compared with KF (Zn3-β-) and KF (Zn3-4-α-).  Based on 
the distribution of Zn
2+
 at this stage in the metalation profile (Figure 4-6 F) it is likely 
that a Zn5-βα-rhMT 1a species using all 20 cysteine residues exists and must significantly 
rearrange to allow a 6
th
 Zn
2+
 ion to bind.   
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The experimental data in Figure 4-8B and 4-8C were modeled based on the KF values 
determined by Krezel and Maret (21) and extrapolated following the trends reported by 
Ngu et al. (2, 18).  Figure 4-9 shows the results of this modeling.  The calculated 
metalation not only predicts the crossover in metalation loading between the full protein 
and the sum of the two isolated domains correctly simulated but also the unusual trends 
between 0 and 4 molar equivalents of Zn
2+
 added to solution.  Most importantly, the KF 
values used for this model are based on the assumption that the requirement for bridging 
Cys leads to a significant decrease in KF for each step after 5 Zn
2+
 have bound to all 20 
cysteines in a terminal fashion (bound to only one metal ion).  Most significantly, the 
data show that it is the 6
th
 Zn
2+
 ion that forces the two domain structure to form. 
 
Figure 4-9.  A model of the average metalation properties of the β- and α-domains 
and the full MT protein as a function of added Zn
2+
.  The calculated average number 
of metals bound to all three species taken from Figure 4-7 (G, H, I): β-domain (blue), the 
α-domain (green) and finally the full MT protein (magenta), as well as the sum of the 
average Zn
2+
 metalated states of the two domains (black).  The modeled lines are based 
upon log10(KF) values for the α-domain of 10.4, 9.8, 9.3 and 8.6, while for the β-domain 
of 10.4, 9.9 and 9.2, and finally for the full MT protein of 11.8, 11.2, 10.6, 10.0, 9.4, 8.8 
and 8.2.  Significantly, the full MT protein outcompetes the sum of the isolated domains 
in the first part of the titration (<8.5 equivalents of Zn
2+
 added to solution), while after 
this point the sum of the isolated domains dominates.  In addition, the crossover between 
the modeled full MT and sum of the isolated domains is at an average number of metals 
bound of 4.5.   
98 
 
 
4.4 Discussion 
To understand the role of metal binding in MT, a large number of metalation, 
demetalation and metal replacement experiments have been reported under both 
equilibrium and kinetic conditions (1-2, 18, 23-24).  Several of these studies have used 
competitive chelators to determine the affinity of MT for its metal ions (21, 25).  To date 
no single experiment has studied the simultaneous competition reaction between the β- 
and α-domains and the full MT protein yet one of the most important questions about the 
metalation properties of metallothioneins concerns the role of the two domains.  ESI mass 
spectrometric studies have focused on both the mechanism of metalation of MT, 
determined for Cd
2+
, As
3+
 and Bi
3+
, and the kinetics of metalation, specifically As
3+
 
metalation (17-18, 26-27). 
In the study described here, we have used the very similar KF values of the Zn
2+
 
binding sites in the isolated fragments containing the β and α domains to compete for the 
incoming Zn
2+
 binding to the two-domain, βα-full protein.  We show in the data 
presented in this study the discriminating power of ESI-mass spectrometry to provide 
both simultaneous and detailed information about all three species and their respective 
dynamic metalation states. By using both the full MT protein and its isolated fragments 
as competitors, the relative metal binding affinity of each species is shown.  These results 
are important, since they provide insight into the possible structures that exist and take 
part in cellular chemistry. 
Initially the metalation properties of the isolated fragments and full protein were 
determined separately (Figure 4-2).  Through an analysis of the changes in the charge 
state profile, and their respective deconvoluted spectra, the effect of metals on protein 
folding can be determined.  The two isolated domains both possess similar charge state 
envelopes throughout the titration, with a slight increase in size upon binding of the first 
Zn
2+
 ion following which the charge state distributions remains constant with the 4+ state 
dominating both fragments when fully metalated with Zn
2+
.  The prominent charge state 
for the apo-two-domain βα-MT is 5+ with about equal contributions from 6+ and 4+.  
Metalation results in an increase in 6+ and a reduction in 4+ suggesting that the apo- and 
metalated proteins are of similar, but not identical, volume.  Additionally, the data in 
Figure 4-2 show clearly that Zn
2+
 metalation takes place step-wise.  These results are 
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fundamental because they establish that metalation of MT and its fragments using the 
biologically relevant Zn
2+
 occur in a noncooperative manner. 
Under a noncooperative mechanism of metalation, partially metalated species may be 
stable and able to take part in cellular chemistry.  Consequently, instances in which 
partially metalated forms of the protein have been purified could in fact represent the 
biologically relevant in vivo forms of the protein.  For example, mouse heart MT has 
been isolated from the organism in a partially oxidized form, where the formation of 
disulfide bonds has been implicated in zinc release necessary to combat the oxidative 
pressures (28).  The twenty cysteine residues present in mammalian MT have long made 
it an attractive agent to combat oxidative stress with concomitant formation of disulfide 
bonds (29).  Under this new mechanism of metalation, MT can now be understood to 
combat oxidative stress in a dynamic way, where progressive oxidation of MT leads to 
the sequential release of Zn
2+
 ions and eventually complete oxidation (or thionin 
formation).  This released Zn
2+
 can then bind to the metal response element binding 
transcription factor 1 (MTF-1) (30).  Zn-MTF-1 leads to an upregulation of MT, and 
other associated proteins, thus combating the oxidative stress. 
The competition experiments provide a detailed view of the Zn
2+
 binding because the 
distribution of the Zn
2+
 between sites is governed by the relative magnitudes of KF.  Our 
interpretation of the data presented here is that when the isolated β- and α-domains 
compete for metals, the β-domain preferentially binds the first Zn2+ ion added to solution.  
There appears to be a decrease in the affinity of the β-domain, relative to the α-domain, 
for the third Zn
2+
 ion to form Zn3-β-rhMT (Figure 4-3).  This decrease in relative affinity 
is likely the result of the 3 bridging interactions necessary to form Zn3Cys9 in the β-
domain, whereas the α-domain only requires 1 bridging interaction to form Zn3Cys11.  
This result was surprising, because Cd-NMR metalation studies by Good et al. using 
rabbit liver MT 2 suggested that the α-domain binds the first four Cd2+ ions, after which, 
any additional metal ions populate the β-domain (31).  This paper also showed the 
presence of a broad 
113
Cd-NMR signal centered at 684 ppm.  This peak, which was not 
identified, could be the result of submetalated species (Cd1-3-rlMT 2), in which the 
abundance of free cysteinyl-thiols allows for tetrahedral coordination to terminal thiols 
for all Cd
2+
 ions.  In NMR studies, the signals associated with the α-domain are 
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significantly more intense than those associated with the β-domain, which is due to an 
increase in fluctionality of the β-domain.  It could be that these weaker signals of Cd3-
cluster could not be detected leading to the conclusion that the α-domain clusters first 
(32).  Based on our interpretation, we modeled the competition reaction for the two 
isolated domains.  Figure 4-5 E and F shows the formation of the individual metalated 
states.  The model very closely matches the experimental data and supports the formation 
of the Zn-β species with at least similar KF(n) values for n=1 and 2 compared with the α-
domain. 
The more challenging experiment allowed for all three species to compete for the 
Zn
2+
.  This pitted the relative values of 14 Zn
2+
 sites with 14 distinct KF values.  The ESI-
MS data allow for the first time the observation of all the metalated species 
simultaneously.  Significantly, and fundamental to the conclusions of this paper, the data 
show that the full protein exhibits higher relative KF values for the first 4-5 Zn
2+
 than the 
isolated domains.  The KF values of all three proteins are essentially in balance and 
therefore equal when the fifth Zn
2+
 ion binds to the -MT (Figures 4-7 and 4-8). After 
this point, the isolated fragments metalate at the expense of the full protein.   
In previous metalation studies, 
113
Cd-NMR data have shown that the chemical shifts 
observed for the α-domain of MT are not affected by either the digestion of the β-domain 
by subtilisin (33) or the identity of the metal ions in the β-domain (either Cd2+ or Cu+) 
(11).  In addition, MT structures have been determined from several sources and in no 
case were interdomain NOEs observed (7-8, 34).  Not until very recently has this view 
been challenged with reports of metalation in excess of traditional levels forming a single 
Cd8Cys20 cluster (9-10, 35-36).   
Previous metal binding studies of β-, α-, and βα-MT with arsenic by Ngu et al. 
demonstrated the affinity of MT for metal ions is directly dependent on the number of 
still-available binding sites (2, 18, 22).  The same trend is observed here with initial 
metalation of MT by Zn
2+
 being dominated by the full protein and not the isolated 
domains that individually contain fewer metal binding sites.  These results are critical 
because they show that 1) there is no domain preference for Zn
2+
 until terminal thiolates 
bridge, 2) bridging interactions lead to a significant decrease in the KF values observed, 
3) KF are directly proportional to the number of available binding sites. 
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From our results, we can see that the proposal by Ngu et al. is followed up to the 4-5 
Zn
2+
 added point, afterwhich the sum of the zinc bound by the isolated domains exceeds 
that in the full MT protein (2, 18, 22).  The key species is the formation of Zn5-βα-rhMT.  
Binding of the fifth Zn
2+
 ion can only occur in one location, thus locking a submetalated 
MT structure that consists of solely terminal Cys thiols.  Additional metalation to Zn6-βα-
rhMT requires bridging interactions that must occur and lead to the eventual formation of 
the traditional Zn7-βα-rhMT, where neither domain interacts.  The significant decrease in 
KF (Zn6, Zn7) past Zn5-βα-rhMT, compared to the sum of the two domains, is strong 
evidence for the existence of a single domain up to the Zn5- point and the complete 
rearrangement of the binding site to the conventional, two-domain structure for Zn6- and 
Zn7-.  Unlike the two isolated domains, the full MT protein contains a total of 20 cysteine 
residues, which could potentially bind 5 Zn
2+
 ions without any bridging interactions.  If 
this is the case, then a metal binding ‘islet of stability’ should exist for Zn5-βα-rhMT, 
where KF for the conversion of Zn5-βα-rhMT to Zn6-βα-rhMT is sufficiently low to allow 
near quantitative formation of Zn5-βα-rhMT.  The presence of Zn5-βα-rhMT would help 
to explain inconsistencies observed between the activity of the isolated fragments and the 
full protein.  For example, the recovery of mice whose cortex had been cryoinjured 
occurred at different rates when exposed to either of the isolated domains, or the full 
protein (37).  In fact, maximal recovery was only observed for the full protein, while the 
isolated α-domain demonstrated some detrimental effects.  If the metalation properties 
and related functions are simply the sum of the two domains, then it is odd that the in 
vivo recovery rates were not merely the summation of the two isolated clusters. 
Because Zn
2+
 is spectroscopically silent, it is difficult to determine the exact 
metalation state that leads to cluster formation spectroscopically (38-40).  However, Co
2+
 
with its rich spectroscopic properties has been extensively used to mimic Zn
2+
 binding to 
MT because of its characteristic tetrahedral coordination with thiols.  Uniquely, the 
electron paramagnetic resonance (EPR) spectroscopic intensity of Co
2+
 is directly related 
to not only the number of Co
2+
 atoms present in MT, but also to the number of 
nonclustered Co
2+
 centers (39).  In seminal work by Vasak and Kagi, MT was titrated 
with Co
2+
 and the EPR signal measured.  Analysis of the data when plotted as a function 
of added Co
2+
  showed an increase in the number of free spins until 4 molar equivalents 
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of Co
2+
 had been added, after which it was proposed that antiferromagnetic coupling led 
to a decrease in the signal intensity reaching near zero at the 7 added Co
2+
 point.  These 
data were interpreted as cluster formation occurring after 4 metal ions have been added.  
We have mimicked the EPR experiment using our data that shows the exact distribution 
of metals in nonclustered (up to 5 Zn
2+
 bound) and clustered (6 and 7 Zn
2+
 bound) 
binding sites assigning a spin to the nonbridging Zn
2+
 ions in a Co
2+
 fashion, while 
cancelling the spins when clustering occurs (Figure 4-10).  We should note that the ESI-
mass spectral data provide the exact speciation and fraction making up the average 
loading, information absent in the Co-binding experiments where the average was 
assumed to represent a single speciation.  We used the following rules to simulate the 
observed magnetic moment: Zn1- through Zn5-MT are formed without any bridging 
interactions, and consequently increase the EPR signal, after which the formation Zn6- 
and Zn7-MT require four and eight bridging interactions, respectively, and consequently 
decrease the signal due to antiferromagnetic coupling.  The simulated EPR data, Figure 
4-10, closely resemble the original Co
2+
 data with identical maxima at 4.  Interestingly by 
using these rules, our data also show maximal intensity at an average of four filled 
binding sites.  While we would intuitively predict 5 molar equivalents would be 
necessary for maximal intensity, the noncooperative nature of metalation requires that 
some M6-MT must also exist at this metal loading.  In the Co
2+
 titration, this species 
would greatly decrease the signal intensity.  We suggest that the close similarity between 
our modeled data and the original Co
2+
 data, supports our interpretation of the ESI-MS 
data that clustering does not occur until the 6
th
 metal ion is added and that Zn5-rhMT is a 
single domain species that does not involve bridging Cys. 
A recent paper by Krezel and Maret demonstrated the presence of three sets of binding 
affinities: four Zn
2+
 ions that bind strongly (logK = 11.8), two with intermediate affinity 
(logK~10) and finally a single weakly bound Zn
2+ 
(logK = 7.7) (21).  The strong affinity 
sites were interpreted as binding to the α-domain and the weaker sites to the β-domain.  
The data presented here suggest that the large KF’s are associated with Zn1-Zn4 formation 
and the two smaller values with Zn5 and Zn6, and finally the weakest is associated with 
Zn7.  For the modeling presented herein (Figure 4-5, 4-7, 4-9), we have based our 
modeling calculations on these previously reported association constants.  However, in 
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addition to these values, we have also incorporated the metalation work by Ngu et al., 
which states the affinity for metal ions is directly related to the number of available 
binding sites (2, 18, 22).  The final result is a series of association constants that decrease 
as the number of Zn
2+
 ions bound increases, and is related to the maximum and minimum 
previously determined association constants.  These differences in affinity suggest that 
under oxidative stress, MT may lose metal ions in order to deactivate the toxic insult. 
MT is often cited as a protective agent against oxidative stress, where the balance of 
metalated MT to metal free MT mediates the redox chemistry of the cell (29, 41-42).  
This view however, does not take into account the noncooperative nature of the 
metalation of metallothionein.  It is likely that the average metal load of MT is what 
dictates the oxidative environment of the cell. DFT calculations of the reactivity of 
polynuclear zinc-thiolate sites have shown the mononuclear ZnCys4 moiety to be more 
nucleophilic than either of the two fully metalated Zn3Cys9- and Zn4Cys11-clusters (43).  
Given this information and the work presented here, even though Zn5-βα-rhMT possesses 
no free thiol groups, it should be able to take part in cellular chemistry as a protecting 
agent against oxidative stress.   
Figure 4-11 shows the results of a series of molecular dynamics calculations that 
illustrate the structural changes that occur during the progressive metalation by Zn
2+
 of 
apo-βα-rhMT to the intermediate Zn5-βα-rhMT, and finally Zn7-βα-rhMT.  In the case of 
apo-βα-rhMT (A), the minimized (5,000 ps) structure resembles that reported by Rigby et 
al. showing a collapse of the traditional dumbbell shape of metalated MT into a more 
globular structure with the free thiols of the 20 cysteines aligned on the surface (44-46).  
Tetrahedral Zn
2+
 coordination by terminal Cys was arranged for the first five Zn
2+
 ions 
forming a single 5-Zn-20-SCYS binding domain.  The significant feature of the model is 
that with 5 Zn
2+
 all 20 Cys are terminal ligands, yet despite the lack of cluster formation 
the overall three-dimensional structure of the protein closely resembles that of the fully 
metalated protein with 7 Zn
2+
.  The ramification of this is many techniques will not detect 
the change from non-clustered to the clustered domains as a function of metalation status. 
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Figure 4-10. Simulated EPR titration.  Simulated spin magnitude calculated by 
assuming the Zn
2+
 have the same spin as Co
2+
.  Metal ion speciation was obtained from 
the titration of MT with Zn
2+
 based on the data shown in Figure 4-2.  The average 
number of simulated spins was determined from the following rules: 1) From M1-βα-
rhMT to M5-βα-rhMT, the number of metal ions present is equal to the number of 
unpaired spins; 2) the number of spins associated with the M6-βα-rhMT species is equal 
to that of M5-βα-rhMT minus 4 due to the bridging interactions required for clustering of 
the α-domain; 3) formation of M7-βα-rhMT leads to a complete spin pairing as a result of 
full clustering of both domains.  In the original Co
2+
 titration of MT the loss of signal was 
associated with antiferromagnetic coupling required for cluster formation (39). 
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Figure 4-11. Molecular models of the metalation of MT from apo- to Zn7.   Ribbons 
show the backbone, with the zinc atoms represented as green spheres and sulfur atoms as 
yellow spheres.  The N-terminal β domain is located on the left hand side, while the C-
terminal α domain is located on the right-hand side.  (A) Metal-free, apo- βα-rhMT 
showing an essentially spherical structure with the cysteinyl sulfurs on the outside.  (B) 
The single domain Zn5-βα-rhMT structure.  The structure was created by assigning a 
single Zn
2+
 ion to every 4 consecutive cysteine residues with respect to the sequence.  (C) 
Development of the two-domain structure with cluster formation in the α domain (right 
lobe) in Zn6-βα-rhMT; (D) Formation of the filled two-domain cluster structure with 
addition of the 7
th
 Zn
2+
 into the β domain in Zn7-βα-rhMT.  Structures were calculated 
using a locally modified force-field with MM3/MD methods for molecular modeling 
(20). Minimization of the structures was carried out for 5000 ps at 300 K.  The conformer 
with the lowest energy is presented above.  The initial structure of the Cd7-βα-rhMT 1a, 
modified for all subsequent structures, was provided by Chan et al. (19). 
 
It is interesting to note that even when there are no bridging Cys present, the model of 
Zn5-βα-rhMT shows that the two Zn
2+
 bonded to the β-domain Cys (ie within residues 1-
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36, Figure 4-1) and the three Zn
2+
 bonded to the α-domain  Cys (ie within residues 37-74) 
are spatially close to one another.  This likely facilitates cluster formation upon further 
metalation to the more traditional two-isolated domains of Zn7-βα-rhMT.    
4.5 Conclusion 
In this study, we demonstrate that Zn
2+
 metalation occurs in a noncooperative manner 
in the same way as for Cd
2+
 and As
3+
 reported previously for the human MT 1a protein.  
Further, in detailed studies of the metalation reaction itself, we show that with the onset 
of cluster formation, which is defined by the use of bridging Cys thiolate ligands rather 
than terminal Cys, that there is a significant decrease in the Zn
2+
 binding affinity to MT 
and its domains for further metalation.  The switch from terminal to bridging Cys to 
accommodate an increase in Zn
2+
 in the binding sites reduces the binding affinity.  The 
individual metalated states can be identified and followed in the ESI-mass spectral data 
and in competition experiments in which the two isolated fragments compete for the 
same metal as the full protein, that the full MT protein has a superior ability to initially 
bind Zn
2+
 (Zn
2+
< 4) but upon binding of the fifth metal ion, the sum of Zn
2+
-bound to the 
isolated domains dominates.  These mass spectral data allow us to conclude for the full 
MT protein that the decreasing association constants necessary for a noncooperative 
mechanism of metalation allow formation of a stable Zn5-βα-rhMT species, which 
contains no bridging interactions.  This is a single binding site domain and is 
mechanistically a key member of the metalation pathway from apo-MT to the fully 
metalated Zn7-MT.  Our recently published study on the supermetalation of MT 1a, 
where addition of an 8
th
 Cd
2+
 ion leads to the coalescence of the two domains to form one 
‘super-domain’ (9), suggests a fundamentally altered view of the metalation properties of 
MT from that of maintaining two-domains, regardless of metal depletion, to a new 
structural characterization of MT, where MT exists as a flexible, single domain protein 
during initial metalation (<5 eq.) and metalation in excess of traditional levels.  
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Chapter 5. Supermetalation of the beta domain of 
human MT 1a
5 
5.1 Introduction  
Metallothionein (MT), first characterized in 1957 (1), is a cysteine rich protein 
implicated in heavy metal detoxification, metal ion homeostasis and protection against 
oxidative stress (2-3). However, despite half a century of intensive research, specific 
roles for MT in living organisms are still largely unknown.  One of the reasons for the 
uncertainty of function is that until very recently the mechanism of metalation of 
metallothionein was thought to proceed in a cooperative manner (4-5), in which the 
binding of one metal acts to facilitate the binding of subsequent metals.  Under this model 
the only structures of biological significance would be the fully metalated or completely 
demetalated species, and any partially metalated species would likely be too unstable to 
have a specific role.  However, new studies have shown metalation to occur in a 
noncoooperative manner for Cd
2+
 and Zn
2+ 
(6-8), as well as As
3+ 
(9-10).  Most 
significantly, a noncooperative mechanism allows for partially metalated and metal 
exchange intermediates to be stable and, therefore, to be able to take part in cellular 
chemistry. 
To further complicate matters recent papers have proposed the existence of 
supermetalated forms of metallothionein, that is proteins where metalation is in excess of 
normal maximum levels, calling into question the so-called “magic numbers” of metal 
binding (11-12).  Supermetalated forms have been reported for a single additional 
cadmium ion binding to both the isolated α domain of human MT-1a (Cd5-α-rhMT 1a) 
(13) and the full human MT-3 protein (Cd8-βα-hMT 3) (14).  Because the cadmium ions 
in MT-1 and -2 isomorphously replace zinc ions, these results suggest that this additional 
metal site may be involved with metal ion homeostasis and may be considered as a model 
for metal-exchange intermediates. In addition, the supermetalated site may also be 
                                                 
5
A version of this work has been published: 
Reproduced with permission from D.E.K. Sutherland, M.J. Willans and M.J. Stillman 
Biochemistry 49 (2010) 3593-3601. Copyright 2010 American Chemical Society. 
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connected with the mechanism for binding of incoming metals with binding affinities 
greater than the resident zinc, for example the essential copper(I) and the toxic 
cadmium(II).  To account for the supermetalation of hMT-3, Meloni et al. have proposed 
the involvement of both the α and β domains in stabilizing the additional metal ion (14).  
However, previous studies involving the oxidation of hMT-3 with nitric oxide (15), as 
well as the lack of long range interdomain peaks associated with the nuclear overhauser 
effect (NOEs) in the solution structure of hMT-3 (16), in fact suggest that little domain 
interaction is involved.  Taken together, these metalation properties emphasize the need 
for precise information on the specific properties of the individual domains in defining 
the function of MT as a whole.  
The many members of the metallothionein family have each developed unique metal-
binding sites and domain structures, with different metal binding properties.  Mammalian 
metallothionein consists of a total of 20 cysteine residues (9 in the N-terminal β domain 
capable of binding 3 Zn
2+
/Cd
2+ 
and 11 in the C-terminal α domain capable of binding 4 
Zn
2+
 or Cd
2+
) (17).  While the seaweed Fucus vesiculosus contains a total of 16 cysteine 
residues (7 in an as yet uncharacterized N-terminal γ domain and 9 in the C-terminal β 
domain, both able to bind 3 Zn
2+
 or Cd
2+
) (18).  Each of these proteins uses the thiolate 
sulfur of cysteine residues to coordinate the bound metals.  Other coordinating amino 
acids have also been identified, with bacterial metallothionein SmtA binding four Zn
2+ 
atoms through 9 cysteine and 2 histidine residues (19).  Furthermore, the Zn
2+
 atom 
coordinated to the two histidine residues was inert to metal exchange and it was 
postulated that this stable metal allowed maintenance of the structure during metal 
depletion.  Recently the C-terminal βE domain of Tricium aestivum, a common wheat 
consisting of a two metal-thiolate domain structure with 17 cysteine residues (6 in the N-
terminal domain capable of binding 2 Zn
2+
 or Cd
2+ and 11 in the βE domain capable of 
binding 4 Zn
2+
 or Cd
2+), was found to have both a traditional β like domain and a fourth 
zinc coordinated to two cysteine and two histidine residues in close proximity (20).  Of 
significant interest is human metallothionein-3 (hMT-3) with approximately 70% 
sequence homology with hMT-2, is expressed predominantly in the central nervous 
system and inhibits neuronal growth (21).  The addition of a single threonine (Thr5) in a 
TCPCP motif (22), and a glutamate-rich hexapeptide (23) near the C-terminal have been 
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shown to be critical to the function and the labilization of Zn
2+
 atoms, respectively.  
Interestingly, Romero-Isart et al. were able to engineer neuronal activity of hMT-3 into 
hMT-1 by addition of the TCPCP inset, which suggests the two isoforms may only differ 
in the slight cluster arrangements brought about by 3 distinct mutations (22).  Analysis of 
the isolated domains demonstrated that the ability to inhibit neuronal growth resides in 
the β domain alone, and that this ability results from its unique sequence suggesting 
preferential interaction with target proteins (24).  These β domain centered protein-
protein interactions have not been well characterized due to a general lack of information 
available about this domain for all metallothionein isoforms. 
Human metallothionein 1a, Figure 5-1A, consists of two independent domains each 
encapsulating a metal-thiolate core, Figure 5-1B.  The sequence of the cleaved 
recombinant β domain human metallothionein 1a (β-rhMT 1a), shown in Figure 5-1C, 
with cadmium atoms coloured green and cysteine residues yellow, contains both a 
glycine and serine residue from the thrombin cleavage reaction.  This fragment 
encompasses residues starting from Cys5 to Lys31 of human metallothionein 1a.  
Numbering of the cadmium-thiolate core is cross referenced to the original naming 
conventions based on the order of the NMR bands in the mammalian MT 2a spectra (25), 
while numbering the cysteine residues has been adjusted to accommodate both the 
additional amino acids from thrombin cleavage (res. 1 and 2), as well as a series of amino 
acids meant to aid in protein expression (res. 3 to res. 9).  The β-MT polypeptide 
backbone wrapping of the metal-thiolate core proceeds in a right-handed manner, as 
opposed to the left-handed wrapping of α-MT.  While properties of the α metal binding 
site, Cd4-α-rhMT, have been well documented through structural studies of both the 
isolated domain (8, 25) and as part of the whole protein (17), far less structural 
information has been reported for the isolated β metal binding site, Cd3-β-rhMT.  
Analysis of the NMR data for β-rhMT in human metallothionein suggested that 
fluctionality causes a decrease in intensity of the 1D 
113
Cd signals.  Further compounding 
this problem is the inability of metallothionein to readily crystallize.  To date, only two 
crystal structures have been reported, including rat Cd5Zn2-MT 2 and much later a Cu8-
yeast metallothionein (17, 26).  In order to determine such basic in vivo data as protein 
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binding partners and metalation status, the complete metalation properties of β-MT must 
be fully characterized, particularly when one considers the β-centered reactions in hMT 3.  
The metal transfer function in MT has been well documented with Zn(II) transfer 
taking place from the fully metalated Zn7-βα-MT to m-aconitase (27), carbonic anhydrase 
(28), and the prototypical transcription factor, Gal4 (29).  These studies have shown the 
importance of protein-protein interactions.  However, no zinc-exchange intermediate has 
been characterized that provides insight into the actual mechanism of metal transfer. 
In this study, we present evidence that the isolated β domain of human metallothionein 
1a, Cd3-β-rhMT 1a, is capable of binding an additional cadmium atom forming Cd4-β-
rhMT 1a.  Exact metal speciation was monitored using ESI-mass spectrometry (ESI-MS), 
which allowed for a direct correlation between the number of cadmium atoms bound to 
the protein and changes observed in the UV and CD spectroscopies.  To ensure that the 
metal was interacting directly with the metal-thiolate cluster, both direct and indirect 
113
Cd NMR spectroscopy was used.  Addition of excess Cd
2+
, in the form of solid 
113
CdCl2, produced four cadmium signals in the range of 600-700 ppm, which 
corresponds to the chemical shift region expected for cadmium bound to the thiolates.  
When considering these results in the context of the supermetalated Cd5-α-rhMT 1a  (13) 
and Cd8-βα-hMT 3 (14), two possible scenarios arise: 1) both domains, when present, 
work in concert to accept an additional cadmium atom or 2) both domains are 
individually capable of supermetalation.  In either case, supermetalation must be fully 
characterized to understand its chemical implications that will have consequences at a 
cellular level. 
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Figure 5-1. Molecular model of MT. (A) A space filling structure of Cd7-βα-rhMT 
1a calculated using molecular modeling.  The N-terminal β-domain is located on the left 
hand side, while the C-terminal α-domain is located on the right hand side. (B)  The 
cadmium-cysteinyl-thiolate clusters of Cd7-βα-rhMT 1a presented as a ball and stick 
model:  β-domain (left) and α-domain (right).  (C) A connectivity diagram of the β-
domain of human metallothionein 1a, which shows that each of the three cadmium atoms 
is connected to exactly four cysteine amino acids.  The connectivity diagram has been 
renumbered to allow for the amino acids glycine and serine, a product of S-tag cleavage 
with thrombin, located on the N-terminal of the domain.  Numbering of the Cd-thiolate 
centers is based on the NMR assignment by Messerle et al. (30).  Molecular modeling 
data from Chan et al. (31). 
5.2 Experimental Methods 
5.2.1 Chemicals 
Chemicals used: cadmium sulfate (Fisher Scientific); cadmium(113) chloride (Trace 
Sciences International Inc.); deuterium oxide (Cambridge Isotopes Laboratories, Inc.); 
tris(2-carboxyethyl)phosphine (PIERCE); ThrombinCleanCleave
TM
 Kit (Sigma) Tris 
buffer, tris(hydroxymethyl)aminomethane (EMD Chemicals/VWR); ammonium formate 
buffer (JT Baker); ammonium hydroxide (Caledon Laboratory Chemicals); formic acid 
(Caledon Laboratory Chemicals); and hydrochloric acid (Caledon Laboratory 
Chemicals).  All solutions were made with >16  MΩcm deionized water (Barnstead 
Nanopure Infinity).  HiTrap
TM
 SP HP ion exchange columns (Amersham Biosciences/GE 
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Healthcare), superfine G-25 Sephadex (Amersham Biosciences/GE Healthcare), stirred 
ultrafiltration cell Model 8010 and 8200 (Amicon Bioseparations/Millipore) with YM-3 
membrane (3,000 MWCO) were used in the protein purification steps.  
5.2.2 Protein sample preparation for CD spectroscopic and ESI mass 
spectrometric studies 
The recombinant Cd3-β-rhMT 1a was prepared by over-expression in E. coli as 
described in detail in Chapter 2.  A solution of Cd3-β-rhMT 1a was prepared in 5 mM 
ammonium formate (pH 9.0) to a concentration of 24.4 µM for CD, UV spectroscopic 
and ESI-mass spectrometric studies.  The protein concentrations was confirmed by UV 
absorption spectroscopy using the absorbance at 250 nm, which corresponds to the 
ligand-to-metal charge transfer transition generated by the metal-thiolate bond (ɛ250 = 
36,000 M
-1
cm
-1
).  To ensure accuracy, all measurements were performed on the same 
sample for a given excess molar equivalents excess of Cd
2+
.  Cadmium sulfate was 
prepared in H2O to a final concentration of 11.4 mM.  The concentrations of both the 
cadmium sulfate solution and the cadmium content of all β-rhMT 1a solutions were 
determined through calibration of Cd
2+
 content using atomic absorption spectroscopy 
(AAS). 
5.2.3 Protein sample preparation for NMR spectroscopic studies 
β-rhMT 1a NMR samples were prepared by pooling protein from five-4 L 
recombinant preparations following thrombin-cleavage of the S-tag.  The natural 
abundance of NMR active 
113
Cd is 12.75%, consequently an eight-fold enhancement of 
signal can be achieved by isotopic enrichment of the NMR sample.  To that end, pooled 
Cd3-β-rhMT 1a of natural 
113
Cd
2+
 abundance was demetalated using formic acid.  The 
protein was then desalted on a G-25 Sephadex column into deionized water, which had 
been adjusted to a pH =2.7 using formic acid, to remove the natural abundance Cd
2+
.  To 
impede the oxidation of the protein, tris(2-carboxyethyl)phosphine (TCEP) was added to 
the solution.  Isotopically enriched Cadmium(113) chloride ( > 95%) was then added to 
the solution followed by neutralization using ammonium hydroxide with concomitant 
metal binding of 
113
Cd
2+
 to the protein.  The solution was then concentrated to 10 mL and 
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desalted into 10 mM ammonium formate buffer using a G-25 Sephadex column at pH 7.5 
in order to remove any excess cadmium(113).  Concentration and D2O exchange was 
performed using stirred ultrafiltration cell models 8200 and 8010, respectively.  The final 
protein concentration was determined to be 7-8 mM based on UV absorption 
spectroscopy using the 250-nm peak (ɛ250 = 36,000 M
-1
cm
-1
).  The sample was Ar-
saturated and sealed in a 5 mm NMR tube for analysis.  Following acquisition of 
113
Cd3/4-
β-rhMT excess cadmium(113) was added as a solid to produce 113Cd4-β-rhMT 1a used 
for both the 1D and 2D NMR spectra.   
5.2.4 Experimental details for the titration of excess Cd2+ into a 
sample of Cd3-β-rhMT 1a 
CD and UV absorption spectroscopy and ESI mass spectrometry 
Spectra were acquired for the Cd3-β-rhMT 1a solution (24.4 µM) in 5 mM ammonium 
formate buffer (pH 9.0) and for a solution from the same stock of Cd3-β-rhMT 1a to 
which 4.4 excess molar equivalent of Cd
2+
 were added, forming (as we show in the ESI-
Mass spectral data) Cd4-β-rhMT 1a. 
5.2.5 Instrumental parameters 
CD spectroscopy 
CD spectra were acquired on a Jasco J810 spectropolarimeter in a 1-cm quartz cuvette 
at room temperature (22 °C) and recorded using Spectra Manager v.1.52.01 (Jasco) 
software.  The wavelength range of 200-350 nm was scanned continuously at a rate of 60 
nm/min with a band width of 2 nm.  The spectral data were organized and plotted using 
Origin® v.7.0383.  The CD spectra are expressed in the units of A.     
UV absorption spectroscopy 
UV spectra were acquired on a Cary 5G UV-Vis-NIR spectrophotometer (Varian 
Canada, Mississauga, ON, Canada) in a 1-cm quartz cuvette at room temperature (22 °C) 
and recorded using the Cary Win UV Scan software application.  The wavelength range 
of 200-350 nm was scanned continuously.  All spectra were baseline corrected. The 
spectral data were organized and plotted using Origin® v.7.0383. 
ESI mass spectrometry 
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ESI-MS measurements were carried out after the UV absorption and CD spectroscopic 
experiments had been completed.  Mass spectra were acquired on a Micromass LCT 
electrospray-ionization time-of-flight (ESI-TOF) mass spectrometer (Waters Micromass) 
at room temperature (22 °C) and recorded using the Mass Lynx software package v. 4.0.  
The ESI-TOF was calibrated with a solution of NaI.  The scan conditions for the 
spectrometer were: capillary, 3000.0 V; sample cone, 15.0 V; extraction cone, 10.0 V; RF 
lens, 450.0 V; desolvation temperature, 20.0 
o
C; source temperature, 80.0 
o
C; nebulizer 
gas flow, 53 L/hr; and desolvation gas flow, 548 L/h.  The m/z range was 500.0 to 
3000.0, the scan mode was continuum, and interscan delay was 0.10 s.   Max Ent 1 from 
the Mass Lynx v.4.0 software package (Waters Micromass, Mississauga, ON, Canada) 
was used for spectra reconstruction program. 
NMR spectroscopy 
All NMR spectra were acquired on a Varian Inova 600 NMR spectrometer (νL(
1
H) = 
599.44 MHz, νL(
113Cd) = 132.99 MHz) using Varian’s VNMRJ 2.2D software with 
Chempack 3.0 add-on.  The 
113
Cd chemical shifts were referenced with respect to an 
external 1.0 M solution of CdSO4 in D2O (δ(
113
Cd) = 0.0 ppm), while 
1
H chemical shifts 
were internally referenced to TMS (δ(1H) = 0.0 ppm) based on the 2H frequency of the 
deuterated solvent. 
Direct-detect 1D 
113
Cd{
1
H} NMR spectra were acquired using a Varian broad-band 
5.0mm HX probe, a spectral range from 540 to 740 ppm, and WALTZ-16 
1
H decoupling 
during acquisition only.  For Cd3/4-β-rhMT 1a, a total of 93 000 transients were 
accumulated using a 1s relaxation delay and a 16.2 µs 90-degree pulse width with a 1.234 
s acquisition time at 10 °C.  The data were processed using a line-broadening of 10 Hz.  
For Cd4-β-rhMT 1a, a total of 84 000 transients were accumulated using a 2s relaxation 
delay and a 10.8 µs 60-degree pulse width with a 0.587 s acquisition time at 25 °C.  The 
data were processed using a line-broadening of 20 Hz.   
Indirect 2D 
1
H-
113
Cd HSQC NMR spectra were acquired using a Varian indirect-
detection 5.0 mm HCX probe, a 
113
Cd spectral range from 540 to 740 ppm, a 
1
H spectral 
range from -0.4 to 4.8 ppm, a 0.15 s acquisition time, and a 1 s relaxation delay.  Water 
suppression was achieved using a selective 1 s presaturation pulse at a power of 4 dB.  In 
the indirect 
113
Cd dimension the data was zero-filled to 1024 total points, and a Gaussian 
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weighting function was applied.  In the direct 
1
H dimension, the data were zero-filled to 
1024 points and a Gaussian weighting function was applied.  For Cd3/4-β-rhMT 1a, a total 
of 84 transients were accumulated for each of the 128 increments, a forward linear 
prediction of 128 points in 
113
Cd dimension, and the 
3
J(
 113
Cd,
1
H) value was set to 60 Hz 
at 30 °C.  For Cd4-β-rhMT, a total of 44 transients were accumulated for each of the 256 
increments, a forward linear prediction of 256 points in 
113
Cd dimension, and the 
3
J(
 
113
Cd,
1
H) value was set to 67 Hz at 25 °C. 
5.3    Results 
5.3.1 Supermetalation of β-rhMT 1a studied by ESI-mass 
spectrometry and CD and UV absorption spectroscopies 
To determine the effect of the fourth metal on the overall fold of the isolated β 
domain, analysis with both CD and UV absorption spectroscopy, coupled with metal 
speciation provided by ESI-MS, was carried out.  These techniques allowed us to directly 
correlate the number of metals bound and observed spectroscopic changes in solution.  
The protein used in this set of experiments was taken directly after purification and 
desalted into an ESI-MS compatible buffer.  This was done to avoid structural changes 
that may occur upon acid induced demetalation and to demonstrate that the additional 
low affinity site for Cd
2+
 is not the result of high concentrations found in the NMR 
experiment (32). 
A solution of Cd3-β-rhMT 1a (Figure 5-2A) was initially measured.  Addition of 4.4 
excess molar equivalents of Cd
2+
 produced a solution with a composition of 10% Cd3- β-
rhMT 1a and 90% Cd4-β-rhMT 1a (Figure 5-2B).  The mass of apo--rhMT 1a is 3754 
Da (spectra not shown), giving the theoretical masses of Cd3-β-rhMT 1a and Cd4-β-rhMT 
1a as 4085 Da and 4195 Da, respectively, which compare well with the experimental 
masses of 4085 Da and 4197 Da, respectively.  Because of the weaker binding of the 
fourth Cd
2+ 
atom to the protein, we attribute this residual 10% Cd3-β-rhMT 1a to MS 
induced dissociation of the metal.  An approximate equilibrium binding constant of 6.0 ± 
0.8 x 10
4 
M
-1
 was determined, using the ratio of Cd3/Cd4 based on an ESI-MS titration of 
apo-β-rhMT for the low affinity site by ESI-MS, a value that is several orders of 
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magnitude less than previously reported binding constants for normal binding of both 
Cd
2+
, 6.0x10
21
 – 1025.6 M-1 (33-34), and Zn
2+
, 5.0x10
7 –  6.3x1011 M-1  (35).   
To determine the location of the fourth cadmium ion, whether it was either attached to 
the cluster or existed as an adduct to other opportunistic amino acids, the UV absorption 
and CD spectra for both Cd3-β-rhMT 1a and Cd4-β-rhMT 1a were measured.  While the 
UV spectra did not change significantly (Figure 5-2C), the CD spectra measured for these 
species (Figure 5-2D) showed drastic changes in the extrema.  Maxima and minima at 
262 and 236 nm, respectively, were observed for Cd3-β-rhMT 1a, while Cd4-β-rhMT 1a 
exhibited maxima and minima of 252 nm and 231 nm, respectively.  For Cd3-β-rhMT 1a 
the maximum at 262 nm was broad suggesting that the traditional structure is flexible and 
exists as a mixture of conformations.   
Upon addition of excess Cd
2+
 to solution, the maximum blue shifted to 252 nm and the 
intensity increased by 60%.  The increase in intensity may be attributed to a decrease in 
the conformational flexibility of the protein, while the blue shift can be associated with a 
breaking of the exciton coupling between the three Cd
2+
 of the system as observed when 
Cd5-α-rhMT 1a is formed (13).  The breaking of exciton coupling strongly suggests that 
the fourth Cd
2+
 atom is involved in the metal-thiolate cluster.  A previous analysis of the 
β domain using mouse MT-1 demonstrated CD spectral changes between 3 and 12 
equivalents of Cd
2+ 
(36), which the author argued was the result of a Cd9-rhβ-MT 1, but 
which we postulate to be supermetalated Cd4-β-rhMT 1.  
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Figure 5-2. ESI-MS deconvoluted spectra, UV-absorption and CD spectra of Cd3--
rhMT 1a and the supermetalated Cd4--rhMT 1a.   (A) ESI-MS deconvoluted 
spectrum of Cd3-β-rhMT 1a, showing the mass equal to the apo-protein with 3 Cd
2+
; (B) 
ESI-MS deconvoluted spectrum of supermetalated Cd4-β-rhMT 1a formed following the 
addition of 4.4 molar equivalents of CdSO4 to the Cd3-β-rhMT 1a, showing the additional 
mass from 1 extra Cd
2+
.  (C) UV absorption and (D) CD spectral changes observed for 
Cd3-β-rhMT 1a and the supermetalated Cd4-β-rhMT 1a formed following the addition of 
4.4 molar equivalents of CdSO4 to the Cd3-β-rhMT 1a.  To ensure accurate speciation, 
the same samples of Cd3-β-rhMT 1a and Cd4-β-rhMT 1a were used in all experiments.  
All experiments were carried out in 5 mM ammonium formate buffer, at pH 9.0, and at 
22 
o
C. 
5.3.2 One dimensional 113Cd NMR spectroscopy of Cd3-β-rhMT 1a and 
Cd4-β-rhMT 1a 
Direct 1D 
113
Cd[
1
H] NMR spectroscopy was used for a mixture of Cd3/4-β-rhMT 1a, a 
result of a slight excess of Cd
2+
 to increase resistance to oxidation, and a pure sample of 
Cd4-β-rhMT 1a in order to determine relative speciation of the individual metal binding 
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sites as well as the type of coordinating ligands through chemical shift data.  Samples 
were isotopically enriched with 
113
CdCl2 in 10 mM ammonium formate pH 7.4, following 
demetalation with formic acid, in order to enhance the NMR signal.  Signals observed for 
Cd3/4-β-rhMT 1a (Figure 5-3A) include 687.9, 674.0, 644.7, 634.5, 629.9, 616.7 and 
601.3 ppm, while the observed signals for the pure Cd4-β-rhMT 1a (Figure 5-3B) are 
688.8, 650.3, 635.9 and 602.5 ppm.   The chemical shift range of all the peaks is between 
600 and 700 ppm, which overlaps significantly with the region expected for tetrahedral 
cadmium-thiolate clusters (37), traditional of metallothioneins, as well as both trigonal 
cadmium thiolate and tetrahedral cadmium-thiolate clusters where a single sulfur has 
been replaced by water (38).  By comparing the signals from both sets of data, the peaks 
for Cd3-β-rhMT 1a can be identified as 674.0, 629.9 and 616.7 ppm.  Previous NMR 
work on human liver MT 1 have shown chemical shifts of 670.5, 652.0 and 645.8 ppm 
for the β domain (25); the differences in the chemical shifts are most likely due to the 
lack of the α domain as well as differences in sample conditions. 
Direct detection of 
113
Cd in the binding site allows one to infer the fluctionality of the 
individual metal ions.  Analysis of the spectrum in Figure 5-3A shows that peaks 
attributed to Cd3-β-rhMT 1a species, with the exception of 674.0 ppm, are significantly 
less intense than those we attribute to Cd4-β-rhMT 1a.  Previous NMR studies involving 
both domains, has suggested that the α domain is less fluctional than the β domain 
leading to sharper peaks of greater intensity (25).  Upon addition of excess 
113
Cd
2+
 to 
solution, the observed chemical shifts of Cd3-β-rhMT 1a almost completely disappear 
with an increase in intensity of the peaks assigned to Cd4-β-rhMT 1a suggesting an 
overall reduction in the fluctionality of Cd4-β-rhMT 1a compared to Cd3-β-rhMT 1a.  
There is a slight chemical shift in each of the four peaks, with the most significant shift 
being a total of 5.6 ppm involving the movement of 644.7 ppm to 650.3 ppm, attributed 
to the increase in chloride ions from 
113
CdCl2 (39).  This peak is also noticeably broader 
and less intense than the other three, which are of comparable size, suggesting that this 
binding site is more solvent exposed and fluctional.  The increase in fluctionality and 
solvent exposure of just this site would make this Cd
2+
 site the most likely candidate for 
the metal-exchange intermediate, allowing both the solvent and acceptor/donor proteins 
access to the metal.  The sharpness of the spectral lines further supports the interpretation 
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of CD spectroscopic data that the maxima blue shift between Cd3-β-rhMT 1a and Cd4-β-
rhMT 1a, with an increase in intensity of 60%, is the result of a reduction in the 
fluctionality of the domain overall. 
 
Figure 5-3. Direct 1D 
113
Cd[
1
H] NMR spectrum (133 MHz) of (A) mixture of Cd3-
β-rhMT 1a and Cd4-β-rhMT 1a and (B) Cd4-β-rhMT 1a formed by addition of 
excess 
113
CdCl2.  Slight shifts in the ppm values of Cd4-β-rhMT 1a were observed 
between the mixture and the pure supermetalated sample.  This shift is attributed to the 
addition of chloride ions from 
113
CdCl2, to the solution and is most pronounced in the 
least intense Cd4-β-rhMT 1a signal at 644.7 ppm, with a total shift of 5.6 ppm downfield.  
The Cd3/4-β-rhMT was prepared in 10 mM ammonium formate pH 7.4 and buffer 
exchanged into 90% D2O.  Subsequent addition of solid 
113
CdCl2 to Cd3/4-β-rhMT 1a led 
to the formation of Cd4-β-rhMT 1a.   Spectra of Cd3/4-β-rhMT 1a and Cd4-β-rhMT 1a 
were acquired at 10 °C and 25 °C, respectively. 
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5.3.3 Two dimensional 1H[113Cd]HSQC NMR spectroscopy of both 
Cd3- and Cd4-β-rhMT 1a 
Indirect 
1
H[
113
Cd] HSQC NMR spectroscopy was used for both Cd3/4-β-rhMT 1a and 
Cd4-β-rhMT 1a (Figure 5-4). Analysis of the β protons of the cysteine residues allowed 
determination of peak relatedness as well as a tentative assignment of the metal-thiolate 
connectivity.  Peaks were interpreted as related based on similarity in both the 
1
H and 
113
Cd chemical shifts.  Chemical shifts in the β protons of the cysteine were observed for 
all metal sites existing in both Cd3-β-rhMT and Cd4-β-rhMT and it is likely these are the 
result of the structural changes necessary for the accommodation of a fourth cadmium 
atom in the β metal-thiolate cluster.  In Figure 5-4, peak 2* possessed intense signals 
observable at both the 2.3 and 2.8 ppm in the 
1
H dimension, both signals overlapped well 
with peaks assigned to 2.   Similarity in both the 
1
H profile as well as their closeness in 
the 
113
Cd chemical shift range suggests that they are related.  Peaks 3 and 3*, from Cd3-β-
rhMT 1a and Cd4-β-rhMT 1a, were interpreted as related with both similar peak shape 
and profile from 2.4 to 3.5 ppm.  A chemical shift disturbance of a β proton from peaks 3 
and 3* is observed in the 3.2 to 3.4 
1
H range with a slight downfield shift that can be seen 
in the Cd4-β-rhMT 1a compared to Cd3-β-rhMT 1a.  Assignment of the cadmium center 
associated with peaks 4 and 4* was based on the significant similarity in the β protons 
region.  Additionally, these peaks are equally broad and have comparable intensities in 
the 1D 
113
Cd[
1
H] NMR spectrum (Figure 5-3a).  The new signal, S, is attributed to the 
supermetalated site and is significantly upfield from all other cadmium peaks.   At 602.5 
ppm, this peak may represent a tetrahedral geometry coordinating either four thiolates or 
three thiolates and a single water molecule/chloride ion.           
Assignment of the HSQC spectrum for Cd3-β-rhMT 1a shows three bridging cysteine 
residues (Figure 5-4a), as one would expect from the connectivity (Figure 5-1).  Upon 
addition of excess cadmium, an additional two bridging interactions are observed.  
Interestingly, the new metal appears to coordinate with all other metal centers at the 
expense of bridging interactions within the original cluster.  It is this loss of original 
bridging interactions that may explain the loss of exciton coupling in CD spectroscopy 
without any significant change in the ligand-to-metal charge transfer band observed in 
UV spectroscopy (Figure 5-2). 
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Figure 5-4. Indirect 2D 
1
H[
113
Cd] HSQC NMR spectra of (A) Mixture of Cd3-β-
rhMT 1a and Cd4-β-rhMT 1a and (B) Cd4-β-rhMT 1a produced upon addition of 
excess 
113
CdCl2.  The spectra were recorded in the 
1
H chemical shift range of -0.4 – 4.8 
ppm and the 
113
Cd range of 540-740 ppm (
3
J = 60 Hz and 67 Hz) for Cd3-β-rhMT 1a and 
Cd4-β-rhMT 1a, respectively.  Spectra (A) was recorded at 30 °C, while spectra (B) was 
recorded at 25 °C.   Both spectra were acquired using an inverse single axis z-gradient 
HCX probe with X tuned to 
113
Cd.  These spectra were used to aid in the correlating Cd3-
β-rhMT 1a peaks with Cd4-β-rhMT peaks 1a. 
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5.4    Discussion 
 It has been proposed over the last 50 years that the various different metallothioneins 
perform many critical functions concerned with metal homeostasis, metal exchange, and 
recently cellular redox status.  In the present study, analysis of the spectroscopic data 
from metalation of the β domain of human metallothionein 1a has shown that a 
supermetalated form of the domain exists, the extra metal ion is located in the metal 
thiolate cluster and we propose that this supermetalated form, with a distorted cluster, 
may be a model of the metal exchange intermediate. 
5.4.1 Location of the fourth Cd2+ ion in Cd4-β-rhMT 1a 
Prior to this report it was unclear whether an additional metal was bound to the protein 
metal-thiolate core, or if the protein was somehow bound to other ligands.   The coupling 
of both spectroscopic and spectrometric analyses clearly demonstrates that this additional 
Cd
2+
 ion is coordinated to the metal-thiolate core and that this coordination leads to a 
significant rearrangement of the cluster.  It is this fourth Cd
2+
 ion that breaks the 
symmetry of the cluster, as monitored through a loss of exciton coupling (Figure 5-2). 
Both direct and indirect 
113
Cd NMR spectroscopy confirm coordination of the fourth 
Cd
2+
 ion to the metal thiolate core and provide tentative connectivities for the Cd3- and 
Cd4-β-rhMT 1a clusters.  Interestingly, an increase in the number of bridging interactions 
from 3 to 5 was observed.  The newly coordinated metal bridges with all three of the 
original metals at the cost of cluster symmetry explaining the change in the CD spectrum.  
We propose an increase in bridging interactions, which is based upon an addition of 
proton-cadmium J-coupling seen as Cd3-βα-rhMT is converted to Cd4-βα-rhMT.  
Expansion of the protein cluster, may be critical for the functions of metal ion 
homeostasis and toxic metal detoxification because formation of these new bonds may be 
the first step in metal insertion, followed by expulsion of one of the originally 
coordinated metals. 
5.4.2 The proposed mechanism of metal ion homeostasis 
An insertion-expulsion mechanism would allow Cd
2+
, which binds several orders of 
magnitude more tightly than Zn
2+
,  to exchange with Zn
2+
 bound metallothionein 
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simultaneous acting to sequester toxic Cd
2+
 and releasing free Zn
2+
 into the cellular 
environment.  The net effect would be upregulation of metallothionein allowing an 
organism to effectively combat toxic metal exposure.  A regulator of metallothionein 
transcription, the metal-responsive-element-binding transcription factor-1 (MTF-1), has 
been shown to upregulate metallothionein upon binding to Zn
2+ 
(40).  MTF-1 has been 
implicated in cellular responses including toxic metal detoxification and oxidative stress, 
both of which are implicated functions of metallothionein.  The metal binding site of this 
transcription factor includes six Cys2His2 zinc fingers making it exceptionally sensitive 
to an organism’s zinc load.  For this reason supermetalation, in the context of toxic 
metals, may be a critical transient species in the regulation of transcription of the protein.  
An incoming toxic metal, such as cadmium, could coordinate in a supermetalated 
position allowing both sequestration of the toxic metal and release of a zinc ion.  This 
zinc ion would consequently lead to the upregulation of MT, through the zinc binding 
motifs of MTF-1, allowing an organism to effectively combat toxic metals.  Through this 
mechanism, supermetalation of metallothionein, the organism would be able to control 
cellular metal load. 
5.4.3 Reports of supermetalated metallothionein in the literature 
Supermetalation has now been reported in the α domain, Cd5-α-rhMT 1a, the β 
domain, Cd4-β-rhMT 1a and the full MT protein, Cd8-βα-rhMT 1a, of human 
metallothionein 1a  (7-8, 31).  In the case of the α domain of human MT-1, analysis of 
113
Cd NMR spectra provided data suggesting that the supermetalated form, Cd5-α-rhMT 
1a, included two bridging interactions through a crevice located on the α domain (13).  
ESI-MS titrations have also provided evidence that a supermetalated Cd8-βα-rhMT 1a 
may exist in a dynamic equilibrium with Cd7-βα-rhMT (7).  Chan et al. attributed 
supermetalation of the full protein to supermetalation of the α domain, with the β domain 
remaining intact (31).  Currently no competition experiments between the two isolated 
domains have been performed that would allow the determination of the relative affinity 
of Cd
2+
 to form supermetalated species, however the NMR chemical shifts would suggest 
that supermetalation first occurs in the β domain.  By comparison, supermetalation of the 
α domain produces a peak at 224 ppm, while supermetalation of the β domain produces a 
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peak at 602 ppm.  The dramatic difference in peak locations suggests that there are more 
cysteine residues coordinating the Cd
2+
 involved in the supermetalated β domain than 
there are in the α domain.  These cysteine residues would act to stabilize the 
supermetalated structure, leading to an increase in the affinity of the β domain for 
Cd
2+
/Zn
2+ 
metal ions. 
 
Figure 5-5. Comparison of the 
113
Cd NMR resonances for the human MTs: Cd7-
βα-MT 3 (16), Cd7-βα-MT 2 (25), Cd7-βα-MT 1 (25), supermetalated Cd4--rhMT 1a 
(this work), Cd3--rhMT 1a (this work), Cd4--rhMT 1a (13), and supermetalated Cd5--
rhMT 1a (13). 
 
Supermetalation of the brain specific MT-3 to produce Cd8-βα-MT 3 has also been 
observed (14).  Unlike supermetalation of MT-1, Meloni et al. have suggested that both 
domains bridge together to accommodate the eighth cadmium atom.  Interestingly, 
comparison of the metallothionein isoforms MT-2 and MT-3 demonstrated that while 
MT-3 was capable of accepting an additional metal ion, MT-2 was not.  However, both 
MT-1 and MT-2 are more closely related than MT-3, the former having diverged before 
distinction of the mammalian orders while the latter, more structurally distinct, evolved 
much earlier (41).  Surprisingly Romero-Isart et al. demonstrated the ability to confer 
neuroinhibitory MT-3 activity onto MT-1, through a series of mutations to the β domain 
(22).  We postulate that supermetalation, a property only observed in distantly related 
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MT-1 and MT-3, may be a factor that leads to the differentiation of each isoform into 
specific functions in cellular chemistry. 
One important aspect, which must be examined further, is the exact location of the low 
affinity binding site(s) on the Cd8-βα-MT (1 or 2) protein.  Figure 5-5 compares the NMR 
spectral data for human Cd7-βα-MT 1, 2 and 3, the two isolated fragments of Cd3--
rhMT 1a and Cd4--rhMT 1a, and the supermetalated species, Cd4-β-rhMT 1a and Cd5-
-rhMT 1a.  The value of this figure is to show how the extra metal for the  domain 
described here exhibits a typical 
113
Cd NMR spectral signature that falls within the range 
of MT data.  Indeed, it is possible that the Cd7-βα-MT 1 spectrum may contain a small 
fraction of Cd4-β-MT as indicated by an overlap of the NMR signals of the Cd4-β-MT 1a 
with those of Cd7-βα-MT 1.  On the other hand, the fifth Cd
2+
 in the Cd5-α-rhMT 1a 
results in a resonance in the region well away from the tetrahedral thiolates.  Two 
possibilities exist for the location of the low affinity sites on Cd8-βα-MT:  1) each domain 
is independently capable of binding an additional metal ion, as supported by 
supermetalation of the isolated β and α domains of MT-1, or 2) the two domains work in 
concert to bind this additional metal, as supported by the decrease in the Stokes radius of 
MT-3 upon supermetalation, which is consistent with the close approach of both clusters.  
It is probable that supermetalation of metallothionein is isoform specific, related to 
cellular function and mechanisms of metalation must be determined on a case-by-case 
basis.  Answers to these questions in the future will have consequences for metal ion 
homeostasis, as well as toxic metal detoxification and could possibly lead to an 
assignment of a specific function for each of the metallothionein isoforms. 
5.5   Conclusion 
In this study, the β domain of recombinant human MT 1a, which is known to 
coordinate 3 Cd
2+
 ions through 9 cysteine residues, was shown to be able to coordinate an 
additional Cd
2+
 ion to form Cd4-β-rhMT 1a using a combination of CD, UV and NMR 
spectroscopy, as well as ESI-mass spectrometry.  The CD spectrum of the Cd4-β-rhMT 
1a showed a sharp monophasic peak centered at 252 nm as compared to the derivative-
shaped spectrum of the Cd3-β-rhMT 1a species with a maximum at 262 nm (+) and a 
minium at 236 nm (-).  This change in the CD maximum indicates a disruption of the 
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exciton coupling between the original 3 Cd
2+
 ions.  The ESI-mass spectrum showed an 
increase in mass corresponding to a single Cd
2+
 ion upon the addition of 4.4 molar 
equivalents excess to a solution of Cd3-β-rhMT 1a further confirming the existence of 
this low affinity binding site.   
Both direct and indirect 
113
Cd NMR spectroscopic techniques were used to probe the 
coordination environment of the additional Cd
2+
 ion.  The signal detected in the 1-D 
NMR spectrum associated with the supermetalated Cd
2+
 ion was located at 602 ppm.  
This location is typical of both trigonal cadmium thiolate and tetrahedral cadmium-
thiolate clusters where a single sulfur ligand has been replaced by water (38).  Evidence 
from the 2-D NMR spectra suggest that binding of the additional Cd
2+
 ion significantly 
perturbs the cluster leading to an increase of bridging interactions from 3 to 5.  These 
enhanced interactions are likely the cause of the loss of exciton coupling observed in the 
CD spectrum as Cd3-β-rhMT 1a is converted into Cd4-β-rhMT 1a.  Based upon the 
significant difference between the NMR chemical shift range of the supermetalated peak 
in Cd4-β- and Cd5-α-rhMT 1a (602 ppm vs. 224 ppm respectively), it is likely that 
supermetalation of the β-domain dominants the full MT protein.  Future research will 
involve the characterization of supermetalated Cd8-βα-rhMT 1a to determine the exact 
location of this additional Cd
2+
 ion. 
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Chapter 6. Single domain metallothioneins: 
Supermetalation of human MT 1a
6
 
6.1 Introduction 
Metallothioneins (MTs), first isolated by Margoshes and Vallee in 1957 (1), are a 
family of small metalloproteins characterized by their high cysteine content, absence of 
disulfide bonds, and a lack of aromatic amino acids (2).  MT is ubiquitous to living 
organisms and since its discovery, members of the MT family have been isolated from a 
wide range of sources including all animal phyla, fungi, plants, as well as cyanobacteria 
(3-6).  Owing to the significant number of cysteine residues in the sequence (~30% of all 
amino acids) (7), the function(s) of MT have been postulated to include toxic metal 
detoxification, protection against oxidative stress and as a metallochaperone involved in 
the metal ion homeostasis of essential Zn
2+
 and Cu
+ 
(8).  However, despite more than 
sixty years of intense research, the exact in vivo role(s) of MT are still largely unknown. 
Mammalian MTs are the most well studied members of the MT family and consist of 
20 cysteine residues that act to encapsulate two metal-thiolate cores.  Figure 6-1A shows 
a space filling model of human MT 1a coordinated to 7 Cd
2+
 ions, Cd7-βα-rhMT 1a 
(mammalian isoforms other than 1a will be noted specifically).  In the X-ray structure of 
rat liver MT 2 (Zn2Cd5-MT 2) (9), and NMR studies from other variants (10-11), the 
metal ions exist with two independent domains: an N-terminal β-domain and a C-
terminal α-domain.  The β-domain is capable of binding 3 Zn2+ or Cd2+ ions through 9 
cysteine residues, while the α-domain is capable of binding 4 Zn2+ or Cd2+ ions through 
11 cysteine residues (Figure 6-1B).  Significantly, the structural data has only been 
reported from metal-saturated proteins.  It is important to note that both Zn
2+
 and Cd
2+
 
bind to metallothionein in an isostructural manner, and that the overall molecular 
architecture of the protein, when coordinated to either Zn
2+
 or Cd
2+
, is identical (11).  The 
                                                 
6
 A version of this work has been published: 
Reproduced with permission from D.E.K. Sutherland, M.J. Willans and M.J. Stillman J. 
Am. Chem. Soc. 134 (2012) 3290-3299.  Copyright 2012 American Chemical Society. 
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sequence of the cleaved recombinant βα-rhMT coordinated to seven divalent metal ions 
is shown in Figure 6-1C, with the metal ions colored green and cysteine residues colored 
yellow. The numbering of the cadmium-thiolate core is cross referenced to the original 
naming conventions based on the order of the NMR bands in the mammalian Cd7-MT 2a 
spectra (10), while the numbering of the cysteine residues has been adjusted to 
accommodate both the additional amino acids from thrombin cleavage (residues 1 and 2) 
and a series of amino acids meant to aid in protein expression (residues 3-9). 
Mammalian MT can be subdivided into four distinct subfamilies (MT-1, -2, -3 and -4), 
each of which contain twenty cysteine residues coordinating seven divalent metals.  
However, different patterns of expression suggest specific in vivo roles for each 
subfamily.  For example, both MT-1 and -2, found in abundance in the liver and kidneys, 
are induced by a number of stimuli, including metal ions, glucocorticoids, cytokines and 
oxidative stress (3, 12-13), while MT-3, found primarily in the central nervous system 
(14), and MT-4, found in stratified squamous epithelial tissues, are more tightly 
controlled (15).  These differences in expression, both causal and spatial, of the MT 
subfamilies are likely the result of the unique biological functions of each member.  In 
fact, it has been shown that disruption of the natural expression of MT-3, through ectopic 
expression in mice, has led to the development of pancreatic acinar cell necrosis and 
death (16).  These results highlight the fact that a dysregulation in the expression of MT 
can lead to a diseased state and eventual death.  However, little is known regarding the 
structural differences of these MT subfamilies that must underlie their functional 
differences. 
One reason for the difficulty in determining structure-function relationships for MT is 
that it is notoriously difficult to crystallize.  To date only two X-ray structures have been 
reported: the first from rat (9), Cd5Zn2-MT 2, and the second from yeast (17), Cu8-MT.  
In the first case, both cadmium and zinc metal centers were tetrahedrally coordinated by 
four thiolate groups into two distinct binding domains, while in the second case a 
combination of both trigonal and digonal coordination was observed for a single domain 
Cu-thiolate cluster.  Much of the structural information known for mammalian MT is a 
result of the many NMR-based studies (10, 18-21).  While NMR studies can provide the 
solution structure of MT, analysis has been limited to the spin ½ nuclei, namely 
111
Cd and 
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113
Cd.  Unfortunately, because of an absence of interdomain peaks associated with the 
nuclear overhauser effect (NOEs), NMR studies can only provide the absolute 
connectivities of atoms in a specific domain and their spatial relationship within that 
domain’s metal-thiolate core.  While the X-ray structure of the rat liver Zn2Cd5-MT 2 did 
provide the alignment of the interdomain linkage, the lack of interdomain NOEs has led 
to the assumption that both domains essentially act independently of each other.  Further, 
subsequent studies have also generally assumed that the metal-based chemistry of each 
domain must also be independent and significantly that MT will adopt a two domain 
structure at all metal loading levels. 
 
Figure 6-1. Molecular model of MT. (A) A space filling structure of Cd7-βα-rhMT 
1a.  The N-terminal β-domain is located on the left hand side, while the C-terminal α-
domain is located on the right hand side. (B)  Cadmium-cysteinyl-thiolate clusters of Cd7-
βα-rhMT 1a presented as a ball and stick model:  β-domain (left) and α-domain (right).  
(C) A connectivity diagram of MT 1a, which shows that each of the seven cadmium 
atoms is connected to exactly four cysteine amino acids.  The connectivity diagram has 
been renumbered to accommodate the amino acids glycine and serine, both of which are 
a product of S-tag cleavage with Thrombin, located on the N-terminal of the β-domain.  
Numbering of the Cd-thiolate centers is based on the NMR assignment by Messerle et al. 
(10).  Molecular modeling data from Chan et al. (22). 
 
The assumption of domain independence has significant consequences for the metal 
exchange properties of metallothionein.  Specifically, the β-domain of MT has been 
associated with a preference for Cu
+
 coordination, while the α-domain has been 
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associated with a preference for Zn
2+
 or Cd
2+
 coordination (23-25).  The question 
remains, however, if the domains do not interact with one another, then how does the 
metal binding reaction reach equilibrium?  This problem is further complicated by the 
fact that MT is capable of binding a very wide range of metals, with differing geometries 
that are dependent on the stoichiometries of the associated metal, for example As6-MT, 
Cd7- or  Zn7-MT, Cu12- or Ag12-MT, and Hg18-MT (26-29).  A recent study with As-MT 
has shown that As
3+
 distribution between the full protein and the domain fragments 
occurred by protein-protein interactions, and not by an dissociative-associative 
mechanism (30).  While not conclusive, these results support the existence of domain-
domain interactions as the driving force behind metal-ion equilibration. 
Another reason for the difficulty in determining the function of MT is that until 
recently, MT was thought to coordinate metals in a cooperative fashion, where the 
binding of one metal facilitates the binding of subsequent metals (31).  However, recent 
studies have shown that metalation of MT by Cd
2+
, Zn
2+
, As
3+
, and Bi
3+
 occurs in a 
noncooperative fashion (26, 32-36).  A noncooperative mechanism allows for partially 
metalated, as well as metal exchange intermediates, to be stable and able to take part in 
cellular chemistry.  Significantly, Krezel and Maret have shown from their competition 
experiments that there exist at least three classes of Zn
2+
 binding site, with log K values 
of 11.8, ~10 and 7.7 corresponding to the binding of four, two and one metal ion, 
respectively (37).  This range of binding affinities shows that MT can act as a dynamic 
metallochaperone, capable of donating and accepting metal ions over a range of cellular 
concentrations.  
Finally MT has been shown to bind metals in excess of traditional levels.  These 
supermetalated states have been reported for both of the isolated α- and β-domains 
forming Cd5-α-rhMT (38) and Cd4-β-rhMT (39), respectively.  This level of metalation 
has also been reported in human MT-3, Cd8-βα-hMT 3 (40).  In the case of MT-1 and 
MT-2, Cd
2+ 
ions are known to isomorphously replace Zn
2+ 
ions (41), which suggests the 
involvement of these supermetalated structures in the metal-exchange reactions that must 
occur for the binding of incoming metals with binding affinities greater than that of the 
resident zinc, for example, the essential Cu
+
 and the toxic Cd
2+
.  Indeed, metal transfer 
reactions in MT have been well documented, for example the Zn
2+
 transfer of fully 
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metalated Zn7-βα-MT to m-aconitase (42), carbonic anhydrase (43), and the prototypical 
transcription factor Gal4 (44).  Interestingly, a recent study involving the incubation of 
Aβ1-40-Cu
2+
, a producer of reactive oxygen critical to Alzheimer’s disease, with Zn7-βα-
MT 3 demonstrated that MT readily exchanged Zn
2+
 for Cu
2+
, with subsequent reduction 
to Cu
+
 and coordination to the remaining reduced thiols, thereby deactivating the Aβ1-40-
peptide (45).  While these studies highlight the importance of protein-protein interactions, 
no exchange intermediates have been characterized that provide insight into the actual 
mechanism of metal transfer.   
In this paper, we present evidence that human metallothionein, Cd7-βα-rhMT, is 
capable of binding an additional cadmium atom to form Cd8-βα-rhMT.  Exact metal 
speciation was monitored using ESI-mass spectrometry (ESI-MS), which allowed for a 
direct correlation between the number of cadmium atoms bound to the protein and 
observed changes in the UV absorption and CD spectra.  Direct and indirect 
113
Cd NMR 
spectroscopies were used to ensure that the incoming metal was structurally significant 
and involved direct interaction with the metal-thiolate cluster.  Possible implications of 
these results with respect to metal ion homeostasis and metal ion domain selectivity are 
discussed both of which have significant consequences for the in vivo function of MT in 
an organism. 
6.2 Experimental Methods 
6.2.1 Chemicals 
Cadmium sulfate (Fisher Scientific); cadmium(113) chloride (Trace Sciences 
International Inc.); deuterium oxide (Cambridge Isotopes Laboratories, Inc.); tris(2-
carboxyethyl)phosphine (PIERCE); ThrombinCleanCleave
TM
 Kit (Sigma) Tris buffer, 
tris(hydroxymethyl)aminomethane (EMD Chemicals/VWR); ammonium formate buffer 
(JT Baker); ammonium hydroxide (Caledon Laboratory Chemicals); formic acid 
(Caledon Laboratory Chemicals); and hydrochloric acid (Caledon Laboratory 
Chemicals).  All solutions were made with >16 M  cm-1 deionized water (Barnstead 
Nanopure Infinity).  HiTrap
TM
 SP HP ion exchange columns (Amersham Biosciences/GE 
Healthcare), superfine G-25 Sephadex (Amersham Biosciences/GE Healthcare), stirred 
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ultrafiltration cell Model 8010 and 8200 (Amicon Bioseparations/Millipore) with YM-3 
membrane (3,000 MWCO) were used in the protein purification steps.  
6.2.2 Protein sample preparation for CD spectroscopic and ESI mass 
spectrometric studies 
The expression and purification of recombinant βα-rhMT has been previously reported 
(22) and is described in detail in Chapter 2. The βα-rhMT used in this study was based on 
the 72-residue sequence MGKAAAACSC ATGGSCTCTG SCKCKECKCN 
SCKKAAAACC SCCPMSCAKC AQGCVCKGAS EKCSCCKKAA AA with no 
disulfide bonds present in the system.  The expression system included, for stability 
purposes, an N-terminal S-tag (MKETAAAKFE RQHMDSPDLG TLVPRGS).  
Recombinant βα-rhMT 1a was expressed in BL21(DE3) Escherichia coli (E. coli) 
transformed using the pET29a plasmid. Removal of S-tag was performed using a 
Thrombin CleanCleave
TM
 Kit.  To impede oxidation of the cysteine residues to disulfide 
bonds, all protein samples were rigorously evacuated and then argon saturated to remove 
any residual oxygen that may be present in the solution. 
6.2.3 Protein sample preparation for NMR spectroscopic studies 
Samples of Cd-bound βα-rhMT for NMR analysis were prepared by pooling protein 
product from five 4 L recombinant preparations following thrombin-cleavage of the S-
tag.  The 
113
Cd7-βα-rhMT used for acquisition of all NMR spectra was prepared by 
addition of concentrated formic acid to demetalate the protein, followed by desalting on a 
G-25 Sephadex column at which point tris(2-carboxyethyl)phosphine (TCEP) was added 
to the solution to impede oxidation.  Isotopically pure (>95%) cadmium(113) chloride 
was added to the solution followed by neutralization using ammonium hydroxide.  The 
solution was then concentrated to 10 mL and desalted into 10 mM ammonium formate 
buffer using a G-25 Sephadex column at pH 7.5 in order to remove any excess 
cadmium(113). Concentration, and D2O exchange to 30% total volume, was performed 
using Amicon stirred ultrafiltration cell models 8200 and 8010, respectively.  The final 
protein concentration was determined to be 5.3 mM based on UV absorption 
spectroscopy using the 250-nm peak (ɛ250 = 89,000 M
-1
cm
-1
).  The buffer used for this 
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sample was 5 mM ammonium formate (pH 8.3).  The sample was Ar-saturated and sealed 
in a 5 mm NMR tube for analysis.  Following acquisition of 
113
Cd7/8-βα-rhMT excess 
cadmium(113) was added to produce 
113
Cd8-βα-rhMT, which was used for both the 1D 
and 2D NMR spectra. 
6.2.4 Experimental details for the titration of excess Cd2+ into a 
sample of Cd8-βα-rhMT 1a 
CD and UV absorption spectroscopy and ESI mass spectrometry 
All protein concentrations were confirmed by UV absorption spectroscopy using the 
absorbance at 250 nm, which corresponds to the ligand-to-metal charge transfer transition 
generated by the metal-thiolate bond (ε250= 89 000 M
-1
cm
-1
).   
CD spectra were recorded on a Jasco J810 spectropolarimeter in a 1 cm quartz cuvette 
at room temperature (22 °C) using Spectra Manager version 1.52.01 (Jasco).  The 
wavelength range of 200-350 nm was scanned continuously at a rate of 50 nm/min with a 
bandwidth of 2 nm.  The spectral data were organized and plotted using Origin version 
7.0383.  The CD spectra are expressed in units of ΔA.  For the CD titration a solution of 
Cd7-βα-rhMT was prepared in 5 mM ammonium formate (pH 8.1) to a concentration of 
7.8 μM.  This solution was then titrated in a stepwise manner with increasing amounts of 
Cd
2+
 using both 0.17 mM and 1.02 mM CdSO4 in order to produce a solution of Cd8-βα-
rhMT 1a.   
UV absorption spectra were recorded on a Cary 5G UV–vis–NIR spectrophotometer 
(Varian) in a 1 mm quartz cuvette at room temperature (22 °C) using the Cary Win UV 
Scan software application.  The wavelength range of 200-350 nm was scanned 
continuously.  All spectra were baseline-corrected.  The spectral data were organized and 
plotted using Origin version 7.0383.  The sample was measured in a 5 mM ammonium 
formate buffer at pH 8.1 with a protein concentration of 28 μM.  This same sample was 
used in the ESI-MS titration.  The extinction coefficient used for Cd8-βα-rhMT 1a was 89 
000 M
-1
cm
-1 
ESI-MS spectra were recorded on a micrOTOF II MS (Bruker).  The operating 
parameters were as follows: End plate offset -500 V; Capillary 4200 V; Nebulizer 2.0 
Bar; Dry gas 8 L/min; Dry temperature 80 ⁰C; Capillary exit 180 V; Hexapole RF 600 
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Vpp; Mass range 500 to 3000 m/z.  Spectra were acquired as a rolling average of 2×0.5 
Hz.  A solution of Cd7-βα-rhMT was prepared in 5 mM ammonium formate (pH 8.1) to a 
concentration of 27.0 μM for MS measurements of Cd7-βα-rhMT and Cd8-βα-rhMT. 
6.2.5 Instrumental parameters 
CD spectroscopy 
CD spectra were recorded on a Jasco J810 spectropolarimeter in a 1 cm quartz cuvette 
at room temperature (22 °C) using Spectra Manager version 1.52.01 (Jasco).  The 
wavelength range of 200-350 nm was scanned continuously at a rate of 50 nm/min with a 
bandwidth of 2 nm.  The spectral data were organized and plotted using Origin version 
7.0383.  The CD spectra are expressed in units of ΔA.  For the CD titration a solution of 
Cd7-βα-rhMT was prepared in 5 mM ammonium formate (pH 8.1) to a concentration of 
7.8 μM.  This solution was then titrated in a stepwise manner with increasing amounts of 
Cd
2+
 using both 0.17 mM and 1.02 mM CdSO4 in order to produce a solution of Cd8-βα-
rhMT 1a. 
UV absorption spectroscopy 
UV absorption spectra were recorded on a Cary 5G UV–vis–NIR spectrophotometer 
(Varian) in a 1 mm quartz cuvette at room temperature (22 °C) using the Cary Win UV 
Scan software application.  The wavelength range of 200-350 nm was scanned 
continuously.  All spectra were baseline-corrected.  The spectral data were organized and 
plotted using Origin version 7.0383.  The sample was measured in a 5 mM ammonium 
formate buffer at pH 8.1 with a protein concentration of 28 μM.  This same sample was 
used in the ESI-MS titration.  The extinction coefficient used for Cd8-βα-rhMT 1a was 89 
000 M
-1
cm
-1
.
 
ESI mass spectrometry 
ESI-MS spectra were recorded on a micrOTOF II MS (Bruker).  The operating 
parameters were as follows: End plate offset -500 V; Capillary 4200 V; Nebulizer 2.0 
Bar; Dry gas 8 L/min; Dry temperature 80 ⁰C; Capillary exit 180 V; Hexapole RF 600 
Vpp; Mass range 500 to 3000 m/z.  Spectra were acquired as a rolling average of 2×0.5 
Hz.  A solution of Cd7-βα-rhMT was prepared in 5 mM ammonium formate (pH 8.1) to a 
concentration of 27.0 μM for MS measurements of Cd7-βα-rhMT and Cd8-βα-rhMT. 
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NMR spectroscopy 
All NMR spectra were acquired on a Varian Inova 600 NMR spectrometer (νL(
1
H) = 
599.44 MHz, νL(
113Cd) = 132.99 MHz) using Varian’s VNMRJ 2.2D software with 
Chempack 3.0 add-on.  The 
113
Cd chemical shifts were referenced with respect to an 
external 1.0 M solution of CdSO4 in D2O (δ(
113
Cd) = 0.0 ppm), while 
1
H chemical shifts 
were internally referenced to TMS (δ(1H) = 0.0 ppm) based on the 2H frequency of the 
deuterated solvent. 
Direct-detect 1D 
113
Cd{
1
H} NMR spectra were acquired using a Varian broad-band 
5.0 mm HX probe, a spectral range from 540 to 720 ppm, and WALTZ-16 
1
H decoupling 
during acquisition only.  For Cd7/8-βα-rhMT 1a, a total of 39 000 transients were 
accumulated, while Cd8-βα-rhMT 1a had a total of 30 176 transients accumulated.  Both 
used a 7 s relaxation delay and a 5.33 µs 60-degree pulse width with a 0.684 s acquisition 
time at room temperature.  The data were processed using a line-broadening of 10 Hz. 
Indirect 2D 
1
H-
113
Cd HSQC NMR spectra were acquired using a Varian indirect-
detection 5.0 mm HCX probe, a 
113
Cd spectral range from 540 to 720 ppm, a 
1
H spectral 
range from -0.5 to 10 ppm, a 0.291s acquisition time, and a 2s relaxation delay.  Water 
suppression was achieved using a selective 2s presaturation pulse at a power of 13 dB.  In 
the indirect 
113
Cd dimension the data was zero-filled to 1024 total points, and a Gaussian 
weighting function was applied.  In the direct 
1
H dimension, the data were zero-filled to 
1024 points and a Gaussian weighting function was applied.  For both Cd7/8-βα-rhMT 1a 
and Cd8-βα-rhMT 1a, a total of 80 transients were accumulated for each of the 128 
increments, a forward linear prediction of 128 points in 
113
Cd dimension, and the 
3
J(
 
113
Cd,
1
H) value was set to 67 Hz at room temperature.  
Molecular Model 
MM3/MD calculations parameterized using the modified force field described by 
Chan et al. and the dielectric constant for water (78.4) were carried out to obtain the 
minimum-energy structure of Cd8-βα-rhMT 1a (46). All MM3/MD calculations and 
model-structure rendering were carried out using CAChe WorkSystem Pro 6.1.1 
Software (Fujitsu America).  The original Cd7-βα-rhMT 1a was modified using CAChe to 
produce molecular models for Cd8-βα-rhMT 1a. The structure was energy-minimized as 
follows: 1) the structure was energy minimized using the MM3 calculation followed by 
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the MD simulation at 500 K for 1000 ps.  2) The lowest structure was taken and again 
minimized at 300K for 5000 ps. 
6.3    Results 
6.3.1 Supermetalation of βα-rhMT 1a studied by ESI-mass 
spectrometry and CD and UV absorption spectroscopies 
To determine the effect of the 8
th
 metal on the overall fold of the protein, analysis with 
both CD and UV absorption spectroscopy, coupled with metal speciation provided by 
ESI-MS, were used.  These techniques correlate the number of metals bound to the 
observed spectroscopic changes in solution.  The protein used in these experiments was 
taken directly after purification and desalted into an ESI-MS compatible buffer.  This was 
carried out in order to avoid structural changes that may occur upon acid induced 
demetalation and to demonstrate that the additional low affinity site for Cd
2+
 is not the 
result of high concentrations found in the NMR experiment (47). 
A solution of Cd7-βα-rhMT (Figure 6-2A) was initially measured.  Addition of 2.8 
excess molar equivalents of Cd
2+
 quantitatively converted Cd7-βα-rhMT to Cd8-βα-rhMT 
(Figure 6-2B).  In the MS spectra, two sets of truncated βα-rhMT were detected:  one in 
which the N-terminal G residue and C-terminal AA residues were truncated, and a second 
in which the N-terminal GSMGK as well as A from either the N-terminal or C-terminal 
were truncated.  None of the metal-binding cysteine residues were affected.  This 
truncation has been previously reported, and it does not affect the metal binding 
properties of the protein (32).  The former truncation is of greater intensity and was used 
for all metal binding analyses.  The theoretical m/z values of Cd7-βα-rhMT are 1275.5 
m/z for +6, 1530.4 m/z for +5 and 1912.7 m/z for +4, while the theoretical mass is 7,647 
Da.  These theoretical data are essentially identical to the experimental results of 1275.8 
m/z for +6, 1530.6 m/z for +5 and 1913.2 m/z for +4 and a mass of 7,649 Da.  The 
theoretical m/z values of Cd8-βα-rhMT are 1293.9 m/z for +6, 1552.5 m/z for +5 and 
1940.4 m/z for +4, while the theoretical mass is 7,757 Da.  These theoretical values also 
compare well with the experimental results of 1294.5 m/z for +6, 1552.8 m/z for +5 and 
1940.7 m/z for +4 and a mass of 7,759 Da.  Of significance, is that the conversion of Cd7-
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βα-rhMT into Cd8-βα-rhMT leads to an increase in the relative intensity of the +6 charge 
state from 38% to 55% and a decrease in the absolute intensity of the +5 charge state.  
These changes in intensity may be attributed to an increase in the overall volume of the 
protein necessary to accommodate the binding the 8
th
 Cd
2+
 ion (48-49). 
The effect of the addition of the 8
th
 cadmium ion was also analyzed using both UV 
absorption and CD spectroscopy to determine the effects of this additional ion on the 
metal-thiolate cores.   The UV absorption spectrum did not change significantly upon 
formation of Cd8-βα-rhMT (Figure 6-2C).  This was observed previously for the 
formation of the supermetalated Cd4-β-rhMT and Cd5-α-rhMT (38-39).  The lack of 
change in the UV absorption profile with the addition of an 8
th
 Cd
2+
 ion is likely related 
to the necessity for the formation of only bridging interactions. 
Addition of 1 molar equivalent Cd
2+
 led to significant changes in the CD spectrum 
(Figure 6-2D).  The original maxima and minima of 260 and 239 nm observed for Cd7-
βα-rhMT were replaced by maxima and minima of 252 nm and 238 nm, respectively.  
Significant reduction in the intensity of the maxima located at 225 nm was also observed. 
Two isodichroic points are observed throughout the titration at 260 and 241 nm and 
provide evidence for the direct conversion of Cd7-βα-rhMT to Cd8-βα-rhMT.  For Cd7-
βα-rhMT the maximum at 260 nm was broad suggesting that the traditional structure is 
flexible and exists as a mixture of conformations.  However, upon supermetalation of 
Cd7-βα-rhMT to form Cd8-βα-rhMT the maximum blue shifted to 252 nm and the 
intensity increased by 50%.  The increase in intensity may be attributed to a decrease in 
the conformational flexibility of the protein, while the blue shift can be associated with 
the metal ion directly interacting with the metal-thiolate core.  These changes to the CD 
envelope provide strong evidence that the 8
th
 Cd
2+
 atom coordinates to both the β- and α-
domain.   
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Figure 6-2. Spectrometric and spectroscopic evidence for the existence of Cd8-βα-
rhMT.  ESI-MS spectra of (A) Cd7-βα-rhMT and (B) Cd8-βα-rhMT with 0.0 and 2.8 
excess molar equivalents of CdSO4, respectively.  The charge states marked with an 
asterisk(*) are the result of a small fraction of truncated protein.  (C) UV absorption 
spectra of Cd7-βα-rhMT and Cd8-βα-rhMT with 0.0 and 2.8 excess molar equivalents of 
CdSO4, respectively.  (D) CD spectral changes observed during the incremental titration 
of Cd7-βα-rhMT with CdSO4 to form Cd8-βα-rhMT.  Aliquots of CdSO4 were added to 
solution in mole equivalents (based on the whole protein) of 0.00, 0.03, 0.06, 0.13, 0.19, 
0.44, 0.62, 0.80, 0.99 and 1.35.  The inset (D) shows the change in absorbance at 252 nm 
as a function of Cd
2+
 added to solution.  Past the addition of one molar equivalent Cd
2+
, 
there is no change in the CD spectrum.  
  
The inset in the CD titration (Figure 6-2D) shows that no change in the absorbance at 
252 nm is observed after a single molar equivalent of Cd
2+
 has been added to solution of 
Cd7rhMT.  We interpret the maxima at 252 nm to be exclusively the result of the Cd8-βα-
rhMT species.  Cd7-βα-rhMT binds the additional Cd
2+
 ion with a significantly greater 
affinity than either Cd3-β-rhMT or Cd4-α-rhMT binds the additional Cd
2+
 to form their 
respective supermetalated species (38-39). 
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6.3.2 One dimensional 113Cd NMR spectroscopy of Cd7- and Cd8-βα-
rhMT 1a 
Direct 1D 
113
Cd[
1
H] NMR spectra were measured for a mixture of Cd7/8-βα-rhMT, a 
result of a slight excess of Cd
2+
 to increase resistance to oxidation, and a pure sample of 
Cd8-βα-rhMT in order to determine the relative speciation of the individual metal binding 
sites as well as the type of coordinating ligands through chemical shift data.  In the Cd7/8-
βα-rhMT spectrum, peaks 1, 5, 5’, 6 and 7 correspond to the α-domain, while peaks 2, 3 
and 4 correspond to the β-domain (50).  Signals observed for Cd7/8-βα-rhMT (Figure 6-
3A) include resonances at 673, 668, 650, 647, 631, 629 and 621 ppm, where the 
resonances at 673, 631, 629 and 621 ppm result from the α-domain and 668, 650 and 647 
ppm result from the β-domain.  An additional peak labeled(*) and located at 680 ppm has 
been previously observed and is likely the result of the presence of some metal-based 
heterogeneity in the Cd7-βα-rhMT. This assignment is based, in part, on previous NMR 
work of human liver Cd-MT 1 by Boulanger and Armitage (50).  The observed signals 
for the pure Cd8-βα-rhMT (Figure 6-3B) are 690, 647, 637 and 595 ppm.  The chemical 
shift range of all the peaks is between 590 and 700 ppm, which overlaps significantly 
with the region expected for tetrahedral cadmium-thiolate clusters (51).  This region is 
commonly found for the NMR spectra of Cd-metallothioneins, as well as both trigonal 
cadmium thiolate and tetrahedral cadmium-thiolate clusters where a single sulfur has 
been replaced by water, or opportunistic chloride ion (52).  No signals in the range of 200 
to 250 nm were observed, which had been previously observed for supermetalated Cd5-α-
rhMT (38). 
Direct detection of 
113
Cd in the binding site allows one to infer the fluctionality of the 
individual metal sites.  Analysis of the spectrum in Figure 6-3A shows that resonances 
attributed to the β-cluster are significantly less intense than those attributed to the α-
cluster.  Previous NMR studies involving both domains have shown the α-domain is less 
fluctional than the β domain leading to sharper peaks of greater intensity for the α-
domain (50).  Addition of excess 
113
Cd
2+
 eliminates the spectral complexity associated 
with the two isolated domains.  The loss of all seven unique Cd
2+
 signals associated with 
the Cd7-MT and the formation of four unique peaks, strongly suggests that the addition of 
the singular Cd
2+
 to Cd7-βα-rhMT leads to the loss of the isolated clusters in favor of a 
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coalesced, single domain of a ‘super cluster’.  While all four peaks are of similar size, 
and intensity, the signal located at 647 ppm is slightly broader and less intense.  This 
suggests that the metal-ion associated with this binding site is more solvent exposed and 
fluxional.  Consequently, it is likely that this smaller broader peak is the most likely 
candidate for the site of metal loss in the metal-exchange intermediate, allowing both the 
solvent and acceptor/donor proteins access to the metal-ion.  The sharpness of the 
spectral lines further supports the interpretation of CD spectroscopic data that the maxima 
blue shift between Cd7-βα-rhMT and Cd8-βα-rhMT, with an increase in intensity of 50%, 
is the result of a reduction in the fluctionality of the protein. 
 
Figure 6-3. Direct 1D 
113
Cd[
1
H] NMR spectrum (133 MHz) of (A) a mixture of 
Cd7-βα-rhMT and Cd8-βα-rhMT and (B) Cd8-βα-rhMT formed by addition of 
excess 
113
CdCl2.  The Cd7/8-βα-rhMT was prepared in 5 mM ammonium formate pH 8.3 
and buffer exchanged into 30% D2O.  Because of the slight excess of 
113
Cd
2+
, a portion of 
the sample has been converted to Cd8-βα-rhMT leading to the formation of additional 
peaks at 682 and 595 ppm.  Subsequent addition of crystalline 
113
CdCl2 to Cd7/8-βα-rhMT 
led to the formation of Cd8-βα-rhMT, which greatly simplifies the spectra reducing it to 4 
peaks.  Spectra of Cd7/8-β-rhMT and Cd8-β-rhMT were acquired at room temperature. 
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6.3.3 Two dimensional 1H[113Cd]HSQC NMR spectroscopy of both 
Cd7- and Cd8-βα-rhMT 1a 
Indirect 
1
H[
113
Cd] HSQC NMR spectra were measured for both Cd7-βα-rhMT and 
Cd8-βα-rhMT (Figure 6-4).  Analysis of the β protons of the cysteine residues allowed 
determination of peak relatedness.  Peaks were interpreted as related based on similarity 
in both the 
1
H and 
113
Cd chemical shifts. In the case of Cd7-βα-rhMT (Figure 6-4A), both 
signals 1 and 2 have the same overall profile as those of the isolated domains, and are 
attributed to the α- and β-domain, respectively.  Signals 3 and 4 result from the remaining 
two cadmium ions found in the β-domain and are significantly downfield compared to 
their counterparts found in the isolated domains (isolated β-domain 630 and 616 ppm 
compared with the full protein 650 and 647 ppm) (39).  We interpret this difference as the 
result of the effect of the α-domain on the chemical shifts of the β-domain.  Signals 5 and 
5’ are both attributed to the same cadmium atom found in the α-domain and have a 
similar cysteine β proton profile.  Signals 6 and 7 both correspond to α-domain and have 
similar chemical shifts to those of the isolated α-domain (isolated α-domain 626 and 611 
ppm compared with the full protein 629 and 621 ppm) (38). 
The loss of cluster identity when Cd7- is converted into Cd8-βα-rhMT (Figure 6-4B) 
significantly simplifies the spectra and the addition of the 8
th
 metal ion results in dramatic 
changes to the β proton profile of all peaks.  These changes indicate that there are 
significant structural rearrangements taking place to accommodate all metal ions.  
Interestingly, no signal was observed in the 245-215 ppm region that had previously been 
assigned to the supermetalated Cd(RS)2(OH2)4 of the α-domain.  This suggests that the 
supermetalated cadmium ion found in Cd8-βα-rhMT is directly coordinated to at least 3 
cysteine residues.  With the exception of the previously mentioned Cd(RS)2(OH2)4, the 
previously reported 
113
Cd NMR data for the  supermetalated isolated domains have 
exactly four 
113
Cd
2+
 signals located between 700-600 ppm and the tentative assignment of 
peak identity for the Cd8-rhMT 1 was based upon this similarity (38-39). 
  Note that supermetalation of the β-domain leads to an inversion of the location of the 
3 and 4 peak, such that 4 is found further downfield than 3.  The β proton profile of Cd8-
βα-rhMT is somewhat more complex than either isolated domain, indicating overlap of 
the profiles of both domains.  It should be noted at this time that there are two reasons 
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why we have not assigned a specific cysteine residue to each 2-D signal: the first is that 
signals associated with the β-domain are significantly less intense than those associated 
with the α-domain and their overlap further complicates the spectra, the second reason is 
that in order to conclusively assign the identity of the peaks, one would require a 
complete backbone assignment.  This type of assignment has been not been carried out 
yet for human MT-1a.  
Figure 6-5 provides a graphical comparison of the NMR data for MT isoforms 1-3, as 
well as the supermetalated data for both Cd-MT and its isolated domains.  The value of 
this figure is that it shows the NMR range where MT-cadmium-thiolate clusters are 
found.  The presence of the 8
th
 cadmium atom causes both the β- and α-domains to adopt 
supermetalated character.  This is strong evidence that this 8
th
 cadmium atom is 
coordinated to Cys previously in both domains.  Also important to this figure is the 
observation that all NMR peaks, with the exception of supermetalated Cd5-α-rhMT, fall 
between 700 and 590 ppm.  It can be clearly seen that Cd8-βα-rhMT, Cd5-α-rhMT and 
Cd4-β-rhMT all exhibit nearly identical 
113
Cd signals in the 700-590 ppm range.  This was 
a surprising result since it had been previously thought that supermetalation of the full 
protein would lead to either 9 unique signals, indicative of Cd9-βα-rhMT 1a, or 
alternatively would only alter the metal binding sites of one of the two domains.  We 
interpret this overlap to mean that supermetalation of the isolated domains is in fact the 
result of residual metal binding capacity. This is supported by CD titrations of all three, 
where the isolated β- and α-domains require an excess of Cd2+ to supermetalate and the 
full protein is completely supermetalated at exactly 1 equivalent (Figure 6-2).  
Consequently, we propose based on these experimental results, that Cd8-βα-rhMT 1a 
adopts a new MT structural motif that requires the coalescence of both domains to a 
single binding domain. 
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Figure 6-4. Indirect 2D 
1
H[
113
Cd] HSQC NMR of (A) Cd7-βα-rhMT 1a and (B) 
Cd8-βα-rhMT 1a formed by addition of excess 
113
CdCl2.  While a total of eight peaks 
exist for Cd7-βα-rhMT, it can be clearly seen that 5 and 5’ have similar proton profiles.  
This heterogeneity has been previously reported by Boulanger and Armitage and is 
attributed to a slight difference in two structural conformers of the protein (50).  The 
signals in (B) are the labeled based upon the assignments of the isolated Cd4-β-rhMT and 
Cd5-α-rhMT (38-39).  The peak labeled 7/S is what we consider to be the site of 
supermetalation and we believe that this may represent a tetrahedral geometry 
coordinating either four thiolates or three thiolates and a single water molecule/chloride 
ion. 
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Figure 6-5. Comparison of the 
113
Cd NMR resonances for the human MTs: Cd7-
βα-MT 3 (21), Cd7-βα-MT 2 (50), Cd7-βα-MT 1a (50), supermetalated Cd8-βα-rhMT 1a 
(this work), Cd3--rhMT 1a (39), supermetalated Cd4--rhMT 1a, Cd4--rhMT 1a and 
supermetalated Cd5--rhMT 1a (38).  Note the significant overlap in the location of 
signals associated with both isolated domains of MT and the full protein.  The sole 
exception to this similarity is the presence of a single peak at 224 ppm associated with 
supermetalated Cd5--rhMT, which is both absent from supermetalated Cd4--rhMT and 
supermetalated Cd8-βα-rhMT. 
6.4    Discussion 
 For the last sixty years, MT has been proposed to be involved in metal homeostasis, 
toxic metal detoxification and in the protection of organisms against oxidative stress (8).  
And while it is likely that MT is involved in all three of these processes, the exact cellular 
function(s) have never been determined.  Critical to these roles are MT’s ability to act as 
a metallochaperone capable of coordinating incoming metal ions and exchanging them 
with the cellular environment.  Indeed several studies have demonstrated the importance 
of MT in both donating to and accepting metal ions from other metalloproteins (42-44).  
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These studies have highlighted the importance of protein-protein interactions, but a 
metal-exchange intermediate has not been observed.  Several studies have documented 
the preference of the β-domain for Cu+ ions and the α-domain for Zn2+/ Cd2+ ions (23, 45, 
53).  Since Zn
2+
 coordination dominates mammalian MT (54), an incoming metal of 
higher binding affinity (Cd
2+
 or Cu
+
) must either 1) coordinate in a domain specific 
manner, or 2) coordinate through either domain with a subsequent redistribution of 
metals leading to the observed metal-domain preferences.  Copper luminescent studies of 
MT have provided evidence for a fluctional model of the protein, in which initial 
metalation occurs in a distributed manner, statistically across both domains, followed by 
a rearrangement of both clusters to their lowest energy conformers (25, 28).  However, 
this model would require an intraprotein intermediate, in which both domains exchange 
metals with each other.  To date both the β- and α-domains of fully metalated MT are 
considered isolated, because of both a lack of interdomain NOEs and the independence of 
their respective 
113
Cd signals in NMR studies (10, 20, 55).   
6.4.1 Location of the eighth Cd2+ ion in Cd8-βα-rhMT 1a 
We report here, for the first time, conclusive evidence for the presence of domain-
domain interactions in fully metalated MT from experimental observation of a species in 
which one Cd
2+
 is proposed to bridge both domains.  Formation of Cd8-MT species 
results in the loss of specific  and  domain character and the formation of a single, 
Cd8Cys20 domain.  This supermetalated species provides evidence for the type of 
intermediate that is critically important in the metal exchange pathway necessary for the 
observed domain selectivity of metal ions.  Implicit in this structure is the existence of a 
‘super domain’, where both domains contribute cysteine residues to produce a single 
Cd8Cys20 cluster in MT 1a.  This supermetalated structure has been effectively ‘frozen’ 
by the higher binding constant of Cd
2+
, compared with Zn
2+
, and is likely critical in the 
metal exchange reactions necessary for MTs role as a metallochaperone.  
Initial ESI-MS studies of the apo-protein of MT provided the first evidence that the 
Cd7-βα-rhMT species was able to supermetalate to form Cd8-βα-rhMT (32).  However, 
prior to this report it was unclear whether this additional metal was bound to either metal-
thiolate core found in the protein, or if the 8
th
 Cd
2+
 was somehow bound to other ligands.  
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The coupling of both spectroscopic and spectrometric analyses (Figure 6-2) demonstrates 
that the addition of only a single equivalent of Cd
2+
 to the fully metalated Cd7-rhMT 
protein causes structural changes, which lead to a significant changes in the  symmetry of 
the eight Cd
2+
 bound in the cluster.  This rearrangement breaks the symmetry of both 
original clusters, observed from the simultaneous loss of exciton coupling in the CD 
spectrum, but with little change in the ligand-to-metal charge transfer profile.  ESI-MS 
spectral data also show that only a single Cd
2+
 ion is found to coordinate to the protein, 
and further that this additional metal ion causes an increase in the relative intensity of the 
+6 charge state compared with the +5 charge state.  This suggests that the protein must 
adopt a significantly larger structure to accommodate the additional metal ion.  The 
observation of two simultaneous isodichroic points during the CD titration of Cd7-βα-
rhMT with Cd
2+
 is evidence for the direct conversion of Cd7-βα-rhMT to Cd8-βα-rhMT 
with no intermediate structures (Figure 6-2D).  The location of the 
113
Cd-NMR chemical 
shifts demonstrates conclusively that the additional metal directly interacts with the 
metal-thiolate core and that this metal ion greatly simplifies the seven unique Cd
2+
 sites 
to four unique Cd
2+
 sites.  Taken together these results demonstrate that supermetalation 
of MT 1a with Cd
2+
 leads solely to the formation a bridged Cd8Cys20 structure as the final 
product of metalation. 
Based on the previous stoichiometric data for the isolated supermetalated domains of 
Cd4-β-MT and Cd5-α-MT it would be reasonable to predict that the supermetalated full 
protein would involve 9 Cd
2+
 ions.  However, only Cd8-MT was actually formed.  This 
now allows us to propose that the two-domain structure does not exist generally for all 
metal loadings, rather only for specific metal loadings.  For Zn
2+
 and Cd
2+
 this would 
occur at 7 metals per MT protein. 
In addition to Cd-hMT-1a, Cd-hMT-3 has also been confirmed to supermetalate by 1-
D 
113
Cd NMR spectroscopy (40).  Cd-hMT-3 is primarily found in the central nervous 
system and, unlike MT-1a and -2, its expression is strictly controlled (12-13).  In the 
central nervous system MT-3 is thought to control metal ion homeostasis and has been 
shown to be downregulated in some Alzheimer’s patients (14). Unlike Cd-hMT-1a, the 
supermetalated NMR spectra of Cd-hMT-3 does not simplify to four peaks.  Moreover, 
the CD spectrum of MT-3 does not exhibit a loss of exciton coupling found in the 
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supermetalation of MT-1a.  However, the formation of supermetalated Cd-hMT-3 does 
result in a decrease in the Stoke’s radius of this protein, which suggests the mutual 
approach of the two domains.  We should note that neither Meloni et al. studying Zn7-
MT-2 using both spectroscopic and spectrometric techniques (40) nor Stillman et al. 
studying rabbit liver Cd7MT 2a by CD spectroscopy (56) found that MT-2 was capable of 
supermetalation.  These differences between isoforms may be critical to the cellular role 
of each MT isoform.  It is probable that supermetalated structures of Cd-hMT-1a and -3 
are different.  Based on these observations, we postulate that the ability of an MT isoform 
to supermetalate and the subsequent structure formed from this process are factors that 
lead to the differentiation of each isoform (MT-1a,-2,-3 and -4) into specific functions in 
cellular chemistry. 
6.4.2 The proposed mechanism of metal ion homeostasis 
This metal exchange structure could have significant consequences for both the metal 
ion homeostasis and toxic meal detoxification properties of an organism.  Previous 
studies, using CD, UV and NMR spectroscopies have shown that Cd
2+
 binding to both 
apo-MT or Zn7-MT leads to the formation of Cd7-MT with almost identical absorption 
and CD properties (23, 56-57).  These experiments suggest that regardless of initial status 
of the MT it is capable of assuming the same conformation when fully metalated.  When 
the protein is fully metalated, such as Zn7-MT, the incoming metal ion must be able to 
coordinate and expel a previously bound Zn
2+
.  In the case of Zn7-MT, the formation of a 
transient M1Zn7-βα-rhMT 1a can be envisioned as an exogenous Cd
2+
, or Cu
+
, ion 
coordinating to Zn7-βα-rhMT 1a, bridging both domains with subsequent rearrangement 
and expulsion of a previously bound Zn
2+
 ion.  The net effect would be 1) metal ion 
selectivity (for example, Cu
+
 in the β-domain and Zn2+/Cd2+ in the α-domain) and 2) 
upregulation of metallothionein allowing an organism to effectively combat toxic metal 
exposure.  A regulator of metallothionein transcription, the metal-responsive-element-
binding transcription factor-1 (MTF-1), has been shown to upregulate metallothionein 
upon binding to Zn
2+
 ions (58-59).  MTF-1 has been implicated in cellular responses 
including toxic metal detoxification and oxidative stress, both of which are implicated 
functions of metallothionein.  The metal binding site of this transcription factor includes 
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six Cys2His2 zinc fingers, making it exceptionally sensitive to an organism’s zinc load.  
Cell free transcription experiments have shown a number of stresses, including exposure 
to Cd
2+
, Cu
+
 and H2O2 function by displacing naturally bound  Zn
2+
 from MT (60).  
These free Zn
2+
 ions bind to MTF-1 leading to a translocation of MTF-1 from the 
cytoplasm to the nucleus where the Zn-MTF-1 interacts with metal response elements 
(MREs) leading to upregulation of MT.  In this way, MT is capable of countering and 
deactivating a wide range of insults in order to return an organism to homeostatic 
balance. 
For this reason, supermetalation, in the context of toxic metals, may be a critical 
transient species in the regulation of transcription of the protein.  An incoming toxic 
metal, such as Cd
2+
, could coordinate in a supermetalated position allowing both 
sequestration of the toxic metal and release of a Zn
2+
 ion.  This Zn
2+
 ion would 
consequently lead to the upregulation of MT, through the Zn
2+
 binding motifs of MTF-1, 
allowing an organism to effectively combat toxic metals.  Through this mechanism, 
supermetalation of metallothionein, the organism would be able to control cellular metal 
load. 
Surprisingly, we did not observe any evidence for the existence of a Cd9-βα-rhMT 
species, which had previously been suggested to exist based on the summation of the 
metalation status of the individual supermetalated β- and α-domains.  These observed 
supermetalated states, Cd4-β-rhMT and Cd5-α-rhMT, are likely the result of the residual 
metal binding capacity necessary for both domains to work in concert to form Cd8-βα-
rhMT.  Unlike other metalation studies, which reported the collapse of the two domain 
structure, for example Hg- and Ag-MT, supermetalation to Cd8-βα-rhMT does not require 
a change in coordination number of the metal ion (29, 61-62). 
We have calculated a tentative model based on all eight Cd
2+
 ions being tetrahedrally 
coordinated to four cysteine residues, which leads to a complete collapse of the two-
domain structure (Figure 6-6A).  While qualitative in nature, the structure presented 
shows how the addition of the 8
th
 Cd
2+
 ion leads to the complete loss of cluster identity 
(Figure 6-6B).  Through supermetalation, the bridging of both domains provides the 
intraprotein interactions necessary for metal ion selectivity.  The coordination of the 8
th
 
Cd
2+
 ion in this model accounts for the absorption, CD and NMR spectral data of Cd8-βα-
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rhMT.  In the case of the CD titration, supermetalation of MT essentially locks the two 
domains in place resulting in a loss of conformational freedom and explains increased 
sharpness of the Cd8-MT spectra.  In the case of the NMR spectra, the complete collapse 
of the Cd7-MT spectra is the result of loss of cluster identity upon binding of the 8
th
 Cd
2+
 
ion. 
Much current research on MT include its interaction with metal based anticancer 
drugs, such as cisplatin (63).  In these cases, MT has been implicated as a cause for the 
development of cisplatin resistant cancers (64-66).  Karotki and Vasak have found that 
the binding of Pt
2+
 to MT occurs via a two step reaction and further that the β-domain is 
the preferred site of coordination.  In the context of supermetalation, initial coordination 
likely leads to a coalescence of both domains with subsequent ejection of one of the 
previously bound metals of the β-domain (67).  These researchers have also characterized 
a previously unknown DNA-cis-Pt-MT ternary structure, where coordination of the DNA 
bound cisplatin does not lead to the release of significant Zn
2+
 in Zn7-MT.  These results 
suggest that coordination occurs in a site specific manner through two sets of solvent 
exposed cysteine residues found in the β- and α-domain (68). The role of supermetalation 
in the initial coordination of metal-based chemotherapeutics may be of significant 
importance for the development of future chemotherapeutics.  
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Figure 6-6. Molecular model of a possible structure for supermetalated Cd8-βα-
rhMT 1a.  A) Ribbon structure of the backbone of Cd7-βα-rhMT and Cd8-βα-rhMT with 
the cadmium atoms represented as spheres calculated using a locally modified force-field 
with MM3/MD methods for molecular modeling. The N-terminal β domain is located on 
the left hand side, while the C-terminal α domain is located on the right-hand side. (B) 
The cadmium-cysteinyl-thiolate clusters of Cd8-βα-rhMT 1a are presented as a ball-and-
stick model: β domain (left) and α domain (right).  The structure was created by inserting 
an additional Cd
2+
 ion between the two domains, and minimizing the structure in two 
steps: 1) 1000 ps at 500 K, and 2) 5000 ps at 300 K.  The conformer with the lowest 
energy is presented above.  The initial structure of the Cd7-βα-rhMT 1a was provided by 
Chan et al. (22). 
 
It is now becoming evident that MT has a significant role in the body’s response to 
neuroinflammation (69).  Recently, a report by Manso et al. has demonstrated that the 
full MT-1 was able to improve the performance of MT knockout mice whose cortex had 
been damaged through cryoinjury (70).  Most interestingly, the authors report that 
exposure of the mice to the isolated MT fragments, β and α, result in markedly different 
recovery rates compared to the full βα-protein.  While the exact mechanism of action is 
not known, it could be postulated that supermetalation of the full protein, which has 
significantly greater affinity than either of the two isolated domains, is the causative 
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agent in recovery. Thus full MT acts as a superior metallochaperone when compared to 
the isolated domains. 
6.5 Conclusion 
In summary, the collapse in the number of unique 
113
Cd-NMR peaks from seven to 
four, the significant changes in the CD spectral envelope and the quantitative formation 
of Cd8-βα-rhMT, and not Cd9-βα-rhMT, are paradigm shifting with respect to the 
structural motifs in metallothionein.  The spectroscopic evidence reported in this paper 
indicate that the β- and α-clusters act in isolation under only very specific metalation 
conditions.  The supermetalated Cd8-rhMT 1a protein adopts a novel single domain 
structure suggesting that the well-known two-domain structure might be the special case 
in the metal-dependent structural landscape of MTs.  Further, with these results we are 
now able to account for both the ability of MT to exchange metals with the solution and 
the observed metal ion selectivity of the individual domains. 
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Chapter 7. Conclusion
7
 
Metallothionein is a small cysteine rich protein, which was first isolated more than 
sixty years ago (1).  In that time, it has been implicated in a number of roles, including 
toxic metal detoxification, metal ion homeostasis, and as a protective agent against 
oxidative stress (2).  MT is found in all organisms and has been isolated from a number 
of sources (3).  It is therefore quite surprising that while there exists a significant body of 
evidence to support all three roles, the exact in vivo function(s) of MT and its associated 
binding partners is not known.  Two potential reasons for this lack of specific function(s) 
includes: 1) an ambiguous mechanism of metalation, and 2) a lack of metal binding 
motifs.  In the first case, the mechanism of metal binding seriously impacts both the 
ability of MT to act as a dynamic metallochaperone, and the biologically relevant 
partially metalated states of the protein.  If MT were to coordinate metals in a cooperative 
manner, then partially metalated forms of the protein would be unstable and unlikely to 
take part in cellular chemistry.  As such, only the fully metalated (Zn7-MT) and apo 
forms of the protein are biologically relevant.  Indeed to address the lack of an exact 
function, much research has recently focused on the metalation chemistry of the apo form 
of the protein (4-7). 
MT has also been traditionally considered a two-domain protein.  The structure has 
always been thought to contain two independent metal-binding domains: an N-terminal 
β-domain, which can bind 3 Zn2+, Cd2+, or 6 Cu+ ions, and a C-terminal α-domain, which 
can bind 4 Zn
2+
, Cd
2+
, or 6 Cu
+
 ions.  The most well known mammalian form is Zn7-MT 
(8-10), and Zn
2+
 is the dominant metal found in human MT. Cu
+
 is also found, 
particularly in fetal MT, and finally also Cd
2+
, due to environmental exposure(11).  But in 
all three cases, metalation is thought to involve two independent metal-binding domains.  
Most interestingly, there exists no metal-exchange intermediate to account for these 
metalated forms.   
                                                 
7
 A version of this work is in preparation 
D.E.K. Sutherland, K.L. Summers and M.J. Stillman (2012). 
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The research in this thesis demonstrates that the mechanism of metalation is 
noncooperative (12-14).  Consequently, partially metalated forms of the protein are stable 
and may take part in cellular chemistry.  Information regarding the metal-binding 
mechanism was extracted from the analysis of the metalated states of the isolated 
domains, and full MT protein, in the presence of sub-stoichiometric amounts of Zn
2+
, or 
Cd
2+ 
(12).  In this way detection of only the fully metalated and the metal-free protein 
would indicate a cooperative mechanism, while the formation of a mixture of 
intermediate partially metalated species would indicate a non-cooperative mechanism of 
metalation.  The results presented in this thesis on the metalation of apo-α-, apo-β and 
apo-βα-rhMT 1a with sub-stoichiometric concentrations of Cd2+ , or Zn2+, at slightly 
basic pH showed the formation of stable, partially-metalated domain species as detected 
by ESI-mass spectrometry (Chapters 3 and 4).  These results unequivocally confirmed a 
non-cooperative metalation mechanism for both Cd
2+
 and Zn
2+
.  
The work presented here also provides evidence for the existence of at least 2 
additional and previously unknown motifs of metalation.  A thorough understanding of 
all possible metal binding motifs of MT is essential for a complete understanding of the 
in vivo functions of MT.  For example, Zn7-MT is often cited as cellular buffer against 
toxic metals, Cd
2+
 and Hg
2+
.  In this case, an incoming metal ion of greater affinity than 
the resident zinc will coordinate forming a transient M1Zn7-MT, where M is the incoming 
metal ion, with concomitant rearrangement and expulsion of the previously bound Zn
2+
 
ion to form M1Zn6-MT.  To date no known metal exchange intermediate has been 
discovered and it is unknown exactly how MT reaches equilibrium with the metal ions in 
the cell.  Furthermore the mechanism by which MT can selectively isolate different metal 
ions into both domains (Zn
2+
 and Cd
2+
 prefer the α-domain, while Cu+ prefers the β-
domain) is not known, but is of critical importance to the function of MT (15-16).  This 
question also has practical implications since MT overexpression is thought to be a 
mechanism that allows cancer cells to overcome metal based chemotherapeutics, for 
example cisplatin (17-19).  The only partially metalated form that has previously been 
described as relevant is one in which the α-domain is completely metalated (4 Zn2+ ions) 
and the β-domain is completely demetalated (0 Zn2+ ions) (20).  However, with a 
noncooperative mechanism of metalation, all partially metalated structure may be stable, 
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depending on metal ion availability, and a thorough understanding of each is a 
prerequisite for a complete understanding of the roles of MT during Zn
2+
 deficiency.   It 
is, therefore, highly unlikely that one domain would be filled, while the other remains 
empty.  More likely is a reversion of the protein to a partially metalated motif, which 
could incorporate cysteine residues from both domains to bind the metal ions.  
In this thesis, the mechanism of metal binding and the subsequent structural motifs 
formed in MT 1a were investigated.  Three proposals naturally fall from these results:  1) 
The mechanism of metalation is in fact always noncooperative, meaning that the partially 
metalated forms of the protein are stable and could potentially take part in cellular 
chemistry, and 2) two additional metal binding motifs of MT exist, the first is a 
supermetalated form of the protein, where an eighth Cd
2+
 ion is coordinated to both 
domains, and the second is a submetalated form of the protein, where five Zn
2+
 ions are 
each coordinated to four terminal thiol groups, where terminal thiol groups defines a 
cysteine residue coordinated to only a single metal ion.  Taken together, these results 
fundamentally alter our understanding of the metalation properties of the protein by not 
only demonstrating that, in fact, all partially metalated forms of the protein are stable and 
the dominant species is directly dependent on the concentration of metal ions present, but 
also that cluster formation occurs only upon the addition of the sixth Zn
2+
 ion and further 
that addition of excess Cd
2+
 leads to the formation of a novel Cd8-MT species.  This latter 
species is of particular interest, since the addition of Cd
2+
 to Zn7-MT leads to the mixed 
metals species until 7.0 molar equivalents have been added at which point Cd7-MT exists.  
We postulate that Cd8-MT is in fact a ‘frozen’ metal-exchange intermediate that is 
observable due to the higher association constant of Cd
2+
 compared to Zn
2+
.   
In order of significance we have discussed above: Noncooperativity.  This led to the 
understanding that partial metalation was stable and, therefore, able to take part in 
cellular chemistry.   
Sub-saturated metalation. In Chapter 4, we demonstrated that the onset of cluster 
formation, which is defined by the use of bridging Cys thiolate ligands rather than 
terminal Cys, leads to a significant decrease in the Zn
2+
 binding affinity to MT and its 
domains for further metalation.  The switch from terminal to bridging Cys to 
accommodate an increase in Zn
2+
 in the binding sites reduces the binding affinity.  These 
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mass spectral data allow us to conclude for the full MT protein that the decreasing 
association constants necessary for a noncooperative mechanism of metalation allow 
formation of a stable Zn5-βα-rhMT species, which contains no bridging interactions.  
This is a single binding site domain and is mechanistically a key member of the 
metalation pathway from apo-MT to the fully metalated Zn7-MT.  In addition, we have 
used this model to reinterpret the Co
2+
 titration of MT(21).  By allowing for the existence 
of a non-clustered Zn5-MT intermediate, we were able to reproduce the data presented by 
Vasak and Kagi, and more importantly, reinterpret their data in the context of a 
noncooperative mechanism of metalation.   
Supermetalation. To date, all reports regarding the speciation of the mammalian MT 
protein state a maximum of seven Cd
2+
 or Zn
2+
 ions coordinating 20 cysteinyl thiolate 
ligands.  These metal ions are divided between the β-domain (3 Cd2+ or Zn2+) and α-
domain (4 Cd
2+
 or Zn
2+
). The work in Chapters 5 and 6, as well as a previous report By 
Rigby-Duncan et al. (22), have shown that human MT-1a isoform is capable of 
expanding its cluster to accommodate an eighth Cd
2+
 ion by the addition of 1.0 molar 
equivalents excess of Cd
2+
 ions to solution (Chapter 6)(23).  Based upon the chemical 
shift range of the NMR spectra, the coordination geometry of this eighth site is predicted 
to include tetrahedral geometry coordinating cysteine residues from both domains.  In 
addition, the breaking of exciton coupling in the CD spectra would suggest that this 
eighth metal ion is directly interacting with the metal-thiolate clusters of both domains.  
The existence of a supermetalated state for the α-domain had been previously determined 
(24).  When combined with the ability of the β-domain to supermetalate, it had been 
previously predicted that supermetalation of the full protein would include two additional 
Cd
2+
 ions binding to both domains.  It was therefore quite surprising that only a single 
Cd
2+
 ion bound to form Cd8-MT.  This result is critically important because this structure, 
for the first time, provides definitive evidence for the existence of domain-domain 
interactions.  When the protein is fully metalated, such as Zn7-MT, the incoming metal 
ion must be able to coordinate and expel a previously bound Zn
2+
. These interactions 
provide a rationale for two important features of MT: metal ion equilibration with cellular 
environment, and the ability for each domain to discriminate between metal ions (Zn
2+
 
and Cd
2+
 in the α-domain, and Cu+ in the β-domain). 
167 
 
 
 
Figure 7-1. Molecular models of the metalation of apo- to Zn7-MT, then to Cd8-
MT. The first four structures represent the sequential metalation of apo-MT using Zn
2+
, 
while the last structure demonstrates the effect of the addition of 8 equivalents of Cd
2+
.  
The traditional two-domain structure of MT is observed in Zn6- and Zn7-MT.  However, 
prior to 6 molar equivalents of Zn
2+
 added, and following the addition of 8 molar 
equivalents of Cd
2+
, the two domain structure collapses.  Zn5-MT was created by 
coordinating 1 Zn
2+
 ion to every 4 consecutive cysteine residues with respect to the 
sequence.  Zn6-MT was created by removing a Zn
2+
 ion from the β-domain of MT.  Cd8-
MT was created by coordinating an additional 8
th
 Cd
2+
 ion to the exposed residues of 
both domains.  All structures were minimized in two steps: 1) 1000 ps at 500 K, and 2) 
5000 ps at 300 K.  The conformer with the lowest energy is presented above.  The initial 
structure of the Cd7-βα-rhMT 1a was provided by Chan et al.(25). 
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Concluding remarks.  The results presented in this thesis support a paradigm altering 
view of MT, in which the two-domain nature of metallothionein is, in fact, the 
exceptional case.  In the early stages of metalation, metal ions, such as Zn
2+
, bind MT in 
a noncooperative manner.  In the new model based on the experimental data described in 
this thesis, clustering, a key feature of MT, does not occur until all cysteine residues are 
bound terminally, that is after 5 Zn
2+
 have bound.  Following this, bridging occurs to lead 
to the more traditional two-domain structure.  Consequently, Zn5-MT, where all twenty 
cysteine residues of MT are terminally coordinating five Zn
2+
 ions, will not contain any 
free thiol groups.  MT is often considered a protective agent against oxidative stress.  A 
metallothionein redox cycle, connecting oxidants with the redox silent Zn
2+
, has been 
suggested to account for the protective role of MT in the cell.  Initially a ROS oxidizes 
MT leading to Zn
2+
 release.  This Zn
2+
 then acts to up regulates Zn-dependent proteins, 
through MTF-1, and subsequently reduction of MT using glutathione, or replacement 
with de novo synthesized MT and reestablishment of zinc homeostasis(26).  With these 
results, one can now begin to assess the redox potential of the differently metalated 
versions of MT (Zn1- to Zn5-MT), and how metalation of all the cysteine residues, 
forming Zn5-MT, affects its ability to act as a protective agent.  It is possible that the 
subtle control of the redox activity of Zn5-MT controls its biological activity - the change 
from terminal Cys to one free Cys (and therefore available SH groups) or additionally to 
a bridging Cys may be a low energy reaction allowing for active but controlled redox 
properties. 
Metallothionein has also been implicated in metal-ion homeostasis, and as a protective 
agent against toxic metal insults (2).   However, no metal-exchange intermediate has been 
isolated.  The results presented in this thesis now demonstrate that MT is capable of 
binding an additional eighth Cd
2+
 ion to form Cd8-MT (23, 27).  This species is stabilized 
due to the higher affinity of Cd
2+
 ions for thiols, compared with Zn
2+
 ions.  Unique to this 
structure is the bridging of both domains to coordinate the eighth metal ion.  We propose 
that when the protein is fully metalated, such as Zn7-MT, the incoming metal ion must be 
able to coordinate and expel a previously bound Zn
2+
.  In the case of Zn7-MT, the 
formation of a transient M1Zn7-βα-rhMT 1a can be envisioned as an exogenous Cd
2+
, or 
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Cu
+
, ion coordinating to Zn7-βα-rhMT 1a, bridging both domains with subsequent 
rearrangement and expulsion of a previously bound Zn
2+
 ion.   
Finally, we propose a metalation chart (Figure 7-1), which begins with metal-free MT, 
which progressively metalates to Zn5-MT, at which point there are no free thiols.  
Following this, the binding of the 6
th
 and 7
th
 Zn
2+
's leads to the formation of the more 
traditional two-domain structure.  MT is capable of coordinating eight structurally unique 
Cd
2+
 ions leading to the formation of Cd8-MT, where the two-domains have collapsed to 
form one ‘super-domain.’  The value of this diagram is that it shows progressive 
metalation of the protein, and highlights the early stages of metalation (apo- to Zn5-MT), 
which are important in the protection of an organism against oxidative stress, as well as 
the latter stages of metalation (Zn7- to Cd8-MT), which are important in protecting an 
organism against toxic metal insult and in maintain the metal ion homeostasis of an 
organism.   
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